Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,glutamate receptor activity (GO:0008066),-0.8106195634112112,-2.2163608837734587,0.0,0.0010096853723560594,0.001,11/19,8.22%,GRM7;GRID2;GRIA4;GRM3;GRIK2;GRM5;GRIK4;GRIA1;GRIK1;GRIA2;GRM8
prerank,transmitter-gated ion channel activity (GO:0022824),-0.6813025002943098,-2.139308477103753,0.0,0.001514528058534089,0.003,18/29,20.36%,GRID2;GRIA4;GRIK2;GRIK4;GABRA2;GABRB3;GABRA3;GRIK1;GLRA3;GABRA4;GRIA2;GABRB1;GABRG3;GABRB2;GRIK3;GABRA5;GLRA2;GABRA1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.7874311191078903,-2.138161350214471,0.0,0.0010096853723560594,0.003,12/17,9.11%,GRIA4;GRIK2;GRIN3A;GRIK4;PTK2B;GRIA1;GRIN2A;GRIK1;GRIA3;GRIN2B;GRIA2;GRIN1
prerank,ligand-gated ion channel activity (GO:0015276),-0.6841658706238054,-2.130896079010706,0.0,0.0007572640292670445,0.003,13/30,9.21%,GRID2;GRIA4;GRIK2;GRIN3A;GRIK4;GRIA1;GRIN2A;GRIK1;GRIA3;GRIN2B;GRIA2;GRIN1;GABRB1
prerank,ligand-gated channel activity (GO:0022834),-0.6883571052023975,-2.1261611586788667,0.0,0.0006058112234136356,0.003,13/29,9.21%,GRID2;GRIA4;GRIK2;GRIN3A;GRIK4;GRIA1;GRIN2A;GRIK1;GRIA3;GRIN2B;GRIA2;GRIN1;GABRB1
prerank,retinoid binding (GO:0005501),0.7851948803908174,2.088004736157905,0.0,0.006951202212040288,0.007,5/22,3.35%,ALDH1A2;RBP1;NR2F2;ABCA4;RBP4
prerank,cell adhesion mediator activity (GO:0098631),-0.6555045815415885,-1.9510991413325924,0.002325581395348837,0.013630752526806802,0.072,11/24,10.36%,LRRC4C;BSG;ESAM;CNTN4;CNTN6;BCAM;ROBO4;NPTN;JAM3;CNTN2;EMB
prerank,acetylation-dependent protein binding (GO:0140033),0.7398409264265401,1.9318803469155474,0.0,0.04799639622599247,0.117,10/20,15.46%,KMT2A;MLLT3;PHIP;BAZ2A;DPF2;TRIM24;PSME4;BRD4;CARM1;SMARCA4
prerank,lysine-acetylated histone binding (GO:0070577),0.7398409264265401,1.9318803469155474,0.0,0.04799639622599247,0.117,10/20,15.46%,KMT2A;MLLT3;PHIP;BAZ2A;DPF2;TRIM24;PSME4;BRD4;CARM1;SMARCA4
prerank,ligand-gated anion channel activity (GO:0099095),-0.6727764925792314,-1.8688669672618525,0.002304147465437788,0.03908924798692744,0.226,12/17,20.36%,GABRA2;GABRB3;GABRA3;GLRA3;GABRA4;GABRB1;GABRG3;GABRB2;GABRA5;GLRA2;GLRA1;GABRA1
prerank,cation:chloride symporter activity (GO:0015377),-0.794302430819798,-1.8628846110840074,0.0,0.036979726762540674,0.242,5/10,10.96%,SLC12A7;SLC12A2;SLC6A1;SLC12A5;SLC12A6
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.7535845130041086,1.8531560048436664,0.0018115942028985507,0.1360449575785028,0.382,4/15,9.22%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.6604702667195075,-1.8508494962264166,0.0,0.03892898046750585,0.277,10/19,16.66%,GRID2;GRIK2;GRIK4;GABRA2;GABRA3;GRIK1;GABRA4;GABRG3;GRIK3;GABRA5
prerank,phospholipase activator activity (GO:0016004),0.8283787177666386,1.8398776559254872,0.0,0.13068260158635744,0.439,2/10,0.50%,PDPK1;ARHGAP6
prerank,voltage-gated cation channel activity (GO:0022843),-0.4638113336897409,-1.839278890676619,0.0,0.041195163192127224,0.318,23/97,10.98%,KCNB2;KCND2;CACNA1E;KCNQ5;CACNB2;GRIN3A;KCNMA1;KCNH7;PTK2B;KCNC2;KCNQ3;CACNB4;HCN1;GRIN2A;OPRM1;GRIN2B;HCN2;KCNH1;KCNH5;GRIN1;KCND3;CACNA1D;KCNB1
prerank,phospholipase binding (GO:0043274),0.7729729902946714,1.8367317326200134,0.0,0.11337079798208566,0.45,2/13,0.50%,PDPK1;ARHGAP6
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5919736271586078,-1.822671084151199,0.0,0.046261947969768534,0.37,13/28,20.36%,GRID2;GRIK2;GRIK4;GABRA2;GABRA3;GRIK1;GABRA4;GABRG3;GRIK3;GABRA5;CHRNA4;CHRNA7;GABRA1
prerank,sialyltransferase activity (GO:0008373),-0.6279087280781983,-1.8104346122464368,0.0,0.05040012817010663,0.408,9/20,18.70%,ST6GALNAC3;ST8SIA4;ST3GAL6;ST8SIA6;ST6GALNAC4;ST6GALNAC5;ST3GAL4;ST6GAL2;ST8SIA5
prerank,lipase activator activity (GO:0060229),0.8183362412537318,1.804538215137917,0.002066115702479339,0.15533809024865544,0.593,2/10,0.50%,PDPK1;ARHGAP6
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.70093590759542,-1.7966181904810352,0.002183406113537118,0.05444534200166136,0.457,6/14,13.29%,KCNJ3;KCNJ2;KCND3;KCNJ8;KCNQ1;KCNE4
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.7613468973057165,1.7938788106409793,0.0018552875695732839,0.15280232005395705,0.635,4/13,9.22%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH2
prerank,glutamate receptor binding (GO:0035254),-0.663992321326706,-1.7931534885858917,0.0,0.05344120435113143,0.477,11/17,18.69%,SHANK3;HIP1;NSF;SYNDIG1;HOMER1;GNAS;SHANK2;CAMK2A;SHISA6;SHANK1;AKAP5
prerank,GABA receptor activity (GO:0016917),-0.6113615511829487,-1.7857659687815155,0.0022522522522522522,0.054321073032756,0.498,11/21,20.36%,GABRA2;GABBR2;GABRB3;GABRA3;GABRA4;GABRB1;GPR156;GABRG3;GABRB2;GABRA5;GABRA1
prerank,AMP binding (GO:0016208),0.7573368189389738,1.7606738319448176,0.003968253968253968,0.20004015254649277,0.765,2/11,1.15%,MPPED2;PRKAG2
prerank,chloride channel activity (GO:0005254),-0.4821917682941189,-1.7604690429943122,0.00273224043715847,0.06998381737142936,0.627,27/59,20.36%,SLC26A7;ANO1;GABRA2;ANO3;GABRB3;GABRA3;GLRA3;CLCN3;GABRA4;CLCN7;SLC1A4;ANO4;TTYH2;GABRB1;GABRG3;CLCN1;TTYH3;ANO2;GABRB2;TTYH1;FXYD1;GABRA5;CLCN5;ANO5;GLRA2;GLRA1;GABRA1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.5408447402189309,-1.7331380942771355,0.006741573033707865,0.0887929195101358,0.743,12/31,15.71%,SLC12A7;SLC12A2;KCNK5;ABCC9;HCN1;TMEM38B;KCNK10;TMEM175;SLC12A5;SLC12A6;KCNA2;KCNK9
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.7123605652828577,-1.7286201678555713,0.006369426751592357,0.08857184460834543,0.763,5/11,13.29%,KCNJ3;KCND3;KCNJ8;KCNQ1;KCNE4
prerank,LRR domain binding (GO:0030275),0.7097332050433037,1.720625897219467,0.015209125475285171,0.2832118386962701,0.886,3/14,4.71%,ROBO1;PAWR;LRRFIP2
prerank,cytokine activity (GO:0005125),0.46625456120821324,1.716609030178499,0.0,0.2668539446596246,0.897,23/131,8.47%,BMP6;WNT4;CXCL10;WNT6;IL16;CXCL16;WNT10B;WNT3A;WNT2B;OSM;IL11;IL34;BMP2;IL17D;IL6;WNT5B;BMP7;CKLF;FAM3B;BMP8B;IL18;CCL2;WNT5A
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6830143646173037,-1.7028895511546833,0.010775862068965518,0.11021512959297196,0.834,9/12,20.36%,GABRA2;GABRB3;GABRA3;GABRA4;GABRB1;GABRG3;GABRB2;GABRA5;GABRA1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6298938849876549,-1.7000168382810281,0.0022727272727272726,0.10226670414292087,0.844,6/16,3.85%,PTPRG;PTPRB;PTPRD;PTPRK;PTPRN2;PTPRM
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6298938849876549,-1.7000168382810281,0.0022727272727272726,0.10226670414292087,0.844,6/16,3.85%,PTPRG;PTPRB;PTPRD;PTPRK;PTPRN2;PTPRM
prerank,wide pore channel activity (GO:0022829),0.6336121306311409,1.6888448094473898,0.012411347517730497,0.33117513395934806,0.949,7/23,10.22%,GJB2;GJB6;PANX3;GJA1;PRF1;GJA3;PANX1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.6922837988374648,1.6709083272991594,0.023391812865497075,0.36451798852589296,0.972,2/14,0.80%,SLC7A11;SLC1A3
prerank,tropomyosin binding (GO:0005523),0.6515132908853078,1.6665593843336672,0.01436265709156194,0.35358921456143716,0.977,4/16,4.79%,TMOD3;CALD1;S100A6;NEBL
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.6536047588257807,-1.6655191256561797,0.011627906976744186,0.13727131585077154,0.918,9/13,20.36%,GABRA2;GABRA3;GLRA3;GABRA4;GABRG3;GABRA5;GLRA2;GLRA1;GABRA1
prerank,potassium channel activity (GO:0005267),-0.41932573223465563,-1.6606350231505225,0.0030120481927710845,0.13692211636428475,0.928,21/89,7.11%,KCNB2;KCND2;KCNQ5;GRIK2;KCNMB2;KCNK5;KCNMA1;ABCC9;KCNH7;GRIK4;KCNC2;KCNQ3;HCN1;GRIK1;KCNT1;TMEM38B;KCNK10;HCN2;KCNH1;TMEM175;KCNH5
prerank,glycerophospholipid flippase activity (GO:0140333),-0.6711620458303866,-1.6559066312923871,0.010482180293501049,0.1376537724312094,0.935,7/11,8.59%,ATP8A1;ATP10A;ABCA3;ATP8A2;ATP11A;ATP8B2;ATP8B1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.510427347189353,1.6519918616612401,0.003169572107765452,0.3774833810767022,0.985,11/55,4.54%,PDPN;SLC7A2;SLC13A3;SLC6A13;SLC16A11;SLC19A1;SLC16A2;SLC16A12;SLC6A12;SLC7A14;SLC16A5
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.5186382932066046,-1.6507669329218029,0.007537688442211055,0.13881154499151105,0.941,10/32,14.85%,KCNB2;KCNQ5;KCNC2;KCNQ3;KCNH1;KCNB1;KCNQ1;KCNE4;KCNC1;KCNA2
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.6460431911216438,1.632322763208136,0.012987012987012988,0.42160282702133645,0.995,2/18,0.33%,ALDH1A2;ALDH1A1
prerank,water transmembrane transporter activity (GO:0005372),0.6986261700860812,1.6286069932609664,0.036290322580645164,0.4102377574383105,0.995,2/11,5.93%,PDPN;SLC4A11
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6942783144774124,-1.6281958068157494,0.014830508474576272,0.1638408686911621,0.973,6/10,16.65%,SHANK3;NSF;GNAS;SHANK2;SHISA6;SHANK1
prerank,GABA-A receptor activity (GO:0004890),-0.5898234242051028,-1.626442916873155,0.00663716814159292,0.16039039118648662,0.974,9/18,20.36%,GABRA2;GABRB3;GABRA3;GABRA4;GABRB1;GABRG3;GABRB2;GABRA5;GABRA1
prerank,frizzled binding (GO:0005109),0.5557437691657535,1.6198681942646884,0.01309328968903437,0.41690662790784494,0.995,10/34,15.17%,WNT4;WNT6;WNT10B;WNT3A;WNT2B;WNT5B;WNT5A;DVL3;RNF43;RYK
prerank,alanine transmembrane transporter activity (GO:0022858),-0.6442899889358081,-1.6194327745430779,0.01646090534979424,0.16493931761273628,0.979,5/12,13.49%,SLC6A6;SLC38A5;SLC1A4;SLC36A1;SLC3A2
prerank,SUMO transferase activity (GO:0019789),0.6344172741777645,1.614119341593155,0.029143897996357013,0.41435436945154447,0.997,7/16,15.52%,RANBP2;HDAC4;PIAS1;NSMCE2;EGR2;CBX4;MUL1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.6199892283722543,1.604188962394313,0.02681992337164751,0.4281444048173101,0.999,6/18,4.72%,TMOD3;ANXA2;ANXA1;RAB10;PKP3;BAIAP2L1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.441579642274855,-1.6028042249778798,0.0,0.1851205905109368,0.991,32/57,31.42%,COX4I1;NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;UQCRH;UQCR11;NDUFA1;CYBRD1;COX8A;NDUFA4;NDUFB2;NDUFA12;COX6A1;NDUFB7;NDUFB10;NDUFC2;NDUFA4L2;NDUFA13;CYB5A;NDUFA9;UQCR10;UQCRQ;CYB561A3;NDUFA10;COX4I2;NDUFS6;NDUFV3;COX5B;NDUFS1;NDUFA2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5365199413363642,1.6013604273892952,0.01353637901861252,0.41593724256534953,0.999,10/38,12.45%,TFPI;ANXA2;SERPING1;SERPINB7;SERPINE1;TFPI2;SPINT2;SERPINE2;SERPINB8;SERPINE3
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.6784666115655654,1.5994723227882177,0.034026465028355386,0.40316972829833675,0.999,5/13,7.34%,BMP6;CDH5;BMP2;BMP7;BMP8B
prerank,cAMP response element binding (GO:0035497),0.7210082540333889,1.5930237346431932,0.036,0.4068827928339607,1.0,4/10,9.91%,CREB5;CREB3L2;ATF7;E4F1
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.582393418202068,-1.5914235427988295,0.016913319238900635,0.19534046337181896,0.994,6/17,8.59%,ATP10A;PITPNC1;PITPNA;ABCA3;ATP8B2;ATP8B1
prerank,pentosyltransferase activity (GO:0016763),0.5306031523164602,1.5897182928928046,0.015517241379310345,0.40076990848703714,1.0,13/36,12.47%,PARP14;ZC3HAV1;PARP9;LARGE1;LACC1;PARP3;PARP10;UPP1;PARP11;SIRT4;TIPARP;UMPS;PARP16
prerank,RNA polymerase II complex binding (GO:0000993),0.5455038816788303,1.5876487685418024,0.03588907014681892,0.39109449702713533,1.0,12/32,19.37%,ELOF1;NCOA3;PCF11;RPRD2;CDC73;WAC;BRD4;PAF1;ERCC5;URI1;UVSSA;RPRD1B
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.5965339278356878,-1.586051483371821,0.026748971193415638,0.19721435256825612,0.996,6/15,2.67%,HS3ST1;HS6ST3;HS6ST2;NDST3;HS3ST4;HS3ST5
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.5524195221694845,-1.5852353236474472,0.033783783783783786,0.19231351076594316,0.996,7/20,14.55%,SLC39A10;SLC39A6;SLC30A1;SLC39A14;SLC39A12;SLC39A13;SLC39A8
prerank,gap junction channel activity (GO:0005243),0.5990345006652077,1.583997459036273,0.030035335689045935,0.3869757187494078,1.0,6/22,10.22%,GJB2;GJB6;PANX3;GJA1;GJA3;PANX1
prerank,transforming growth factor beta binding (GO:0050431),0.5832475153385589,1.5810117542167086,0.039655172413793106,0.3817276600992919,1.0,7/23,6.93%,TGFBR3;LTBP1;TWSG1;LRRC32;WFIKKN1;TGFBR1;TGFBR2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.716567561115358,1.5804238221222908,0.02697495183044316,0.3700096565215119,1.0,1/10,0.24%,DPYSL3
prerank,anion channel activity (GO:0005253),-0.43209926783087593,-1.57865635425822,0.0027472527472527475,0.19621552402786088,0.996,26/61,20.36%,SLC26A7;ANO1;GABRA2;ANO3;GABRB3;GABRA3;GLRA3;CLCN3;GABRA4;CLCN7;SLC1A4;ANO4;GABRB1;LRRC8C;GABRG3;TTYH3;ANO2;GABRB2;VDAC1;FXYD1;GABRA5;CLCN5;ANO5;GLRA2;GLRA1;GABRA1
prerank,amyloid-beta binding (GO:0001540),-0.4084268582079205,-1.5768817026876898,0.002890173410404624,0.19335474880618536,0.997,24/79,13.58%,APBB2;NLGN1;COL25A1;GRIA4;CST3;TGFB2;INSR;GRIA1;ITM2A;GRIN2A;SORL1;GRIA3;GRIN2B;APBA2;PFDN5;BCHE;GRIA2;LDLRAP1;GRIN1;CD74;ADRB2;PFDN2;CLSTN1;FZD4
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.6506792947515632,1.576262900253553,0.05204460966542751,0.3687218986169943,1.0,3/14,5.06%,SDR9C7;RDH10;RDH5
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.5011084001127047,-1.5743410958161357,0.02763819095477387,0.1920133096686266,0.997,10/30,15.36%,SLC39A10;SLC40A1;SLC39A6;SLC31A1;SLC30A1;SLC39A14;SLC39A12;SLC39A13;SLC39A8;TTYH1
prerank,hormone receptor binding (GO:0051427),0.6548649287119589,1.5698339393122849,0.0497131931166348,0.374007779970682,1.0,5/14,13.10%,GHRH;PTHLH;NCOA6;NPPC;JAK1
prerank,BMP receptor binding (GO:0070700),0.6784712032936946,1.5676316825462402,0.04007633587786259,0.36790118619945955,1.0,5/12,7.34%,BMP6;CDH5;BMP2;BMP7;BMP8B
prerank,R-SMAD binding (GO:0070412),0.6047534946519135,1.565735665480743,0.03531598513011153,0.361462515026095,1.0,6/18,11.50%,SMAD3;PPM1A;LDLRAD4;PMEPA1;SMAD6;SMAD4
prerank,peptidase inhibitor activity (GO:0030414),0.5269075841727338,1.563360506724635,0.022847100175746926,0.3574001241229546,1.0,8/33,9.57%,TFPI;CSTB;ITIH2;SPINT2;PZP;TIMP2;PROS1;CAST
prerank,poly(U) RNA binding (GO:0008266),0.5987059820984745,1.5582697769824134,0.041666666666666664,0.35874628895164234,1.0,7/20,8.07%,ATXN1;RBMS1;RBMS3;RBMS2;PABPC5;HNRNPH1;HNRNPC
prerank,endopeptidase inhibitor activity (GO:0004866),0.4505343169001801,1.5551913292861772,0.012102874432677761,0.3564122538271433,1.0,18/82,9.57%,TFPI;COL4A3;TIMP3;ANXA2;SERPING1;CSTB;ITIH2;SERPINB7;SERPINE1;TFPI2;BST2;SPINT2;PZP;TIMP2;SERPINE2;UBE2Z;PROS1;CAST
prerank,filamin binding (GO:0031005),0.6943994312518127,1.554401279118952,0.04970178926441352,0.34885656498283146,1.0,5/11,9.74%,DPYSL3;SYNPO2;NEBL;FBLIM1;RFLNA
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3953638770841781,1.5498556452174084,0.0025220680958385876,0.351639580626069,1.0,58/232,17.00%,RNF220;PDZRN3;CBLB;RNF152;SMURF2;TRIM56;TRIM10;RNF217;SH3RF1;TRIP12;NEDD4;NHLRC3;RC3H1;DTX4;MYCBP2;TRIM17;RNF19A;RNF216;DTX1;SIAH2;PELI2;TRIM5;DTX3L;BIRC3;MGRN1;ANAPC11;TRIM24;RNF111;PIAS1;RNF145;AMFR;UBR4;WWP2;HUWE1;RFWD3;HECTD1;CUL3;NSMCE2;TRIM21;EGR2;HECW2;TRIM26;TRIM7;CBX4;PRPF19;RNF39;BFAR;RNF43;RNF181;BRAP;RCHY1;MUL1;RNF180;RNF185;KCMF1;RING1;RNF2;RNF135
prerank,receptor ligand activity (GO:0048018),0.38750522095331813,1.5471483228366525,0.0012610340479192938,0.3487883305417359,1.0,31/245,7.73%,SEMA3D;BMP6;WNT4;PTN;DPP4;EPHA7;CXCL10;WNT6;IL16;FGF1;WNT10B;WNT3A;WNT2B;OSM;NBL1;IL11;VEGFD;TGFA;IL34;PTHLH;BMP2;IL17D;IL6;WNT5B;BMP7;FAM3B;SEMA4B;EDA;BMP8B;IL18;NPPC
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.5538471862838313,-1.5449128207230771,0.031982942430703626,0.2351725513112655,1.0,4/19,3.76%,NRG3;EFNA5;GRM5;GAS6
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.5570217682337651,1.5431672880364127,0.03860294117647059,0.35000448940185275,1.0,12/25,18.56%,PARP14;ZC3HAV1;PARP9;PARP3;PARP10;PARP11;SIRT4;TIPARP;PARP16;TNKS2;PARP4;SIRT3
prerank,phospholipid transfer activity (GO:0120014),-0.5447179316642379,-1.536699322325661,0.02696629213483146,0.2428975540362509,1.0,7/21,8.19%,CERT1;PITPNC1;PITPNA;ABCA3;GLTP;PRELID2;PRELID1
prerank,acylglycerol lipase activity (GO:0047372),-0.6243454452820039,-1.526803219382373,0.04319654427645788,0.25465327917527564,1.0,6/11,25.62%,MGLL;ABHD2;LIPE;ABHD6;FAAH;ABHD15
prerank,neurexin family protein binding (GO:0042043),-0.6445037633071171,-1.5248310716488813,0.04184100418410042,0.25143754708518073,1.0,4/10,8.74%,NLGN1;CPE;SYTL2;NLGN3
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.3960594227158504,1.5222957305058067,0.004010695187165776,0.3960199203088096,1.0,36/181,12.36%,TCF7L2;SMAD3;RBPJ;ARNT2;NCOA3;PARP9;LDB2;DACT1;CRY1;TACC2;MIER3;ARNT;MTDH;PRRX1;CPNE1;BAZ2A;MIER1;TACC1;FOXP3;ANXA4;DTX3L;HDAC4;PPARA;CREBBP;POU1F1;STAT1;GSK3B;MEF2A;PIAS1;MAPK14;WWP2;RERE;ATN1;RBBP8;IFI27;EGR2
prerank,poly-purine tract binding (GO:0070717),0.5361891124831428,1.5165152572932161,0.04957264957264957,0.4021524791941357,1.0,5/27,5.42%,ATXN1;RBMS1;RBMS3;RBMS2;PABPC5
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.5147825698677185,1.5132558398542204,0.047697368421052634,0.40144374951779616,1.0,11/33,19.37%,ELOF1;NCOA3;PCF11;RPRD2;CDC73;WAC;PAF1;ERCC5;URI1;UVSSA;RPRD1B
prerank,ligand-gated cation channel activity (GO:0099094),-0.39163558682938304,-1.5047836982910858,0.00821917808219178,0.2821565773049008,1.0,17/75,12.30%,GRIA4;GRIK2;GRIN3A;KCNJ3;KCNJ2;GRIK4;PTK2B;GRIA1;GRIN2A;GRIK1;GRIA3;GRIN2B;GRIA2;GRIN1;KCNJ6;KCNJ8;KCNJ15
prerank,Tat protein binding (GO:0030957),-0.633907888412535,-1.5042749836156932,0.05521472392638037,0.27630902141060937,1.0,5/10,9.01%,ACTB;CTDP1;GABARAPL1;NPM1;SMARCB1
prerank,ubiquitin protein ligase activity (GO:0061630),0.38495615187999394,1.5011072291027707,0.008962868117797696,0.4252703944675147,1.0,57/228,17.82%,RNF220;PDZRN3;CBLB;RNF152;SMURF2;TRIM56;TRIM10;RNF217;SH3RF1;TRIP12;NEDD4;NHLRC3;RC3H1;DTX4;MYCBP2;TRIM17;RNF19A;RNF216;DTX1;SIAH2;PELI2;TRIM5;DTX3L;BIRC3;MGRN1;ANAPC11;TRIM24;RNF111;RNF145;AMFR;UBR4;WWP2;HUWE1;RFWD3;HECTD1;CUL3;TRIM21;HECW2;TRIM26;TRIM7;PRPF19;RNF39;BFAR;RNF43;RNF181;BRAP;RCHY1;MUL1;RNF180;RNF185;KCMF1;RING1;RNF2;RNF135;SHPRH;UBE4B;TRIM3
prerank,microtubule motor activity (GO:0003777),-0.4270463044312086,-1.499483638294854,0.024,0.2798511290380211,1.0,30/51,38.47%,KIF1B;KIF26B;KIF21A;KIF1C;STARD9;DNAH8;KIF26A;KIF18A;KIF5C;KIF15;KIF3B;DYNC1I2;KIF16B;KIF5A;KIF27;KIF23;KIF22;KIF4A;KIF14;KIFC3;KIF19;DNAH17;KIF20A;KIF20B;DNAH3;KIFC1;DYNLRB1;KIF2C;DNAH1;DYNLRB2
prerank,sterol binding (GO:0032934),0.46333446941629136,1.4929999139263572,0.038880248833592534,0.4373389495614179,1.0,16/56,15.36%,RORA;SIDT1;GRAMD1C;APOA2;APOF;OSBPL8;VDAC2;NR1H3;NPC1;INSIG2;SCP2;SOAT1;OSBPL5;STAR;ABCA1;OSBPL9
prerank,NAD+ binding (GO:0070403),0.6390704088031683,1.4923385636315598,0.04085603112840467,0.43002564287628287,1.0,3/12,4.43%,ZC3HAV1;PARP9;CRYL1
prerank,protein kinase C activity (GO:0004697),-0.5871885766319054,-1.4912680576216966,0.042735042735042736,0.2898736260868733,1.0,4/14,5.93%,PRKCH;PRKCB;PRKCQ;PKN1
prerank,poly-pyrimidine tract binding (GO:0008187),0.5562729413516221,1.4851451854984505,0.06196213425129088,0.43919940684459524,1.0,7/23,8.07%,ATXN1;RBMS1;RBMS3;RBMS2;PABPC5;HNRNPH1;HNRNPC
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6140002110650439,1.4802297584765038,0.05273069679849341,0.44458114573176827,1.0,4/15,11.07%,KMT2A;KMT2C;SETD4;SETD1B
prerank,telomerase RNA binding (GO:0070034),0.5522118077180798,1.4736918182209224,0.06417112299465241,0.4556347545177837,1.0,12/22,21.67%,TERT;DCP2;HNRNPC;XRN1;SMG5;SMG6;SMG7;EXOSC10;DHX36;PARN;TENT4B;TEP1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3625254423750095,1.466840476164363,0.002372479240806643,0.4643119355103646,1.0,83/346,17.00%,RNF220;PDZRN3;CBLB;RNF152;RNF213;SMURF2;TRIM56;TRIM10;RNF217;TRAF5;FBXO11;SH3RF1;TRIP12;NEDD4;TTC3;NHLRC3;RC3H1;DTX4;BCOR;MYCBP2;TRIM17;RNF19A;KLHL21;UBE2U;RNF216;DTX1;DZIP3;SIAH2;CUL4A;PELI2;TRIM5;DTX3L;BIRC3;FBXO9;MGRN1;ANAPC11;RNF20;FBXL3;TRIM24;RNF111;RNF145;AMFR;UBE2Z;PJA2;UBR4;UBE2C;FBXO4;WWP2;FBXO24;HUWE1;RFWD3;HECTD1;CUL3;KLHL13;TRIM21;BTRC;HECW2;UBE2E3;UBE2Q2;FBXW11;TRIM26;TRIM7;PRPF19;RNF39;FBXO3;BFAR;RNF43;RNF103-CHMP3;RNF181;BRAP;RCHY1;BIRC6;PML;UBE2R2;RNF146;MUL1;RNF180;RNF185;KCMF1;RING1;TRIM23;RNF2;RNF135
prerank,cholesterol transfer activity (GO:0120020),0.5981522112528479,1.466298532649764,0.07243816254416961,0.45633649493157064,1.0,2/16,2.03%,GRAMD1C;APOA2
prerank,amino acid transmembrane transporter activity (GO:0015171),0.4690699960353636,1.4618970158104216,0.0352,0.4601228556658938,1.0,6/47,4.20%,SLC7A11;PDPN;SLC7A2;SLC6A13;SLC16A2;SLC7A14
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.6089447146119108,-1.4603609811225258,0.07039337474120083,0.35049850857651027,1.0,5/11,23.07%,PPP1R11;PPP1R1A;PPP1R14B;PPP1R14C;PPP1R8
prerank,channel activity (GO:0015267),0.4771583916294808,1.459263592032344,0.03767123287671233,0.4587793459946591,1.0,7/41,10.22%,PDPN;PANX3;PRF1;BCL2;MPV17;BAX;PANX1
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.5830473118865908,-1.4554557230512608,0.07674943566591422,0.3539059417371583,1.0,5/13,12.65%,CCDC88A;ARHGDIB;GDI2;RANBP1;ARHGDIA
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.6342263905171648,1.4550893022309417,0.08022388059701492,0.46147738674542405,1.0,5/12,6.93%,TGFBR3;LTBP1;BMPR1A;TGFBR1;TGFBR2
prerank,sterol transfer activity (GO:0120015),0.5844550820154356,1.454640142820427,0.08156028368794327,0.4542739371535218,1.0,2/17,2.03%,GRAMD1C;APOA2
prerank,MAP-kinase scaffold activity (GO:0005078),0.6515179442308259,1.450526124871814,0.07738095238095238,0.4569016186438742,1.0,3/11,3.27%,AKAP13;KSR1;SH3RF1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.6206604648617422,-1.4504812166810568,0.0755939524838013,0.35723107467597537,1.0,6/10,20.36%,GABRA2;GABRA3;GABRA4;GABRG3;GABRA5;GABRA1
prerank,outward rectifier potassium channel activity (GO:0015271),0.6344617748604399,1.448822413195964,0.08506616257088846,0.4533176871137703,1.0,2/11,0.51%,KCNK2;KCNT2
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.4963669690469854,-1.4466869165203617,0.06798245614035088,0.35775086182649907,1.0,11/22,21.48%,ATP6V0A1;ATP6V1B2;ATP2C1;ATP2A3;ATP6V0C;ATP6V1D;ATP5F1B;ATP2A2;ATP6V0A2;ATP6V0E2;ATP6V0D2
prerank,NAD binding (GO:0051287),0.5190952023665091,1.4466628917992863,0.04325259515570934,0.4513403401186159,1.0,7/26,12.38%,ALDH1A1;ZC3HAV1;PARP9;CRYL1;NNT;ALDH2;NUDT6
prerank,histone methyltransferase binding (GO:1990226),-0.5907870870540785,-1.4447492952949075,0.06924643584521385,0.35463095192814176,1.0,8/11,28.91%,LCORL;CTNNB1;HSP90AB1;CBX3;NOP56;WIZ;CBX1;PRDM4
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.5711171718721099,-1.433693137215854,0.0899581589958159,0.3730478363496755,1.0,7/12,13.74%,PDE4D;PDE4B;PDE8A;PDE3B;PDE3A;PDE2A;PDE4C
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.44021341900827154,-1.4336328393497355,0.07142857142857142,0.3586164869579933,1.0,21/34,35.27%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;NDUFA4;NDUFB2;NDUFA12;NDUFB7;NDUFB10;NDUFC2;NDUFA13;NDUFA9;NDUFA10;NDUFS6;NDUFV3;NDUFS1;NDUFA2;NDUFA6;NDUFS2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.44021341900827154,-1.4336328393497355,0.07142857142857142,0.3586164869579933,1.0,21/34,35.27%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;NDUFA4;NDUFB2;NDUFA12;NDUFB7;NDUFB10;NDUFC2;NDUFA13;NDUFA9;NDUFA10;NDUFS6;NDUFV3;NDUFS1;NDUFA2;NDUFA6;NDUFS2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.6319300811779613,1.4322165252906494,0.08653846153846154,0.48386188599623303,1.0,3/10,9.38%,CXADR;CD47;DSC2
prerank,peptide hormone receptor binding (GO:0051428),0.6136481459041027,1.431858933776805,0.09961685823754789,0.47662020397229277,1.0,2/11,3.77%,GHRH;PTHLH
prerank,translation elongation factor activity (GO:0003746),-0.5542063416313184,-1.431498466026758,0.07068607068607069,0.3566131067056036,1.0,7/14,16.50%,EEF1A1;GTPBP1;EEF2;GFM1;EIF5A;EIF5AL1;EIF5A2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.5157935009654647,1.4273800143721338,0.08,0.4817679647387637,1.0,10/27,15.90%,POLR2D;TERT;POLR1D;POLR1C;POLR3F;POLR2C;MED20;POLR2F;TENT2;POLR3H
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3306784665353428,1.4247798961750944,0.0,0.4806748190044815,1.0,170/830,16.64%,TCF7L2;TCF4;CREB5;RORA;ZBTB20;SOX5;ZKSCAN2;EBF1;FOXD1;SMAD3;RBPJ;ZEB2;MXI1;NR2F2;ELF1;KCNIP3;ARNT2;OSR1;TEAD1;FOXC1;NFIA;STAT2;NFYC;NFAT5;GATA6;SPIB;TCF24;MAF;HIF3A;ZBTB4;ZNF395;NR6A1;ZIC2;FOXC2;GLI3;NFATC4;MYB;ZIC4;HIVEP2;IKZF2;PRRX2;HIVEP1;HOXC6;ZBTB8A;HOXC4;ZIC1;LITAF;STAT5B;RFX3;CREB3L4;ZFP30;EPAS1;HLF;GLI1;ARNT;EN2;SIM2;TOP1;AEBP1;GLIS3;GZF1;STOX1;SALL1;OTP;PRRX1;ZNF3;MGA;TCF12;KLF5;SP9;ZNF35;CREB3L3;NR1H3;FOXP3;HDAC4;ZKSCAN4;PPARA;TCF7L1;RARB;GLIS2;NSD1;ZBTB37;ZBTB7C;POU1F1;KLF9;HOXA2;CREBRF;STAT1;SKI;ZSCAN21;MEF2A;NFXL1;ZNF25;TEAD2;ATF7;CUX1;ZNF182;ZFP37;SP8;ZEB1;ZNF394;ELF4;ZBTB3;CREM;E4F1;EBF4;SOX21;PBX1;RFXANK;MAFB;MSC;CUX2;HEYL;ZNF235;RFXAP;TCF7;SMAD4;STAT4;HIVEP3;EGR3;FOXO3;NR4A1;LHX9;ZNF219;ZFAT;EGR2;ZKSCAN7;THAP1;HOXA10;BPTF;NFIC;MZF1;BHLHE41;NR3C1;GMEB1;PKNOX1;NRF1;NFE2L1;HIC1;POU2F1;ZNF205;PRDM5;SALL2;DMTF1;RFX2;ZNF569;ZBTB12;RARA;ZNF18;SP3;SNAPC3;ZNF383;HOXB4;TEF;SOX4;IRF9;VEZF1;POU5F1;ELK4;ZNF260;MUC1;JDP2;DRGX;SMAD2;BCL11B;ZNF483;POU6F1;NFATC2;CCAR1;ZBTB5
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.48328040164924474,-1.4243183474755219,0.05687203791469194,0.3669539555155173,1.0,5/23,1.55%,PLCB1;EDNRA;CHRM3;PLCB4;PLCG2
prerank,pyridoxal phosphate binding (GO:0030170),0.5408161219467381,1.4226193419257744,0.06725663716814159,0.47921652116185587,1.0,5/20,10.09%,SHMT1;PYGB;PDXK;PYGM;ABAT
prerank,calcium channel regulator activity (GO:0005246),-0.43655340522451147,-1.4202034102398216,0.05822784810126582,0.36947005477325434,1.0,7/37,7.54%,PRKG1;NRXN1;FKBP1A;MCUB;CALM1;CALM2;SLC30A1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3331890841961399,1.4200390126749929,0.0,0.47879754737627167,1.0,176/730,19.20%,TCF7L2;TCF4;CREB5;RORA;ZBTB20;SOX5;ZKSCAN2;EBF1;FOXD1;SMAD3;RBPJ;ZEB2;MXI1;NR2F2;ELF1;KCNIP3;CREB3L2;ARNT2;TEAD1;FOXC1;NFIA;STAT2;NFYC;NFAT5;GATA6;SPIB;MAF;HIF3A;ZBTB4;ZNF395;NR6A1;ZIC2;FOXC2;GLI3;NFATC4;MYB;ZIC4;HIVEP2;IKZF2;PRRX2;HIVEP1;HOXC6;HOXC4;ZIC1;LITAF;STAT5B;RFX3;CREB3L4;ZFP30;HLF;GLI1;ARNT;EN2;TOP1;GLIS3;GZF1;SALL1;PRRX1;MGA;TCF12;KLF5;SP9;CREB3L3;NR1H3;FOXP3;HDAC4;ZKSCAN4;PPARA;TCF7L1;RARB;GLIS2;NSD1;ZBTB37;ZBTB7C;POU1F1;KLF9;HOXA2;STAT1;TRIM24;SKI;ZSCAN21;MEF2A;TEAD2;ATF7;ZNF182;SP8;ZEB1;ZNF394;ELF4;ZBTB3;CREM;E4F1;EBF4;SOX21;PBX1;MAFB;MSC;HEYL;ZNF235;TCF7;SMAD4;STAT4;HIVEP3;EGR3;FOXO3;NR4A1;ZNF219;ZFAT;EGR2;ZKSCAN7;THAP1;HOXA10;BPTF;NFIC;MZF1;BHLHE41;NR3C1;GMEB1;PKNOX1;NRF1;NFE2L1;HIC1;POU2F1;ZNF205;PRDM5;SALL2;DMTF1;RFX2;ZNF569;ZBTB12;RARA;ZNF18;SP3;SNAPC3;ZNF383;HOXB4;TEF;SOX4;IRF9;POU5F1;ELK4;ZNF260;MUC1;JDP2;SMAD2;BCL11B;ZNF483;POU6F1;NFATC2;CCAR1;ZBTB5;DNMT3A;ZFP1;ZNF467;KLF15;STAT5A;ATF2;RFX7;NKX2-1;NRIP1;ZSCAN25;MAFG;DHX36;FOXS1;NFYA;CLOCK;ESRRA;FOXP4;CEBPB;KLF6;PGR;E2F2;MEOX2;NFATC3;SOX30;GLIS1
prerank,leak channel activity (GO:0022840),0.5416562533893077,1.4195054086976033,0.07509157509157509,0.4728369111824013,1.0,2/18,2.14%,KCNK2;NALCN
prerank,growth factor receptor binding (GO:0070851),0.3988211056406204,1.4178173653173276,0.03474320241691843,0.46982488269642864,1.0,14/95,6.10%,EFEMP1;PDGFRA;FGF1;IL6ST;IL11;FRS2;FER;ITGA5;VEGFD;TGFA;KL;IL6;ARF4;PDGFRB
prerank,sequence-specific DNA binding (GO:0043565),0.33552216306419086,1.4168164471655216,0.0,0.46494816181053894,1.0,131/590,19.20%,TCF7L2;TCF4;CREB5;KMT2A;RORA;ZBTB20;FOXD1;SMAD3;RBPJ;ZEB2;NR2F2;ELF1;ARNT2;OSR1;TEAD1;FOXC1;LBX1;NFAT5;GATA6;SPIB;MAF;ZBTB4;NR6A1;FOXC2;GLI3;NFATC4;ZIC4;MBD2;PRRX2;HIVEP1;HOXC4;ZIC1;RFX3;TERT;CREB3L4;EPAS1;HLF;ARNT;EN2;BCL2;ZNF276;GZF1;TCF12;KLF5;SP9;ZNF35;FOXP3;HDAC4;PPARA;TCF7L1;RARB;GLIS2;ZBTB37;POU1F1;HOXA2;MEF2A;TEAD2;ATF7;CUX1;SP8;ELF4;CREM;PBX1;MAFB;MSC;CUX2;SMG5;ELF2;TCF7;SMAD4;EGR3;SMG6;FOXO3;NR4A1;LHX9;KDM5B;EGR2;THAP1;HOXA10;BPTF;KDM2A;NFIC;BHLHE41;NR3C1;GMEB1;PKNOX1;HIC1;POU2F1;PRDM5;ERH;RFX2;SMG7;ZBTB21;ZBTB12;HDAC2;RARA;SP3;HOXB4;TEF;SOX4;IRF9;KDM2B;POU5F1;ELK4;MBNL2;JDP2;DRGX;BCL11B;POU6F1;NFATC2;UPF3A;ZFP1;LRWD1;SMG1;KLF15;ATF2;TEN1;HMBOX1;RFX7;KDM1A;MAFG;SIRT3;CLOCK;ESRRA;CEBPB;KLF6;E2F2;MEOX2;NFATC3;SOX30;GLIS1
prerank,MHC class II protein complex binding (GO:0023026),-0.5816033595168439,-1.4168090469389911,0.09129511677282377,0.3701873733374534,1.0,6/11,12.81%,HSPA8;ATP1B1;PKM;HSP90AB1;CD74;HSP90AA1
prerank,protein phosphatase 1 binding (GO:0008157),-0.48692701634269475,-1.4140292531997882,0.054373522458628844,0.36985135791321155,1.0,9/21,23.86%,PPP1R16B;PHACTR4;PPP1R3B;PPP1R11;KCNQ1;PPP1R3C;SH3RF2;PPP1R15A;SMTNL2
prerank,voltage-gated potassium channel activity (GO:0005249),-0.3663492409851391,-1.4138070766439192,0.024615384615384615,0.36392957850974106,1.0,22/80,13.66%,KCNB2;KCND2;KCNQ5;KCNMA1;KCNJ3;KCNH7;KCNJ2;KCNC2;KCNQ3;HCN1;KCNT1;HCN2;KCNH1;KCNH5;KCND3;KCNJ6;KCNB1;KCNJ8;KCNQ1;KCNJ15;KCNE4;KCNC1
prerank,platelet-derived growth factor binding (GO:0048407),0.6133113631500876,1.4115396910524414,0.10956175298804781,0.4723853238851772,1.0,4/11,6.10%,COL3A1;PDGFRA;COL5A1;PDGFRB
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.32979727379953905,1.4073198887997846,0.0,0.4763179885506683,1.0,175/731,19.20%,TCF7L2;TCF4;CREB5;RORA;ZBTB20;SOX5;ZKSCAN2;EBF1;FOXD1;SMAD3;RBPJ;ZEB2;MXI1;NR2F2;ELF1;KCNIP3;ARNT2;TEAD1;FOXC1;NFIA;STAT2;NFYC;NFAT5;GATA6;SPIB;MAF;HIF3A;ZBTB4;ZNF395;NR6A1;ZIC2;FOXC2;GLI3;NFATC4;MYB;ZIC4;HIVEP2;IKZF2;PRRX2;HIVEP1;HOXC6;HOXC4;ZIC1;LITAF;STAT5B;RFX3;CREB3L4;ZFP30;HLF;GLI1;ARNT;EN2;TOP1;GLIS3;GZF1;SALL1;PRRX1;MGA;TCF12;KLF5;SP9;CREB3L3;NR1H3;FOXP3;HDAC4;ZKSCAN4;PPARA;TCF7L1;RARB;GLIS2;NSD1;ZBTB37;ZBTB7C;POU1F1;KLF9;HOXA2;STAT1;SKI;ZSCAN21;MEF2A;TEAD2;ATF7;ZNF182;SP8;ZEB1;ZNF394;ELF4;ZBTB3;CREM;E4F1;EBF4;SOX21;PBX1;TIPARP;MAFB;MSC;HEYL;ZNF235;TCF7;SMAD4;STAT4;HIVEP3;EGR3;FOXO3;NR4A1;ZNF219;ZFAT;EGR2;ZKSCAN7;THAP1;HOXA10;BPTF;NFIC;MZF1;BHLHE41;NR3C1;GMEB1;PKNOX1;NRF1;NFE2L1;HIC1;POU2F1;ZNF205;PRDM5;SALL2;DMTF1;RFX2;ZNF569;ZBTB12;RARA;ZNF18;SP3;SNAPC3;ZNF383;HOXB4;TEF;SOX4;IRF9;POU5F1;ELK4;ZNF260;MUC1;JDP2;SMAD2;BCL11B;ZNF483;POU6F1;NFATC2;CCAR1;ZBTB5;DNMT3A;ZFP1;ZNF467;KLF15;STAT5A;ATF2;RFX7;NKX2-1;NRIP1;ZSCAN25;MAFG;DHX36;FOXS1;NFYA;CLOCK;ESRRA;FOXP4;CEBPB;KLF6;PGR;E2F2;MEOX2;NFATC3;SOX30;GLIS1
prerank,phospholipase inhibitor activity (GO:0004859),0.6284749478522271,1.4015008338314758,0.10567514677103718,0.48523133288022857,1.0,7/10,21.39%,ANXA2;ANXA1;ANXA4;ANXA5;ANXA9;ANGPTL3;SNCB
prerank,alkali metal ion binding (GO:0031420),0.5918874259289332,1.4013945876822322,0.11864406779661017,0.47858317923549226,1.0,4/13,11.27%,ATP1A2;HDAC4;PDXK;ACAT1
prerank,motor activity (GO:0003774),-0.3853858533872976,-1.4004939586932847,0.045845272206303724,0.3866224557699262,1.0,33/60,38.47%,KIF1B;KIF26B;KIF21A;KIF1C;MYL6;STARD9;DNAH8;KIF26A;KIF18A;KIF5C;KIF15;KIF3B;DYNC1I2;KIF16B;KIF5A;GPR88;KIF27;KIF23;KIF22;KIF4A;KIF14;KIFC3;KIF19;DNAH17;KIF20A;KIF20B;DNAH3;KIFC1;DYNLRB1;PIN1;KIF2C;DNAH1;DYNLRB2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.36440329452457537,1.3996560720994213,0.025435073627844713,0.4764021121660288,1.0,40/188,15.89%,TCF7L2;ZBTB20;SOX5;SMAD3;ARID4A;CREB3L2;TBL1XR1;FOXC1;NFYC;GATA6;FOXC2;CRY2;RFX3;GABPB2;GABPB1;GLI1;BCOR;TCF12;CREB3L3;NR1H3;HDAC4;GLIS2;YAP1;SMAD6;PBX1;TAF7;PSPC1;TCF7;SMAD4;FOXO3;EGR2;MZF1;ARID5B;PRDM5;DMTF1;CARM1;SOX4;PER3;POU5F1;TAF9
prerank,phospholipase C activity (GO:0004629),-0.467023113352868,-1.3972912045891364,0.08188585607940446,0.38689774403772526,1.0,5/25,1.55%,PLCB1;EDNRA;CHRM3;PLCB4;PLCG2
prerank,bHLH transcription factor binding (GO:0043425),0.5415575206102979,1.3969472629326243,0.11015490533562823,0.47676420251152524,1.0,4/19,6.74%,FHL2;SMAD3;TCF12;CREBBP
prerank,C-C chemokine receptor activity (GO:0016493),0.5382425520793621,1.395858276671837,0.08756567425569177,0.4728449880440713,1.0,6/21,17.30%,ACKR2;CCR9;ACKR3;CCRL2;CXCR4;GPR75
prerank,diacylglycerol kinase activity (GO:0004143),-0.5781175089907058,-1.3945395440503383,0.1069182389937107,0.3865917009855959,1.0,4/11,6.91%,DGKB;DGKI;DGKH;DGKZ
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5962309811867675,-1.3940810232595922,0.08731808731808732,0.38124726527011665,1.0,2/10,3.43%,MECOM;PRDM16
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.42080211441823173,1.3855319926732708,0.0629800307219662,0.4922202647444745,1.0,17/60,9.85%,EFEMP1;EPHA7;PDGFRA;FGFR1;AXL;DDR2;INSRR;EPHA3;EPHA8;NRP1;KIT;ROR1;EPHA1;PDGFRB;EPHA4;MST1R;MUSK
prerank,chloride transmembrane transporter activity (GO:0015108),-0.5225510730759623,-1.3817329160343532,0.10256410256410256,0.4029947455535975,1.0,5/16,8.67%,SLC26A7;SLC26A2;CLCN7;SLC1A1;SLC12A5
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5436724254412223,1.3813142255927144,0.11070780399274047,0.49689841488697145,1.0,5/18,6.93%,TGFBR3;LTBP1;BMPR1A;TGFBR1;TGFBR2
prerank,carboxylic acid binding (GO:0031406),-0.410338458986454,-1.375820985479881,0.06476683937823834,0.4103649834789984,1.0,15/38,22.82%,GRM7;NOS3;GRIN3A;GLRA3;GRIN2B;SESN3;GRIN1;NOS1;GCLC;EPDR1;UBR1;GLRA2;GLRA1;HIF1AN;SHMT2
prerank,poly(A) binding (GO:0008143),0.5136296400103948,1.3740006098962365,0.10619469026548672,0.5095152824408103,1.0,4/21,5.42%,RBMS1;RBMS3;RBMS2;PABPC5
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5577266773370306,-1.3714063171229702,0.11596958174904944,0.41370280498895223,1.0,4/11,15.91%,SGMS1;SGMS2;PTDSS1;PIGO
prerank,serotonin receptor activity (GO:0099589),-0.47326416199204413,-1.3698626240253082,0.08126410835214447,0.3985243234620297,1.0,8/22,19.46%,CHRM3;HTR2C;CHRM2;HRH1;HTR2B;HTR4;HTR2A;HRH2
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.47326416199204413,-1.3698626240253082,0.08126410835214447,0.3985243234620297,1.0,8/22,19.46%,CHRM3;HTR2C;CHRM2;HRH1;HTR2B;HTR4;HTR2A;HRH2
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.47326416199204413,-1.3698626240253082,0.08126410835214447,0.3985243234620297,1.0,8/22,19.46%,CHRM3;HTR2C;CHRM2;HRH1;HTR2B;HTR4;HTR2A;HRH2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.6101486007346147,1.3660627552662725,0.14624505928853754,0.525531521596738,1.0,6/10,26.95%,NSD3;NSD1;SETD5;SETD2;ASH1L;SMYD2
prerank,ribosomal large subunit binding (GO:0043023),-0.5717395132036358,-1.3657136642766292,0.11422845691382766,0.4018399298834123,1.0,7/11,29.95%,CPEB2;NPM1;RBM3;MALSU1;LTN1;EIF6;CPSF6
prerank,RNA polymerase core enzyme binding (GO:0043175),0.46826987034708256,1.3648012308959871,0.09302325581395349,0.5221549588363011,1.0,12/33,19.46%,ELOF1;NCOA3;PCF11;RPRD2;CDC73;WAC;PAF1;ERCC5;URI1;UVSSA;RPRD1B;ERBB2
prerank,rRNA binding (GO:0019843),-0.3954881005912967,-1.3638339421277716,0.07853403141361257,0.4000402711517384,1.0,14/42,17.35%,RPS9;RPL5;RPS3;RPL11;RPLP0;RPS13;MRPS18A;RPL23;RPS5;PPAN;FASTKD2;RPS14;RPL12;ERI1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.5498121103771862,1.3634277761818867,0.13345864661654136,0.519341538142236,1.0,2/15,6.29%,PLA2G4A;PLA2G4C
prerank,transcription cis-regulatory region binding (GO:0000976),0.3290729472813849,1.363296643246021,0.008158508158508158,0.5132345676093389,1.0,82/406,16.64%,TCF7L2;RORA;ZBTB20;SOX5;SMAD3;MXI1;ARID4A;CREB3L2;OSR1;TBL1XR1;TEAD1;FOXC1;NFYC;GATA6;TCF24;HIF3A;ZBTB4;ZNF395;FOXC2;GLI3;CRY2;ZBTB8A;RFX3;GABPB2;GABPB1;EPAS1;GLI1;BCOR;ARNT;SIM2;AEBP1;STOX1;OTP;ZNF3;TCF12;ZNF35;CREB3L3;NR1H3;HDAC4;GLIS2;CREBRF;MEF2A;NFXL1;ZNF25;CUX1;ZFP37;YAP1;CREM;SMAD6;E4F1;PBX1;TIPARP;RFXANK;TAF7;MSC;PSPC1;CUX2;RFXAP;TCF7;SMAD4;FOXO3;LHX9;EGR2;MZF1;NR3C1;ARID5B;PRDM5;SALL2;DMTF1;CARM1;RARA;SP3;SNAPC3;SOX4;PER3;VEZF1;POU5F1;TAF9;DRGX;SMAD2;TBL1X;ZBTB5
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.40850280132860095,1.3592880971019665,0.06521739130434782,0.5170983388036109,1.0,20/69,16.77%,PLA2G4A;CERS6;CERS5;LIPT1;ZDHHC3;PLA2G4C;MOGAT3;CREBBP;SCP2;KAT6B;NAA16;ESCO1;SOAT1;NAA15;DGAT2;PORCN;KAT6A;ZDHHC17;KAT2B;LPGAT1
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.5717607412397073,-1.3520865410531269,0.10474308300395258,0.4203320205118275,1.0,4/10,17.85%,CACNB2;CACNB4;CACNA1D;CACNA1A
prerank,retinoic acid binding (GO:0001972),0.5901201256031272,1.3499930703585235,0.1254681647940075,0.5351941298935688,1.0,1/12,0.95%,NR2F2
prerank,monocarboxylic acid binding (GO:0033293),0.5202262474160185,1.3436004643306156,0.13448275862068965,0.5468717760932006,1.0,3/18,16.06%,NR2F2;RARA;NAPEPLD
prerank,cholesterol binding (GO:0015485),0.43046982816530305,1.343526178924733,0.09046849757673667,0.5405505461658882,1.0,13/47,14.75%,SIDT1;GRAMD1C;APOA2;APOF;OSBPL8;VDAC2;NR1H3;NPC1;SCP2;SOAT1;OSBPL5;STAR;ABCA1
prerank,ion channel activity (GO:0005216),-0.35013917950956736,-1.3428489480591805,0.043596730245231606,0.4358001159979076,1.0,18/80,9.21%,GRID2;PIEZO2;GRIA4;GRIK2;GRIN3A;ABCC9;GRIK4;GRIA1;UNC80;MCUB;GRIN2A;GRIK1;GRIA3;GRIN2B;TRPC6;GRIA2;GRIN1;GABRB1
prerank,intracellular chloride channel activity (GO:0061778),-0.49224361977895426,-1.3378834745039752,0.12857142857142856,0.43507757634016714,1.0,9/16,22.95%,ANO1;ANO3;ANO4;TTYH2;TTYH3;ANO2;TTYH1;ANO5;NMUR2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.49224361977895426,-1.3378834745039752,0.12857142857142856,0.43507757634016714,1.0,9/16,22.95%,ANO1;ANO3;ANO4;TTYH2;TTYH3;ANO2;TTYH1;ANO5;NMUR2
prerank,nuclear localization sequence binding (GO:0008139),0.5224108826538533,1.3377732552768897,0.12110091743119267,0.5494720901493965,1.0,6/18,14.30%,TNPO1;KPNA6;KPNA7;KPNA4;POM121;BRAP
prerank,leucine zipper domain binding (GO:0043522),0.5982901206418916,1.337534340982767,0.16733067729083664,0.543798784345577,1.0,1/10,0.55%,PAWR
prerank,potassium ion leak channel activity (GO:0022841),0.5366851093036958,1.3353531015039104,0.12710280373831775,0.5433694274288636,1.0,1/15,0.04%,KCNK2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.5004811318882719,-1.335269183221676,0.14377682403433475,0.42939899515558483,1.0,8/16,21.48%,ATP6V0A1;ATP6V1B2;ATP6V0C;ATP6V1D;ATP5F1B;ATP6V0A2;ATP6V0E2;ATP6V0D2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.5004811318882719,-1.335269183221676,0.14377682403433475,0.42939899515558483,1.0,8/16,21.48%,ATP6V0A1;ATP6V1B2;ATP6V0C;ATP6V1D;ATP5F1B;ATP6V0A2;ATP6V0E2;ATP6V0D2
prerank,thyroid hormone receptor binding (GO:0046966),0.48023519985295327,1.33356021735567,0.1206896551724138,0.541945515317284,1.0,10/28,13.23%,NCOA3;TRIP12;NCOA6;TACC1;NSD1;OASL;TAF7;ZNHIT3;MED12;BRD8
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.4340509729098365,-1.331679924866211,0.13537117903930132,0.43205234203146586,1.0,9/27,14.55%,SLC26A7;SLC26A2;ANO1;XPR1;SLC5A5;SLC39A14;SLC22A6;SLC25A30;SLC39A8
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.31507957954937976,1.3306595328826174,0.006593406593406593,0.5439232048711911,1.0,133/597,19.20%,TCF7L2;TCF4;CREB5;ZBTB20;SOX5;SMAD3;ARID4A;ELF1;CREB3L2;ARNT2;OSR1;TBL1XR1;TEAD1;FOXC1;LBX1;NFYC;NFAT5;GATA6;SPIB;MAF;NR6A1;FOXC2;ORC5;GLI3;NFATC4;ZIC4;MBD2;PRRX2;HIVEP1;CRY2;HOXC4;ZIC1;RFX3;GABPB2;GABPB1;CREB3L4;HLF;GLI1;BCOR;ARNT;EN2;ZNF276;TCF12;KLF5;SP9;CREB3L3;NR1H3;FOXP3;HDAC4;TCF7L1;RARB;GLIS2;ZBTB37;POU1F1;HOXA2;TEAD2;ATF7;CUX1;SP8;YAP1;ELF4;CREM;SMAD6;PBX1;TAF7;MSC;MCM4;PSPC1;CUX2;ELF2;TCF7;SMAD4;EGR3;FOXO3;NR4A1;TSPYL2;LHX9;KDM5B;EGR2;HOXA10;NFIC;MZF1;BHLHE41;NR3C1;GMEB1;MCM6;PKNOX1;HIC1;ARID5B;PRDM5;DMTF1;RFX2;ORC3;CARM1;ZBTB12;RARA;SP3;HOXB4;ORC4;TEF;SOX4;IRF9;PER3;POU5F1;ELK4;TAF9;MBNL2;JDP2;DRGX;BCL11B;POU6F1;NFATC2;TBL1X;CENPC;ZFP1;KLF15;ATF2;HMBOX1;RFX7;NKX2-1;MAFG;DHX36;NFYA;CLOCK;ESRRA;CEBPB;BRD7;KLF6;E2F2;MEOX2;NFATC3;SOX30;GLIS1
prerank,calcium channel inhibitor activity (GO:0019855),-0.5465136636247034,-1.3303847180418575,0.141280353200883,0.42952277995967636,1.0,5/11,7.54%,FKBP1A;MCUB;CALM1;CALM2;SLC30A1
prerank,titin binding (GO:0031432),-0.5261570749071363,-1.3273777500918496,0.1402061855670103,0.4311227093117764,1.0,4/13,7.24%,CALM1;CALM2;CALM3;CAMK2D
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.40129913221932034,-1.32689345798083,0.08048780487804878,0.42693076174913674,1.0,17/37,33.71%,LARS2;KARS1;CARS1;EARS2;TARS3;IARS1;RARS2;VARS2;HARS1;YARS2;FARSB;YARS1;TARS1;WARS2;NARS1;PARS2;QARS1
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5346355418904194,-1.3224217289627689,0.1694915254237288,0.4322967921742468,1.0,4/12,6.75%,INSR;PIK3R1;GNAS;YWHAH
prerank,sodium:proton antiporter activity (GO:0015385),-0.5533740654948305,-1.3201075217960887,0.146,0.43263148417730557,1.0,3/11,6.32%,SLC9A2;SLC9B2;SLC9A8
prerank,chemokine binding (GO:0019956),0.4694490214244818,1.3196989544818882,0.12033898305084746,0.5682773313157509,1.0,4/30,7.76%,PDPN;ACKR2;CCR9;ACKR3
prerank,chemokine activity (GO:0008009),0.45253253918516784,1.3189102889343736,0.13973063973063973,0.5642913933858954,1.0,4/31,7.70%,CXCL10;CXCL16;CKLF;CCL2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.4040535325469233,1.3172889947424498,0.09888357256778309,0.5624753081857633,1.0,4/53,2.87%,SLC7A11;SLC7A2;SLC1A3;SLC6A9
prerank,endopeptidase regulator activity (GO:0061135),0.42905425274058034,1.3146432068038456,0.10981697171381032,0.5641685408223667,1.0,7/40,9.57%,TFPI;CSTB;ITIH2;SPINT2;PZP;PROS1;CAST
prerank,histone acetyltransferase binding (GO:0035035),0.4856868098780286,1.3127509108126694,0.16117216117216118,0.563670663264185,1.0,12/21,24.06%,GLI3;EPAS1;FOXP3;STAT1;MEF2A;TAF7;KANSL1;CITED2;SIRT2;HIF1A;ECD;EGR1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.5109654666026521,1.3086779404008149,0.15543071161048688,0.5695700110253584,1.0,6/18,11.17%,TGFBR3;SMAD3;TGFBR1;TGFBR2;SMAD6;TGFBRAP1
prerank,FAD binding (GO:0071949),0.4826401514013695,1.305047272392202,0.16607142857142856,0.5737327837660932,1.0,5/24,4.60%,MICAL3;DDO;CRY2;CRY1;SQOR
prerank,phosphoric diester hydrolase activity (GO:0008081),0.4414782156353009,1.304634423628684,0.1551433389544688,0.5690669769671334,1.0,6/35,6.21%,ENPP3;MPPED2;SMPD3;ENPP1;PLCE1;PLCB3
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.5264406627571466,-1.2985566567577114,0.18661257606490872,0.4766330619333011,1.0,3/12,6.32%,SLC9A2;SLC9B2;SLC9A8
prerank,nuclear import signal receptor activity (GO:0061608),0.5358210232066227,1.2961194960256004,0.1575091575091575,0.5873056562825877,1.0,4/15,7.23%,TNPO1;KPNA6;KPNA7;KPNA4
prerank,protease binding (GO:0002020),0.3696587081904471,1.2948386434087498,0.09022556390977443,0.5848538923195283,1.0,20/99,9.33%,DPP4;COL3A1;FN1;ECM1;TIMP3;ANXA2;CSTB;ADAMTSL4;CFLAR;BCL2;SERPINE1;BDKRB2;POLG;GSK3B;RIPK2;PZP;TIMP2;AMFR;INSL3;SUMO1
prerank,insulin-like growth factor I binding (GO:0031994),0.5354471660046213,1.2946876617672247,0.1685823754789272,0.5794919375511758,1.0,3/13,3.96%,IGFBP3;IGFBP5;IGFBP6
prerank,glycine binding (GO:0016594),-0.5357216280769224,-1.2946265661454341,0.18318965517241378,0.48104817306563863,1.0,8/11,28.99%,GRIN3A;GLRA3;GRIN2B;GRIN1;GLRA2;GLRA1;GLDC;GNMT
prerank,DNA-binding transcription factor binding (GO:0140297),0.3367682652845681,1.294565841352221,0.05759162303664921,0.5740886805672312,1.0,38/189,14.82%,TCF7L2;FHL2;SMAD3;RBPJ;TLE1;LDB2;DACT1;TLE3;MIER3;BCL2;MTDH;PRRX1;TCF12;MIER1;HDAC4;PPARA;CREBBP;POU1F1;STAT1;GSK3B;SKI;MEF2A;PIAS1;YAP1;CRTC1;CREM;WWP2;RERE;ATN1;CRTC3;RBBP8;IFI27;EGR2;BHLHE41;PRDM5;TLE6;RUNX1T1;HDAC2
prerank,insulin-like growth factor binding (GO:0005520),0.5173337760629135,1.2931174926091564,0.1751412429378531,0.5724032689872672,1.0,3/15,3.96%,IGFBP3;IGFBP5;IGFBP6
prerank,metal ion:proton antiporter activity (GO:0051139),-0.5139009726599293,-1.2927732830778322,0.16563146997929606,0.47993711365991354,1.0,3/13,6.32%,SLC9A2;SLC9B2;SLC9A8
prerank,fibroblast growth factor receptor binding (GO:0005104),0.4948994714026376,1.2920365153618871,0.16483516483516483,0.569796119186953,1.0,3/21,3.38%,FGF1;FRS2;KL
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.5837119519670166,1.2919531754741926,0.1862348178137652,0.5645369225064149,1.0,2/10,1.15%,CXCL10;PRKAG2
prerank,cadherin binding (GO:0045296),-0.27771156159829674,-1.2908557698519196,0.01020408163265306,0.4789591046913961,1.0,81/315,14.88%,PTPRB;DOCK9;CTNND2;COBLL1;CTNNA2;BSG;ITGA6;PTPRJ;CDH2;CDH11;PROM1;FNBP1L;HSPA8;LRRFIP1;CDH12;CTNNA3;MRTFB;BMPR2;KDR;RPL24;FXYD5;NOTCH3;CDH1;CSNK1D;EPN2;PTPRM;ANK3;MACF1;DIAPH3;TRPC4;EEF1G;DAB2IP;CDH10;RPL6;CTNNB1;CLINT1;CDH8;MRE11;PUF60;PKM;CDH22;HSP90AB1;CDH4;EFHD2;TES;EEF2;RPS2;CDH7;CDH20;HNRNPK;RPL14;SHTN1;PCBP1;STXBP6;BZW2;RPS26;PTPRT;VASP;RACK1;CDC42EP1;CBL;DBNL;ARHGAP1;CD46;PPP1CA;PTPRO;ANLN;RPL29;EGFR;GPRC5A;RANBP1;ACVR1;SLC3A2;F11R;NOP56;EHD4;TJP2;MPP7;PARK7;GLOD4;PAK4
prerank,flavin adenine dinucleotide binding (GO:0050660),0.39982770811059415,1.2864629627088107,0.13782051282051283,0.5739423246831142,1.0,10/53,6.78%,MICAL3;DDO;AOX1;CRY2;POR;CRY1;SQOR;ACOXL;NOS2;DPYD
prerank,DNA binding (GO:0003677),0.3025540078749421,1.2860910885415973,0.012087912087912088,0.5694552259583302,1.0,162/694,19.10%,TCF7L2;TCF4;RORA;TSHZ2;FOXD1;SMAD3;RBPJ;ZEB2;ARID4A;RBMS1;NR2F2;TEAD1;NUPR1;FOXC1;NFYC;DDX60;PDS5B;ZBTB4;ZNF395;DENND4A;SSBP2;NR6A1;ZIC2;FOXC2;ZIC4;NHEJ1;POLR2D;HIVEP2;CRY2;NUCKS1;RFX3;TERT;CRY1;WRN;EPAS1;HLF;GLI1;ARNT;SIM2;BCL2;TOP1;GZF1;OTP;ZBP1;ZNF3;RAD50;APLP2;HDGFL3;ZNF35;NR1H3;FOXP3;HDAC4;PPARA;TCF7L1;TSHZ3;CREBBP;RARB;RFC1;OASL;POLG;STAT1;FBH1;QRICH1;MEF2A;ZMYND11;NTHL1;CRLF3;SYCP2;CUX1;XRCC4;ACR;RLF;GLYR1;NABP1;CREM;HDGFL2;FUBP1;RPA3;SOX21;PBX1;MAFB;MCM4;CUX2;HUWE1;DCLRE1A;ZNF292;CENPX;POLR3F;XRN1;SMAD4;RTF1;ZMYM6;FOXO3;NR4A1;RBBP8;ZNF219;MTERF2;SPO11;ILF3;KDM5B;EGR2;OGG1;THAP1;TRIM26;BPTF;SUPV3L1;RBM5;MCM6;RAD51B;HIC1;ARID5B;RBM6;POU2F1;KAT6A;MND1;GTF2H4;ERCC5;ERCC6;PRDM5;RFX2;ZBTB21;HDAC2;DNASE1L1;SURF6;SNAPC3;ERCC1;SMARCA4;KDM2B;LIN9;POU5F1;ZMYM3;ELK4;APP;TAF9;SMAD2;TRIM16;POU6F1;NFATC2;DNMT3A;CENPC;CHD8;NUFIP1;JRKL;HMBOX1;C1D;PARP4;TSHZ1;NKX2-1;PCBP2;DHX36;FOXS1;SIRT3;NFYA;CHD4;CLOCK;ESRRA;CEBPB;PGR;E2F2;XPC;MEOX2;TDP2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.5430818337908775,-1.2856216790682622,0.20242914979757085,0.486151766261857,1.0,2/11,6.59%,HCN1;HCN2
prerank,semaphorin receptor binding (GO:0030215),-0.43069119541551937,-1.2845614370059086,0.13646055437100213,0.4828849307240335,1.0,10/23,12.74%,SEMA6D;RIT2;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B;SEMA3A
prerank,store-operated calcium channel activity (GO:0015279),-0.5601905920617692,-1.2837912824451334,0.16393442622950818,0.47917602506484214,1.0,4/10,6.77%,TRPC3;TRPC5;TRPC4;TRPC6
prerank,amino acid binding (GO:0016597),-0.4039639492142734,-1.2816228765159847,0.1211340206185567,0.4789198651012477,1.0,7/31,10.30%,GRM7;NOS3;GRIN3A;GLRA3;GRIN2B;GRIN1;NOS1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.531706908441117,1.2810410278266793,0.17398945518453426,0.577543744803043,1.0,2/15,2.39%,ACKR2;CCR9
prerank,nucleotide diphosphatase activity (GO:0004551),0.5259495349516191,1.2805487151610209,0.18574108818011256,0.5733730406621963,1.0,6/14,18.67%,ENPP1;FHIT;NUDT13;NUDT6;NUDT4;CILP2
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.5543460907570319,1.2773753674422639,0.19288389513108614,0.5764942657610714,1.0,7/11,24.17%,ANAPC11;AMFR;PRPF19;UBE4B;UBR5;UBE2K;PPIL2
prerank,fatty acid synthase activity (GO:0004312),-0.5369420034093098,-1.2757357366989859,0.1944990176817289,0.48781265956429076,1.0,2/10,3.52%,ELOVL5;ELOVL7
prerank,translation initiation factor activity (GO:0003743),-0.384202643936257,-1.2753651872980334,0.13402061855670103,0.48318438016880955,1.0,11/36,19.87%,EIF2B2;EIF3F;EIF5B;EIF4A1;EIF1B;EIF3A;COPS5;EIF1;EIF3H;EIF4A2;EIF3G
prerank,GTPase inhibitor activity (GO:0005095),-0.5067434020850928,-1.2741249114346709,0.19491525423728814,0.4805992624004804,1.0,7/13,21.74%,SLIT2;CPEB2;TNK2;RHOH;PDE6D;GPS1;ARL2
prerank,inward rectifier potassium channel activity (GO:0005242),-0.4255784720860123,-1.2702840077178008,0.17523364485981308,0.4843775579318881,1.0,10/24,26.78%,ABCC9;KCNJ3;KCNJ2;KCNJ6;KCNJ8;KCNJ15;KCNJ10;KCNN3;KCNK1;KCNJ16
prerank,acyl-CoA hydrolase activity (GO:0047617),0.5115320976795326,1.269621410375292,0.19107142857142856,0.5910417662655711,1.0,4/17,9.97%,ACOT11;PLA2G6;ACOT9;ACOT1
prerank,solute:anion antiporter activity (GO:0140323),0.5257039208458767,1.2642206362153106,0.18410852713178294,0.600362005206692,1.0,2/14,3.49%,SLC7A11;SLC26A9
prerank,calcium activated cation channel activity (GO:0005227),-0.4572496633135106,-1.263317129571279,0.16835699797160245,0.496120723174273,1.0,4/17,7.08%,KCNMB2;KCNMA1;ANO1;TMEM63C
prerank,C-C chemokine binding (GO:0019957),0.47957492377674504,1.2619129070961193,0.1721170395869191,0.6013233229882454,1.0,5/22,15.74%,ACKR2;CCR9;ACKR3;CCRL2;CXCR4
prerank,lysine N-methyltransferase activity (GO:0016278),0.4832416197184524,1.2611610755144138,0.18411552346570398,0.5981636927521445,1.0,10/20,26.95%,METTL21C;ETFBKMT;SETD4;SETD7;ATPSCKMT;SETD2;EHMT2;SETD6;EEF1AKMT4;SMYD2
prerank,adenylate cyclase binding (GO:0008179),-0.5345569818668046,-1.257354977029365,0.21301775147928995,0.5049595971158813,1.0,6/10,10.76%,AKAP6;CAP2;CALM1;CALM2;CALM3;ADCY2
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.3680085480190658,-1.2568684880367007,0.12561576354679804,0.5008775675803397,1.0,13/42,11.40%,LRRC4C;BSG;ESAM;CNTN4;CNTN6;ROBO4;NPTN;JAM3;STXBP6;CNTN2;EMB;CDC42EP1;PPP1CA
prerank,Hsp90 protein binding (GO:0051879),-0.3844531510915486,-1.2548654636325067,0.1580188679245283,0.5007206716682049,1.0,10/33,19.43%,SLC12A2;KDR;RPS3;HDAC6;UNC45B;NPAS2;MAPT;NOD2;PACRG;AHSA1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.3873891686659788,-1.2544210631237624,0.17857142857142858,0.4964870245761851,1.0,8/32,13.49%,SLC6A6;SLC7A5;SLC38A5;SLC1A1;SLC1A4;SLC43A2;SLC36A1;SLC3A2
prerank,manganese ion binding (GO:0030145),0.39727059628509737,1.2529602468488994,0.15763546798029557,0.6146848813218484,1.0,9/48,7.94%,MPPED2;FAM20C;WRN;LARGE1;GALNT2;GALNT1;GYG1;B4GALT1;NEK4
prerank,amino acid:sodium symporter activity (GO:0005283),0.541753260732154,1.2465956112087968,0.22264150943396227,0.6267825636809397,1.0,3/11,3.94%,SLC1A3;SLC6A13;SLC6A12
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3712556533189845,1.2451355839529188,0.14328808446455504,0.6251544876091949,1.0,19/71,12.72%,PTPN13;EYA2;EYA1;TPTE;PTPN14;PTPN4;PTPN3;PTPN22;PTPRA;MTMR3;PTPN2;PTPN9;PTPN21;PTPN6;EYA4;CDC14A;PTPRU;PTPN1;PTPN18
prerank,voltage-gated ion channel activity (GO:0005244),-0.4881701843844474,-1.244553800763099,0.20084566596194503,0.5151435167444904,1.0,3/14,3.19%,KCND2;CACNA1E;HCN1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5553357250118036,1.2437992148838073,0.22350674373795762,0.6231638202837877,1.0,3/10,5.50%,CASP12;CFLAR;CASP4
prerank,retinoid X receptor binding (GO:0046965),0.5475072068832254,1.2430537026383817,0.23992673992673993,0.6200960472084608,1.0,5/11,20.35%,NCOA6;TACC1;NSD1;NRIP1;ARID5A
prerank,chemokine receptor binding (GO:0042379),0.41734961317983077,1.2428635710041773,0.19934640522875818,0.6153190846449157,1.0,6/35,15.01%,CXCL10;CXCL16;CKLF;CCL2;CCL25;CCRL2
prerank,kinesin binding (GO:0019894),-0.40985073399179006,-1.241877002914747,0.19679633867276888,0.5156766102234102,1.0,10/27,17.13%,KIF1B;ACTB;SNCA;AP1AR;MAPK8IP1;NEFH;CLSTN1;MAPK8IP3;TOR1B;PRC1
prerank,methyl-CpG binding (GO:0008327),0.46255657243994414,1.2412188653065117,0.1936619718309859,0.6146104041552908,1.0,10/22,25.58%,ZBTB4;MBD2;ERH;ZBTB21;LRWD1;TET1;PRMT1;ZCWPW1;MECP2;ZBTB33
prerank,actinin binding (GO:0042805),0.46227705744555964,1.2379292035804774,0.20795660036166366,0.6183779639610669,1.0,7/21,15.77%,CSRP3;DAG1;SYNPO2;CSRP1;CACNA1C;RARA;PKD2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.4413927607537663,1.2340711016749693,0.19243986254295534,0.6239233058074055,1.0,8/27,15.90%,POLR2D;POLR1D;POLR1C;POLR3F;POLR2C;MED20;POLR2F;POLR3H
prerank,protein tyrosine kinase activity (GO:0004713),0.3377143475418694,1.2338436605780183,0.11715481171548117,0.61957736510872,1.0,29/108,15.93%,TEC;STYK1;EPHA7;PDGFRA;FGFR1;AXL;DDR2;INSRR;EPHA3;EPHA8;FER;KIT;ROR1;EPHA1;PDGFRB;EPHA4;BAZ1B;MST1R;MUSK;HIPK3;PTK2;EPHA2;JAK1;ALK;FRK;NTRK3;RYK;TXK;IGF1R
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.4975850729733402,1.233122104116199,0.22977941176470587,0.6165828478244446,1.0,4/16,13.39%,PIR;HGD;ALOXE3;BCO2
prerank,symporter activity (GO:0015293),-0.5161776748111025,-1.2314253245421711,0.21367521367521367,0.5348033501478426,1.0,3/10,13.08%,SLC5A5;SLC5A6;MFSD2A
prerank,actin binding (GO:0003779),-0.28048176072835457,-1.2312760496768844,0.06772908366533864,0.5299165395915384,1.0,49/170,18.47%,SYNE1;MYRIP;SSH2;PARVB;DMD;NOS3;FMN2;TMSB4X;KCNMA1;KLHL2;CAP2;EPS8;FXYD5;PHACTR4;UTRN;SNCA;MACF1;KLHL1;TMSB10;TLN2;MOBP;SPTB;CCDC88A;MSRB2;MAP1B;CEACAM1;MSRB1;CORO7;ARPC1A;KIF18A;DBNL;PDLIM3;MLPH;ANLN;ACTN4;PHACTR3;MAPT;NOD2;TWF1;FHL3;ADD1;ADCY8;SSH3;LDB3;GAS2L3;LCP1;HPCA;PACRG;MAEA
prerank,glucuronosyltransferase activity (GO:0015020),-0.4278099060744015,-1.2303886393872128,0.2037037037037037,0.5266440480044362,1.0,3/19,5.29%,CSGALNACT1;EXT1;B3GAT2
prerank,sodium channel activity (GO:0005272),-0.36949301310714017,-1.2263213667917805,0.1558139534883721,0.531463429360725,1.0,10/37,11.70%,GRIK2;GRIK4;SCN1A;HCN1;GRIK1;HCN2;SCN2A;CACNA1G;SCN8A;SCN9A
prerank,calcium-activated potassium channel activity (GO:0015269),-0.5106601349080079,-1.2260826590368934,0.21906693711967545,0.5270749964721936,1.0,2/11,1.65%,KCNMB2;KCNMA1
prerank,potassium channel regulator activity (GO:0015459),-0.3521280136717328,-1.2223120843625785,0.1585677749360614,0.5305420365046017,1.0,11/49,13.29%,DPP10;KCNAB1;KCNMB2;ABCC9;KCNIP4;KCNIP1;DPP6;AKT1;NEDD4L;ADRB2;KCNE4
prerank,semaphorin receptor activity (GO:0017154),0.5374426075741565,1.2213523949430158,0.2430939226519337,0.6440467594655066,1.0,2/11,2.97%,PLXNA2;NRP1
prerank,regulatory RNA binding (GO:0061980),0.40775200621772595,1.2195792944252697,0.18339100346020762,0.6442156689505502,1.0,16/38,25.27%,TUT4;PIWIL4;RC3H1;TARBP2;ZC3H7B;POU5F1;DDX21;HNRNPA2B1;PUM2;TUT7;ELAVL1;ZC3H12A;PNPT1;DHX9;ZC3H10;MATR3
prerank,transcription coactivator binding (GO:0001223),0.4705643470099838,1.2181671319975773,0.21699819168173598,0.6431308584280381,1.0,6/20,12.21%,RORA;SMAD3;TERT;TEAD2;SMAD4;VGLL4
prerank,I-SMAD binding (GO:0070411),0.5115759886998373,1.2149749812422377,0.25140712945590993,0.6470824487743934,1.0,5/13,11.50%,SMAD3;TGFB1I1;TGFBR1;SMAD6;SMAD4
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.49739835040616986,-1.2132606851106016,0.22244897959183674,0.5474759433023724,1.0,6/12,19.24%,PIK3R6;PIK3C2B;PIK3R3;ATM;PIK3CD;PIK3C3
prerank,ephrin receptor activity (GO:0005003),0.4733670365663007,1.2126999187418823,0.21746880570409982,0.6434827190574439,1.0,6/17,12.29%,EPHA7;EPHA3;EPHA8;EPHA1;EPHA4;EPHA2
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.4733670365663007,1.2126999187418823,0.21746880570409982,0.6434827190574439,1.0,6/17,12.29%,EPHA7;EPHA3;EPHA8;EPHA1;EPHA4;EPHA2
prerank,RNA stem-loop binding (GO:0035613),0.5177319160061591,1.2122307099428735,0.2537878787878788,0.6397910773156079,1.0,6/12,23.45%,RC3H1;METTL16;CPEB3;EPRS1;ZC3H12A;DHX9
prerank,active ion transmembrane transporter activity (GO:0022853),-0.3617769169661963,-1.2118490861981688,0.18703241895261846,0.5459686672242732,1.0,17/37,24.50%,SLCO1C1;SLCO2A1;COX4I1;UQCRH;SLC16A7;UQCR11;SLC22A6;COX8A;NDUFA4;COX6A1;SLCO4A1;NDUFA4L2;SLCO4C1;CYB5A;SLCO1B1;UQCR10;UQCRQ
prerank,syntaxin-1 binding (GO:0017075),-0.42637903489115453,-1.2109673154204676,0.20140515222482436,0.5430162037879317,1.0,7/22,9.75%,SYT1;SYNPR;NSF;SNAP25;STXBP1;CPLX1;SNPH
prerank,GTPase activator activity (GO:0005096),0.29914842211512344,1.2095268924744822,0.09305210918114144,0.6424821672238926,1.0,61/313,13.38%,ARHGAP29;RANBP3L;ALDH1A1;RASGRF1;RIN2;RAPGEF4;AKAP13;ARHGAP10;ARHGAP42;DOCK5;DOCK11;ARHGAP20;ARHGAP18;SBF2;ASAP1;DLC1;DENND2A;DENND4A;ARHGAP28;ARFGAP3;ARHGAP32;FGD4;RCBTB2;NRP1;TBC1D16;PCP2;ERRFI1;SEC23A;MYCBP2;RANBP2;PLCE1;ASAP3;GRTP1;RASA1;TAGAP;RALBP1;DENND1A;ARHGEF10L;ARHGEF11;ACAP2;ARHGAP26;SYDE1;GMIP;EIF2B3;LRRK2;HPS1;IQGAP2;NGEF;DNM1L;FNIP1;IQSEC2;NUCB2;ARHGAP9;RAB3IP;SIPA1L2;RAP1GAP;ARRB1;GNB5;SMAP2;LLGL2;NPRL3
prerank,exonuclease activity (GO:0004527),0.3900225056312921,1.2092070118704916,0.20033112582781457,0.63851010823766,1.0,8/46,10.73%,ENPP3;ENPP1;REXO5;WRN;RAD50;POLG;EXD1;ENPP2
prerank,telomeric DNA binding (GO:0042162),0.41479296343368455,1.2079655234087132,0.22295081967213115,0.6370947272591724,1.0,14/32,20.09%,TERT;WRN;RAD50;SMG5;SMG6;SMG7;HNRNPA2B1;UPF3A;SMG1;TEN1;HMBOX1;KDM1A;UPF2;CTC1
prerank,MAP kinase kinase activity (GO:0004708),0.4934922353816545,1.2063800357587142,0.24581005586592178,0.6365682956930864,1.0,8/15,18.80%,MAP2K6;LRRK2;MAPK14;MAP2K5;MAP2K1;MAPKAPK5;MAPKAPK3;MAP2K4
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.28000589492515726,-1.2060276464994062,0.1095890410958904,0.5501041277333726,1.0,36/147,13.37%,RAPGEF5;DOCK9;DOCK4;FGD5;ARHGEF28;CYTH3;PREX2;RASGRF2;ELMO1;ABR;DOCK10;SPATA13;CYTH1;TIAM1;DOCK2;ARHGEF6;ARHGEF15;RAB3GAP1;ARHGEF2;EIF2B2;FGD6;PREX1;RAPGEF2;CCDC88A;HERC2;SMCR8;SH3BP5L;BCR;DOCK8;ALS2;ARHGEF7;VAV1;RGP1;DOCK1;RAPGEF6;RABGEF1
prerank,double-stranded DNA binding (GO:0003690),0.28723528637468726,1.204657560922132,0.06636670416197975,0.6366191370413538,1.0,98/531,16.48%,TCF4;CREB5;ZBTB20;RBMS1;ELF1;ARNT2;OSR1;TEAD1;LBX1;NFAT5;DDX60;GATA6;SPIB;MAF;NR6A1;FOXC2;GLI3;NFATC4;ZIC4;PRRX2;HIVEP1;NUCKS1;HOXC4;ZIC1;RFX3;CRY1;CREB3L4;HLF;ARNT;EN2;ZNF276;TOP1;ZBP1;TCF12;RAD50;KLF5;HDGFL3;SP9;FOXP3;TCF7L1;RARB;GLIS2;ZBTB37;POU1F1;HOXA2;STAT1;FBH1;ZMYND11;NTHL1;TEAD2;ATF7;CUX1;SP8;ELF4;CREM;HDGFL2;PBX1;MSC;CUX2;CENPX;POLR3F;ELF2;TCF7;EGR3;FOXO3;NR4A1;RBBP8;LHX9;KDM5B;EGR2;HOXA10;NFIC;BHLHE41;NR3C1;GMEB1;RAD51B;PKNOX1;HIC1;MND1;GTF2H4;ERCC5;RFX2;ZBTB12;RARA;SP3;HOXB4;TEF;SOX4;IRF9;POU5F1;ELK4;MBNL2;JDP2;DRGX;SMAD2;BCL11B;POU6F1;NFATC2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.39102324388412585,-1.2042329942670615,0.20319634703196346,0.5496599819401765,1.0,14/28,32.14%,PRORP;RPP30;DBR1;NUDT16L1;DICER1;ENDOV;EXO1;EDC3;POP7;NUDT16;MRPL44;APEX1;FEN1;ELAC1
prerank,voltage-gated sodium channel activity (GO:0005248),-0.4158638283741243,-1.2037003377295776,0.22121896162528218,0.5458521393820271,1.0,12/22,27.39%,SCN1A;HCN1;HCN2;SCN2A;CACNA1G;SCN8A;SCN9A;SCN3A;SCN2B;SCN1B;CACNA1I;HCN4
prerank,O-acyltransferase activity (GO:0008374),0.4181011537192513,1.2021770054956031,0.23909531502423265,0.6386045552527483,1.0,6/30,12.04%,PLA2G4A;MBOAT2;PLA2G4C;MOGAT3;SOAT1;DGAT2
prerank,mRNA 3'-UTR binding (GO:0003730),0.3523575259354153,1.2015582591968823,0.17522658610271905,0.6356824051880322,1.0,11/79,8.07%,CELF2;RBMS1;RBMS3;RC3H1;RBMS2;IGF2BP1;PABPC5;SECISBP2L;CPEB1;RNF20;HNRNPC
prerank,protein heterodimerization activity (GO:0046982),0.31375476475930464,1.1991919757902936,0.1394736842105263,0.6374888252692611,1.0,28/178,11.85%,TCF4;BMP6;ATP1A2;ZHX2;MICU1;ARNT2;APOA2;DGKD;EPAS1;TLR4;ARNT;BCL2;TPM1;MCL1;CREB3L3;TOP2B;BDKRB2;VAPA;MEF2A;PHB2;BAX;TPM4;TAF7;PAFAH1B3;BCL2L1;IRAK3;ATP1B2;NR4A1
prerank,protein serine/threonine kinase activity (GO:0004674),0.2944948271920133,1.1981766764094748,0.09773539928486293,0.6357087214815295,1.0,75/335,15.81%,PDPK1;ROCK2;CAMK1D;NRK;STK32B;GRK3;FAM20C;MAPK4;STK39;PRKAA2;OXSR1;EIF2AK2;TSSK3;BMPR1A;BMP2K;CASK;FAM20A;CDK8;DAPK1;TAOK3;NEK8;IKBKE;PRKCZ;TOP1;ARAF;LATS2;MAP3K1;AAK1;TGFBR1;MAPK6;TGFBR2;MAP4K1;CLK4;GSK3B;NEK4;WNK4;RIPK2;STK24;STK3;SIK3;LRRK2;TLK2;CDK7;CDK12;BRD4;CDK16;MAPK14;AKT3;HIPK3;GRK5;IRAK3;MAP3K7;RPS6KA3;MASTL;DAPK2;MAP2K1;MAP3K13;SRPK1;MAPK9;ACVR1C;WNK1;MAPKAPK5;TBK1;NUAK2;CSNK2A2;MAP3K2;EIF2AK3;ILK;LIMK1;CDKL3;STK4;ACVR2B;PKN2;PRKD2;ERN2
prerank,histone acetyltransferase activity (GO:0004402),0.414677274855781,1.1946005742062518,0.22934232715008432,0.6400740241530595,1.0,14/30,20.12%,NCOA3;CREBBP;KAT6B;EPC1;BAZ1A;SRCAP;ARRB1;KAT6A;KAT2B;TAF9;ATF2;CLOCK;EPC2;NAA40
prerank,transition metal ion binding (GO:0046914),0.28948915172466383,1.1943971549031531,0.08983451536643026,0.6360559818852238,1.0,74/397,14.52%,KMT2A;AGMO;ENPP3;MPPED2;CBLB;SMAD3;MOXD1;FAM20C;ENPP1;PAPPA;KDM7A;SHMT1;AOX1;RC3H1;LITAF;LOXL3;WRN;UBA5;LARGE1;ANPEP;SEC23A;LACC1;MYCBP2;PAM;ZNF3;CSRP1;GALNT2;HDAC4;CUTA;NPEPPS;GALNT1;NSD1;SEC24D;GLO1;GYG1;B4GALT1;TRIM24;SKI;NEK4;ZMYND11;TIMP2;BAZ1B;ZFP37;ZEB1;ACR;PDXK;SLU7;MNAT1;QPCTL;ERAP1;CUTC;ENPP2;SCD5;ESCO1;ENDOU;SEC24C;ZCCHC4;FNTB;KDM5B;NQO2;EEA1;THAP1;PTPN1;KDM2A;TET2;PPM1M;TIMM9;RNPEP;ZNF205;KAT6A;LNPEP;MDM4;IFIH1;RCHY1
prerank,voltage-gated chloride channel activity (GO:0005247),-0.5129254096536098,-1.1910755523117722,0.252212389380531,0.5713657622593648,1.0,4/10,16.91%,ANO1;CLCN3;CLCN1;CLCN5
prerank,pre-mRNA binding (GO:0036002),0.42372051895121976,1.1906214766810423,0.2391681109185442,0.6416008251518865,1.0,5/28,10.38%,CELF2;RBM41;ZRSR2;SLU7;RNPC3
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.44861074536859186,1.1879195257467237,0.2509090909090909,0.6443929955375921,1.0,3/21,1.53%,PDE1A;PDE8B;PDE5A
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.4364780566507833,1.1866230952911554,0.2667844522968198,0.6433320526055573,1.0,3/23,1.53%,PDE1A;PDE8B;PDE5A
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.5094713518517552,-1.186367431530852,0.27391304347826084,0.5781334445661559,1.0,9/10,33.79%,MGME1;EXD2;DCLRE1C;POLD1;EXO1;APEX1;DCLRE1B;FEN1;TATDN1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.5190566604162993,1.185834080942065,0.2607003891050584,0.6409185280261922,1.0,3/11,5.50%,CASP12;CFLAR;CASP4
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.3591647295820679,1.185510287351952,0.20401854714064915,0.6374299715530822,1.0,16/60,9.85%,EPHA7;PDGFRA;FGFR1;AXL;DDR2;INSRR;EPHA3;EPHA8;KIT;ROR1;EPHA1;PDGFRB;TGFBR2;EPHA4;MST1R;MUSK
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.46779954952287417,-1.1845111962952872,0.26506024096385544,0.5774961336236505,1.0,7/14,20.73%,NOD1;MAL;ATP2A3;RACK1;PYCARD;CASP1;BAD
prerank,sulfuric ester hydrolase activity (GO:0008484),0.5256907013806388,1.1828048483734679,0.2868217054263566,0.6400473758792927,1.0,3/12,12.60%,SULF1;ARSI;ARSB
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.48980413930334477,-1.1825897681110984,0.250501002004008,0.5771570488809102,1.0,6/10,23.42%,SLCO1C1;SLCO2A1;SLC22A6;SLCO4A1;SLCO4C1;SLCO1B1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.37253088157852177,1.1818376673728483,0.21546052631578946,0.6382176665670203,1.0,11/48,11.88%,TRPM3;TRPM6;NALCN;P2RX1;SLC4A11;CALHM2;TMEM165;PKD1L3;TRPC1;GRIN3B;SLC41A1
prerank,tubulin binding (GO:0015631),-0.25450871461306535,-1.180369017672815,0.06770833333333333,0.5774796244611147,1.0,73/296,18.18%,DNM3;MTUS1;SGIP1;UNC5C;AGBL4;SYBU;NAV3;TTLL7;DIP2B;MID1;KIF1B;EML6;REEP1;PAK1;KIF26B;SNCA;KIF21A;RPS3;KIF1C;FMN1;RP1;STARD9;TTLL5;ARHGEF2;GABARAP;CRIPT;MID2;STMN2;CCDC88A;EFHC2;DIXDC1;RCC2;MTCL1;MAP1B;PHF6;TERF1;HDAC6;GABARAPL1;ARL8A;SNPH;KIF26A;KIF18A;NEFH;FGF13;TRIM36;ARHGEF7;KIF5C;PRUNE1;WASHC1;KIF15;KIF3B;NDE1;CLASP2;RAE1;KIF16B;BRCA2;RAB11FIP5;KIF5A;MAPT;CLIP2;KRIT1;MAP2;SKA2;STMN4;CCDC69;GAS2L3;BRCA1;PRC1;CCT5;KIF27;TPPP;STMN1;PACRG
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.4799828708605395,1.1794864984220554,0.2626641651031895,0.639993877566258,1.0,2/14,9.44%,CMPK2;AK5
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.3898580874391143,-1.1763727755122666,0.226457399103139,0.5821520704088516,1.0,8/27,18.12%,SLC9A2;SLC9B2;SLC8A1;SLC9A8;CNNM4;SLC3A2;SLC9A5;SLC8B1
prerank,copper ion binding (GO:0005507),0.3790510123956328,1.1755811361908557,0.2306451612903226,0.6456200328880145,1.0,7/42,10.61%,MOXD1;LOXL3;LACC1;PAM;CUTA;ACR;CUTC
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.348609457745325,1.1750045663609539,0.20615384615384616,0.6429731384441553,1.0,13/73,11.10%,LGR4;FPR2;GCGR;GP1BA;GLP2R;MC2R;SORCS2;RXFP2;BDKRB2;OPRD1;NMUR1;MAS1;NLRP6
prerank,chemokine receptor activity (GO:0004950),0.4371238885837083,1.1745783469501978,0.23479729729729729,0.639828632367081,1.0,6/24,17.30%,ACKR2;CCR9;ACKR3;CCRL2;CXCR4;GPR75
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.4776176164235527,1.1742803642250739,0.29523809523809524,0.6364476897315293,1.0,4/13,6.10%,PDGFRA;ITGA5;VEGFD;PDGFRB
prerank,growth factor activity (GO:0008083),0.34118437705724414,1.1728499259242895,0.20280811232449297,0.6356986539075554,1.0,19/74,19.81%,PTN;FGF1;OSM;IL11;VEGFD;TGFA;IL6;IGF2;FGF18;ENDOU;CSF1;BDNF;INHA;OSGIN2;OSGIN1;GDNF;IL7;HBEGF;ANGPTL3
prerank,cytokine receptor binding (GO:0005126),0.3383764970154446,1.1716714497136078,0.2115085536547434,0.6346664048965687,1.0,20/83,16.33%,TGFBR3;SMAD3;IL6ST;OSM;IL11;VEGFD;IL34;IL6;IL18;IL13RA1;ERAP1;TGFBRAP1;SH2B3;CSF1;JAK1;IL22;CCL25;CCRL2;IL23R;SMAD2
prerank,hexose transmembrane transporter activity (GO:0015149),-0.4814948658235885,-1.171606026899229,0.2597938144329897,0.5889265688675132,1.0,8/12,43.33%,SLC2A1;SLC2A4;SLC2A2;SLC5A3;SLC2A3;PPBP;SLC2A5;SLC2A6
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.5019421700486281,1.1702913286399204,0.29213483146067415,0.6341533075353698,1.0,1/13,0.34%,SLC7A2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.49067792588731696,1.1698313651305363,0.29111531190926276,0.6312709777391851,1.0,3/12,9.80%,SLC19A1;SLC17A9;SLC25A24
prerank,CXCR chemokine receptor binding (GO:0045236),0.5102138905379594,1.169276423747364,0.2896281800391389,0.6285185856342196,1.0,1/11,1.07%,CXCL10
prerank,glucose transmembrane transporter activity (GO:0005355),-0.4280452656909756,-1.1659338548454823,0.2736842105263158,0.5984405201954364,1.0,10/17,43.33%,SLC2A1;SLC2A4;SLC2A2;SLC5A11;SLC2A10;SLC5A3;SLC2A3;PPBP;SLC2A5;SLC2A6
prerank,nuclear receptor binding (GO:0016922),0.32556600050675205,1.1632225393432092,0.2023121387283237,0.6397278285768329,1.0,21/111,13.23%,TCF7L2;SMAD3;NCOA3;TRIP12;TGFB1I1;STAT5B;CRY1;TACC2;NCOA6;BAZ2A;TACC1;NSD1;OASL;STAT1;PHB2;TAF7;PPID;ZNHIT3;NR4A1;MED12;BRD8
prerank,protein phosphatase regulator activity (GO:0019888),0.36256189958276563,1.1631074081397053,0.25,0.6360689257487727,1.0,11/53,12.86%,RCAN2;PTN;PPP2R2B;EIF2AK2;RCAN1;PPP4R2;PPP4R1;PPP6R3;PPP1R16A;PPP1R7;SHOC2
prerank,iron ion binding (GO:0005506),0.3715785019237886,1.1619064935801169,0.23274478330658105,0.6350235840904108,1.0,9/48,15.09%,AGMO;KDM7A;AOX1;FECH;FTO;SCD5;TET2;PHYH;ALKBH1
prerank,nuclease activity (GO:0004518),0.36186365435544443,1.1585468590063024,0.23848684210526316,0.639882227815274,1.0,18/52,22.01%,ENPP1;REXO5;WRN;NTHL1;SND1;OGG1;ERCC5;DNASE1L1;DIS3;ERN2;RNASEH1;RNASE3;DFFB;DNA2;RNASEL;PARN;STK31;ZC3H12A
prerank,nucleotidyltransferase activity (GO:0016779),0.4490899267172328,1.1581428823479674,0.29739776951672864,0.6369735358013957,1.0,9/19,22.61%,TUT4;TERT;REV1;TENT2;CRPPA;TUT7;PAPSS1;TENT4B;PNPT1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4986307435644373,1.1573332702410706,0.29750479846449135,0.6351172029754214,1.0,3/11,9.80%,SLC19A1;SLC17A9;SLC25A24
prerank,acid-thiol ligase activity (GO:0016878),0.48868396132955155,1.1569845630577964,0.2734375,0.6321586004796537,1.0,4/13,17.44%,ACSL1;SLC27A2;ACSS1;ACSS3
prerank,GTPase regulator activity (GO:0030695),0.29718571115577713,1.1530266644071308,0.1928665785997358,0.6388089423776632,1.0,44/212,13.91%,ARHGAP29;RANBP3L;ALDH1A1;RIN2;ARHGAP10;ARHGAP42;ARHGAP20;ARHGAP18;ASAP1;DLC1;ARHGAP28;ARFGAP3;ARHGAP32;NRP1;TBC1D16;ERRFI1;SEC23A;RANBP2;ASAP3;GRTP1;RASA1;TAGAP;RALBP1;ARHGEF10L;ACAP2;ARHGAP26;SYDE1;GMIP;LRRK2;IQGAP2;RALGDS;DNM1L;IPO7;ARHGAP9;SIPA1L2;RAP1GAP;ARRB1;GNB5;SMAP2;LLGL2;NPRL3;WASL;TBC1D7;CDC42SE1
prerank,miRNA binding (GO:0035198),0.3985299836638409,1.1474103072333053,0.28146853146853146,0.6486488336265963,1.0,13/30,25.27%,TUT4;RC3H1;ZC3H7B;POU5F1;DDX21;HNRNPA2B1;PUM2;TUT7;ELAVL1;ZC3H12A;PNPT1;ZC3H10;MATR3
prerank,kinase binding (GO:0019900),-0.23693888261703,-1.1470212566568547,0.06015037593984962,0.6423184424554352,1.0,109/435,16.72%,FRMD5;DLG2;UNC5C;SLC12A7;SLC12A2;PTPRJ;PTPRK;PLCG2;PDE8A;BCAR3;TFRC;ACSL3;CSPG4;CIT;ACTB;RPS19;TIAM1;NSF;NBEA;CADPS;ACVRL1;UTRN;CALM1;CALM2;LRBA;EMP2;RPS6;RPS3;ESR1;RPS7;EEF1A1;DAB2IP;CTNNB1;ACTA2;HDAC7;HSP90AB1;CEP68;CALM3;RCC2;EEF2;WWC1;HNRNPA0;CEACAM1;CNTLN;RAD23A;SMCR8;RHOB;PIK3IP1;SIK1;NPM1;RFFL;SYN1;CCND1;FAS;TRIM68;TRIP6;TTC28;SNAP91;CNKSR2;INKA2;SPRED2;DVL1;RHOG;SMAD1;BORA;CAV2;POLA1;NEFH;BARD1;NBEAL2;ANKRA2;TBC1D14;BCAR1;ARHGEF7;EGFR;ATF4;JTB;USF1;SRCIN1;CEP43;CAV1;WDCP;CASP9;RAC1;USP37;RGCC;PRKRIP1;PPP1CC;RHOH;PGAM1;PARK7;PTPRC;SHC4;VDAC1;CDKN1A;NEK9;NR4A3;CYLD;MAPT;IRGM;LYST;NOD2;PLCG1;MYOM1;SPRED3;IBTK;VRK1;AP1B1;BTG1
prerank,cAMP binding (GO:0030552),-0.4815001928477753,-1.145340140777561,0.29791666666666666,0.6412826291998494,1.0,6/11,9.24%,PDE4D;PDE4B;HCN1;PDE10A;RAPGEF2;PDE2A
prerank,actin monomer binding (GO:0003785),-0.3895148563801648,-1.1446088684988422,0.2555066079295154,0.6382114523948499,1.0,8/22,24.79%,NOS3;TMSB4X;TMSB10;TWF1;PFN2;ABITRAM;PRKCE;PFN1
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.328538717301876,-1.144409406571152,0.24043715846994534,0.6335857137773978,1.0,12/46,15.97%,MGAT5;HEXB;EXT1;POMGNT1;LFNG;MFNG;B3GNT2;PIGQ;MGAT4A;GCNT1;B3GNT9;POMGNT2
prerank,chemorepellent activity (GO:0045499),0.42138578922969155,1.1421882629599522,0.2675521821631879,0.6579492108968718,1.0,3/25,1.02%,SEMA3D;DPP4;EPHA7
prerank,calcium ion binding (GO:0005509),0.2801410723590543,1.141664872159353,0.16183574879227053,0.6552238253147556,1.0,50/323,11.81%,ENPP3;TNNC1;FBN1;MAN1C1;ITPR1;SELP;GJB2;PLA2G4A;ENPP1;MICU1;CLEC3B;CEMIP2;PRF1;S100A6;ANXA2;CDH5;FBLN1;AMY1B;AMY1C;AMY1A;RCN1;ANXA3;S100A10;ANXA1;ADGRV1;PAM;ANXA11;CPNE1;ANXA4;PLA2G4C;CRP;THBS3;GLCE;ESYT1;ANXA5;DCHS1;PCDHB8;ANXA7;DSC2;DSC3;PLSCR4;SLC25A24;TPM4;STIM2;ENPP2;CDH13;PLSCR2;IHH;NUCB2;PPP3CB
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.3946608164338125,1.1406378118384322,0.2852233676975945,0.6537846678662655,1.0,15/32,23.26%,KDM7A;P4HTM;FTO;TMLHE;KDM2A;TET2;KDM8;PHYH;ALKBH1;KDM2B;ALKBH4;EGLN1;TET1;PHF8;HSPBAP1
prerank,PDZ domain binding (GO:0030165),0.34704700848117187,1.1357255646403501,0.2693498452012384,0.6629968913802812,1.0,6/61,3.41%,ARHGAP29;TGFBR3;PLEKHA2;CXADR;SDC2;FZD2
prerank,sulfotransferase activity (GO:0008146),0.38699010113958787,1.1346123199989786,0.30153321976149916,0.6618738436547825,1.0,3/33,4.64%,UST;CHST15;TPST1
prerank,metalloendopeptidase activity (GO:0004222),0.3380777560456686,1.13448053917221,0.24924471299093656,0.6583153746806727,1.0,13/76,12.01%,ADAMTSL5;ADAMTS12;ADAMTS10;ADAMTS1;ADAMTSL4;ADAMTS6;NRDC;THSD4;MMP14;PMPCB;NLN;ADAM19;PAPLN
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.44382362304997436,1.1240430803234467,0.3165735567970205,0.6812064678783777,1.0,2/17,9.44%,CMPK2;AK5
prerank,organic anion transmembrane transporter activity (GO:0008514),0.30175173392500837,1.122475838995537,0.24242424242424243,0.6816409824990255,1.0,15/134,5.93%,PDPN;SLC7A2;SLC1A3;SLC13A3;SLC6A13;SLC16A11;GJA1;SLC19A1;SLC6A9;SLC26A9;SLC16A12;SLCO3A1;SLC17A9;SLC35D1;SLC4A11
prerank,epidermal growth factor receptor binding (GO:0005154),0.4014344240796275,1.1205592669800128,0.33152173913043476,0.6826877239466591,1.0,4/25,6.05%,EFEMP1;FER;TGFA;ARF4
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4806199736288571,1.117487692839477,0.35555555555555557,0.6867129485446832,1.0,3/12,11.18%,TRAF5;STAT1;TRAP1
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.4001716875783603,-1.1166585732376064,0.31125827814569534,0.7014001569853285,1.0,4/18,6.99%,PIK3R1;PIK3R6;PIK3R3;WDR81
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.34934850727016525,-1.1164189005796137,0.31009615384615385,0.6964665457744618,1.0,6/34,7.21%,MYO10;CYTH3;ARAP2;ARAP3;HIP1R;AKT1
prerank,adrenergic receptor binding (GO:0031690),-0.4169490306004652,-1.1138500481269233,0.3304904051172708,0.6983365648583585,1.0,7/16,24.13%,PDE4D;GNAS;RAPGEF2;AKAP5;C1QBP;ADRB1;APLP1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.3795643895198374,1.1096183179740517,0.32669983416252074,0.7033862158536218,1.0,15/34,26.95%,NSD3;METTL21C;ETFBKMT;SETD4;SETD7;ATPSCKMT;SETD2;SETDB1;KMT5B;SMYD3;EHMT2;SUV39H1;SETD6;EEF1AKMT4;SMYD2
prerank,lipase activity (GO:0016298),0.3661619947839533,1.1081173283324957,0.3283582089552239,0.7035885508829828,1.0,2/43,1.31%,PLA1A;SMPD3
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.5004728971310783,1.1072801387875855,0.35952848722986247,0.7017806470015167,1.0,3/10,10.66%,SLC6A13;SLC6A12;SLC10A1
prerank,CoA hydrolase activity (GO:0016289),0.4539677138056076,1.1070333231505232,0.3550185873605948,0.6984757858511285,1.0,3/16,9.97%,ACOT11;ACOT9;ACOT1
prerank,CoA-ligase activity (GO:0016405),0.46029368276513555,1.1067291446717247,0.34296724470134876,0.6953589822480022,1.0,4/14,17.44%,ACSL1;SLC27A2;ACSS1;ACSS3
prerank,RNA binding (GO:0003723),-0.21273848830282627,-1.1062848312488713,0.04,0.7133269392356129,1.0,364/1321,22.83%,SORBS2;SYNE1;RIMS1;STRBP;NOL4;RPS24;ACTN1;TMSB4X;RALYL;QKI;HSPA8;LRRFIP1;TCF20;RPS9;RPL18A;TFRC;RPL19;TPT1;RFTN1;CMSS1;NOVA2;FAU;RPS12;ADARB1;RPL26;RPL41;RPS15;RPL24;RPS23;MBNL1;CELF4;RPL5;KHDRBS2;RPS27;RPS19;RPL38;RBFOX3;LIN28B;RBFOX1;SCG3;PUS7;RPS8;SETX;RPL10A;RPL27A;RPL13;LUC7L3;CSTF2;RPS18;MACF1;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;R3HDM1;ELAVL2;RPL39;RPS17;ATXN2;RPS7;RPL37A;KIF1C;RPL4;RPS25;EEF1A1;PTBP1;CPEB2;RPS15A;ELP1;CEBPZ;RPL6;ADARB2;RPL11;RPLP0;RPS21;RPS28;RPL28;TAF15;RPL32;RPL8;HMGB1;PUF60;KHDRBS3;STXBP1;SCAF4;PKM;RPL13A;RPL30;DHX15;SRP14;SRSF2;HSP90AB1;YBX1;ATP5F1A;RPS20;RPS4X;ZFR2;GTPBP1;MRPL4;RPL18;KPNB1;RPS13;TES;CPSF2;NOL11;RCC2;EEF2;MTCL1;UNK;RPS2;RRP7A;SRSF1;APOBEC1;ZCRB1;HNRNPA0;PHF6;CNBP;MYEF2;DDX54;HNRNPK;RPL14;DDX49;RPL22;PCBP1;TIAL1;DDX11;PUM3;HNRNPH2;SSRP1;ZC3H11A;PPIL4;NPM1;YTHDF2;SREK1;DDX47;DYNC1H1;WDR36;DDX17;TRA2A;THOC2;SART3;FAM32A;YY1;DNTTIP2;BUD13;GFM1;KCTD12;MAP3K20;HSPE1;RPS26;TRIP6;CALR;NKAP;BYSL;KARS1;GNL3L;RO60;CCAR2;DHX30;YTHDC2;CARS1;RACK1;GDI2;PSMD4;NELFCD;MAK16;MANF;RPS10;NOL12;IGHMBP2;EXOSC2;NIP7;EIF5B;RALY;NVL;EIF4A1;BARD1;FTSJ3;RPL23;RPL17;PSMA6;PTCD2;PABPC4;EIF1B;EIF5A;WBP11;FKBP3;RPL29;MRPL1;PABPC4L;H1-0;THUMPD1;RPP30;S100A16;HSP90AA1;MRPS30;GSPT2;EIF3A;MRPS23;RPL22L1;RPS5;ELP5;PPAN;GRN;FASTKD2;RPS14;SLC3A2;NOP56;SNRNP35;DCP1A;PRKRIP1;LSM14B;ACTN4;PPP1CC;RAE1;SART1;TUBB4B;PPRC1;SNRPB;DBR1;ANP32A;VIRMA;MSI2;FAM120C;PPIA;PARK7;HNRNPF;XPOT;AKAP1;MRM1;CCDC47;CPEB4;RARS2;TUBA1B;ZC3H13;MAPT;HMGN2;ZGRF1;SRBD1;MTPAP;SRP9;ZMAT3;ENO1;MRPL28;RPL12;ZCCHC3;NOL7;NUDT16L1;MYO18A;CSTF2T;ADD1;RBM33;RPL9;SMNDC1;ESF1;FRG1;DDX51;UBE2O;RBM3;XRN2;BRCA1;RPS19BP1;RPL37;IMP3;RBM19;GNL3;ERI1;LUC7L;RPS11;CS;EIF1;PPIB;DUSP11;HSD17B10;MEX3A;DICER1;RNPS1;PABPC1;LGALS1;LLPH;N4BP1;SNRPF;CCDC9;TRIM28;SRSF9;SNU13;RAVER2;YRDC;POLDIP3;FKBP4;MRPS5;RIDA;ZCCHC8;NOC2L;NONO;RPL7;RPL31;RPL7A;C1QBP;MKRN1;EWSR1;UTP6;EIF3H;TYW5;RBM15B;RBM47;EIF4A2;WRAP53;EIF3G;PPP1R10;SAFB2;TRMT6;BMS1;YARS2;RTCA;UPF1;PURB;LSM4;FAM98A;MKI67;ALKBH5;RPL3;BAG4;SNRPD1;SNRPD2;NANOS3;MEX3D;HNRNPLL;HEATR1;DHX35;UTP11;TFB2M;TRMT9B;MRPL23;MRPL9;FAM50A;FBRSL1;MDH2;ZC3H8;SRSF6;CAPRIN1;SF3B5;CELF6;GSPT1;CHTOP;NKRF;FASN;MCAT;TFB1M;CPSF3;MRPS31;HEXIM2;TOE1;WDR46;FLYWCH2;HDGF;SRF;MRPS12;RPL23A;SYF2;YWHAZ;TUFM
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.42096670843941636,1.1061013455368511,0.3262786596119929,0.6931881323904339,1.0,7/20,20.04%,AGPAT4;MOGAT3;AGPAT3;DGAT2;LPGAT1;ABHD5;DGAT1
prerank,E-box binding (GO:0070888),0.37498303540325706,1.1058016359864724,0.34775374376039936,0.6902141217277317,1.0,1/34,0.06%,TCF4
prerank,ion channel inhibitor activity (GO:0008200),-0.3334240347122909,-1.1045298495721112,0.3033419023136247,0.7129239700856719,1.0,9/35,10.38%,KCNMB2;FKBP1A;MCUB;CALM1;CALM2;CAMK2D;SLC30A1;NEDD4L;RACK1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.37012490270310106,1.104027592504692,0.32348111658456485,0.6909879397047054,1.0,3/35,2.99%,TEC;STYK1;FER
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.33836768624075164,1.1034124177710911,0.3241491085899514,0.6889814971726167,1.0,16/60,17.03%,LRRK1;CTDSPL;PPM1E;PPM1A;MTMR3;PPEF2;CTDSP2;LRRK2;PPM1B;PPP1CB;CDC14A;PPP3CB;PPM1M;CTDSP1;PPP2CA;CDKN3
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.3991720614376348,1.102465340175564,0.3415929203539823,0.6879154797015798,1.0,6/26,4.54%,SLC6A13;SLC16A11;SLC16A2;SLC16A12;SLC6A12;SLC16A5
prerank,protein kinase inhibitor activity (GO:0004860),-0.3274931682943361,-1.1021132519464905,0.27848101265822783,0.7136611548023758,1.0,15/42,19.56%,CIT;SNCA;SMCR8;NPM1;SH3BP5L;MAPK8IP1;INKA2;SPRED2;RACK1;CEP43;PRKRIP1;CDKN1A;IBTK;CDKN1C;SPRED1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.4779608292510685,1.0990770883655459,0.36446886446886445,0.6931341634291603,1.0,2/11,8.11%,SASH1;PPEF2
prerank,solute:sodium symporter activity (GO:0015370),-0.35068926496127595,-1.0984712709050553,0.3175355450236967,0.7181714780564343,1.0,9/27,32.62%,SLC4A10;SLC5A6;SLC4A7;SLC20A2;SLC5A11;SLC13A5;SLC5A3;SLC4A4;SLC4A5
prerank,metal ion binding (GO:0046872),0.26302992573381434,1.0952466227667477,0.22606689734717417,0.6994529630339398,1.0,76/477,13.27%,EYA2;IGFBP3;ENPP3;TNNC1;FBN1;MAN1C1;ITPR1;SELP;GJB2;PLA2G4A;ENPP1;MICU1;OXSR1;CLEC3B;TSSK3;CEMIP2;PRF1;DCTPP1;S100A6;CLYBL;ANXA2;CDH5;FBLN1;AMY1B;AMY1C;AMY1A;RCN1;ANXA3;S100A10;ANXA1;ADGRV1;WRN;PAM;ANXA11;PIR;CPNE1;IDH1;TESMIN;ANXA4;PLA2G4C;CRP;THBS3;PAPOLG;GLCE;ESYT1;ANXA5;DCHS1;PCDHB8;ANXA7;STK3;SIK3;PDXK;LRRK2;DSC2;DSC3;PLSCR4;SLC25A24;TPM4;STIM2;GEM;ENPP2;HACL1;CDH13;PLSCR2;IRAK3;ADPRS;IHH;NUCB2;PPP3CB;CRNN;TRIM26;OPA1;SRPK1;IDH2;SMOC2;BAIAP3
prerank,vinculin binding (GO:0017166),-0.4525495124620128,-1.0929104063516628,0.363265306122449,0.7279602060738926,1.0,3/11,3.65%,ACTN1;DMD;UTRN
prerank,cation channel activity (GO:0005261),0.3128131026279102,1.0927049503253394,0.29515418502202645,0.7025133472664981,1.0,18/94,11.63%,TRPM3;MCU;TRPM6;NALCN;ANXA2;KCNQ4;SLC24A3;P2RX1;TMEM38A;SLC4A11;ANO10;CALHM2;OTOP1;PKD1L3;PANX1;TRPC1;ANO6;GRIN3B
prerank,protein kinase binding (GO:0019901),-0.22331493862760166,-1.0913696048930286,0.1223021582733813,0.7267229446581089,1.0,117/480,16.54%,FRMD5;UNC5C;SLC12A7;SLC12A2;PTPRJ;PTPRK;PRKCB;PLCG2;GRM5;PDE3B;BMPR2;TFRC;ACSL3;RYR2;CSPG4;CIT;ACTB;RPS19;NSF;NBEA;CADPS;ACVRL1;UTRN;CALM1;CALM2;LRBA;EMP2;RPS6;RPS3;ESR1;RPS7;EEF1A1;DAB2IP;NELL2;PKN1;HINT1;PRKAR1A;ACTA2;HDAC7;HDAC9;CEP68;CCDC88A;CALM3;TCF3;RCC2;EEF2;MAP3K11;ACE;HNRNPA0;CEACAM1;CNTLN;SMCR8;RHOB;SIK1;PINK1;NPM1;RFFL;SYN1;CCND1;TRIM68;DUSP22;SNAP91;CNKSR2;INKA2;SPRED2;DVL1;DUSP8;GCH1;RHOG;RACK1;SMAD1;BORA;CAV2;POLA1;NEFH;NBEAL2;ANKRA2;TBC1D14;BCAR1;PRKAR2B;ARHGEF7;KCNQ1;ATF4;JTB;USF1;SRCIN1;ACVR1;HSP90AA1;CEP43;CAV1;CAVIN2;MAPK8IP3;CASP9;RAC1;USP37;RGCC;PRKRIP1;PPP1CC;RHOH;TJP2;PGAM1;PTPRC;SHC4;VDAC1;CDKN1A;NEK9;NR4A3;CYLD;MAPT;IRGM;LYST;NOD2;PLCG1;SPRED3;IBTK;VRK1;AP1B1
prerank,"DNA binding, bending (GO:0008301)",0.4481021449997259,1.0887805249994194,0.35583941605839414,0.7087795404317063,1.0,2/14,1.80%,FOXD1;FOXC1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.37946096801614687,-1.0868910971570553,0.35344827586206895,0.7339659160482017,1.0,5/21,20.27%,GRM5;GRIA1;CHRNA4;CHRFAM7A;CHRNA7
prerank,voltage-gated calcium channel activity (GO:0005245),-0.33056718080494457,-1.0849676480455681,0.31666666666666665,0.7337794954211332,1.0,6/37,9.86%,CACNA1E;CACNB2;CACNB4;OPRM1;CACNA1G;CACNA1D
prerank,potassium:proton antiporter activity (GO:0015386),-0.4660548946008872,-1.0828569538230555,0.374749498997996,0.734137779745801,1.0,3/10,14.68%,SLC9A2;SLC9A8;SLC9A5
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.46991417087648457,-1.0816506193629405,0.3895582329317269,0.7321471843839099,1.0,5/10,19.24%,PIK3C2B;PIK3R3;ATM;PIK3CD;PIK3C3
prerank,acetyltransferase activity (GO:0016407),0.37630689760762154,1.07986464646473,0.348993288590604,0.7280188051742625,1.0,10/31,16.97%,CREBBP;KAT6B;NAA16;PAFAH1B3;ESCO1;ACAT1;NAA15;KAT6A;KAT2B;PAFAH2
prerank,metallopeptidase activity (GO:0008237),0.30393466692899046,1.0776269513235552,0.33760683760683763,0.7297738581521237,1.0,22/113,14.01%,ADAMTSL5;PAPPA;ADAMTS12;ADAMTS10;ADAMTS1;ADAMTSL4;ADAMTS6;NRDC;ANPEP;BMP1;THSD4;MMP14;ADAM12;ERAP1;MYSM1;PMPCB;NLN;ADAM19;PAPLN;RNPEP;ADAMTS7;LNPEP
prerank,transferrin receptor binding (GO:1990459),0.4802724450157451,1.076415786275498,0.3799621928166352,0.7292702300201037,1.0,2/10,12.58%,RGMA;HFE
prerank,aminopeptidase activity (GO:0004177),0.39161620582637013,1.0751948602021304,0.3623931623931624,0.7288781369028806,1.0,9/26,14.11%,ANPEP;MMP14;NPEPPS;CTSH;ERAP1;BLMH;RNPEP;LNPEP;KDM8
prerank,microtubule binding (GO:0008017),-0.2397449098188565,-1.074238479890674,0.2672811059907834,0.7470135277694298,1.0,50/222,17.80%,DNM3;MTUS1;SGIP1;SYBU;NAV3;MID1;KIF1B;EML6;REEP1;KIF26B;MACF1;KIF21A;RPS3;KIF1C;FMN1;RP1;STARD9;ARHGEF2;CRIPT;MID2;CCDC88A;RCC2;MTCL1;MAP1B;TERF1;HDAC6;SNPH;KIF26A;KIF18A;NEFH;FGF13;KIF5C;KIF15;KIF3B;NDE1;CLASP2;RAE1;KIF16B;KIF5A;MAPT;CLIP2;KRIT1;MAP2;SKA2;CEP290;CCDC69;GAS2L3;PRC1;KIF27;TPPP
prerank,cytokine receptor activity (GO:0004896),0.3071689835177395,1.0670735252926613,0.34852941176470587,0.7463998296906756,1.0,6/83,2.39%,LEPR;GHR;IL31RA;IL6ST;ACKR2;CCR9
prerank,protein phosphatase binding (GO:0019903),-0.2580890663329905,-1.063722539374658,0.29605263157894735,0.7704553144195524,1.0,24/117,16.20%,PPP1R16B;GRIN3A;FOXO1;PIK3R1;PHACTR4;MAP3K5;PPP1R3B;MET;DAB2IP;CTNNB1;SNX3;FBXL2;CEACAM1;MFHAS1;PPP1R11;PTPRT;RACK1;EGFR;KCNQ1;SOD1;MYO16;MAPT;PPP1R3C;ADCY8
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.4486070845039907,1.0625314709973324,0.399624765478424,0.7546467861785644,1.0,4/14,8.34%,COL4A3;TIMP3;BST2;TIMP2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.43605015992180873,1.0610031992855222,0.37595419847328243,0.7547817959686762,1.0,2/14,10.33%,RSAD2;ACO1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.4037352960644988,-1.059821769095407,0.4012738853503185,0.7757845438114043,1.0,8/15,30.34%,COX4I1;COX8A;NDUFA4;COX6A1;NDUFA4L2;CYB5A;COX4I2;COX5B
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2658316325360319,1.0581475316560656,0.32702020202020204,0.7582669281559778,1.0,39/254,13.49%,TCF4;SMAD3;RBPJ;ELF1;FOXC1;NFIA;NFYC;NFAT5;SPIB;ZNF395;FOXC2;MYB;HOXC4;LITAF;HLF;PRRX1;TCF12;KLF5;CREB3L3;PPARA;GLIS2;CREBRF;ZSCAN21;MEF2A;RLF;ELF4;E4F1;RFXANK;RFXAP;SMAD4;FOXO3;NR4A1;EGR2;HOXA10;NFIC;MZF1;NR3C1;GMEB1;NRF1
prerank,histone methyltransferase activity (GO:0042054),0.3610386624993857,1.0566935018967385,0.3695652173913043,0.7584863331952362,1.0,13/32,26.95%,SUZ12;KMT2C;NSD3;SETD7;CARM1;SETD2;SETDB1;KMT5B;SMYD3;PRMT1;EHMT2;SUV39H1;SMYD2
prerank,zinc ion binding (GO:0008270),0.26290649133582455,1.0564658447701978,0.3316770186335404,0.7552230488167619,1.0,55/293,14.52%,KMT2A;ENPP3;CBLB;SMAD3;ENPP1;PAPPA;KDM7A;SHMT1;RC3H1;LITAF;UBA5;ANPEP;SEC23A;MYCBP2;PAM;ZNF3;CSRP1;HDAC4;NPEPPS;NSD1;SEC24D;GLO1;TRIM24;SKI;ZMYND11;TIMP2;BAZ1B;ZFP37;ZEB1;ACR;PDXK;SLU7;MNAT1;QPCTL;ERAP1;ENPP2;ESCO1;SEC24C;ZCCHC4;FNTB;KDM5B;NQO2;EEA1;THAP1;PTPN1;KDM2A;TET2;TIMM9;RNPEP;ZNF205;KAT6A;LNPEP;MDM4;IFIH1;RCHY1
prerank,tau-protein kinase activity (GO:0050321),0.4081477271993257,1.0555176240756703,0.3953488372093023,0.7538703539039612,1.0,3/20,8.64%,ROCK2;GSK3B;SIK3
prerank,lysophospholipase activity (GO:0004622),0.39281501243666966,1.054827917238832,0.4,0.7520538774169304,1.0,4/20,10.73%,PLA2G4A;PLA2G4C;PLA2G6;ENPP2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3370591432609658,1.0511120304405999,0.3984,0.7578990230632916,1.0,7/44,11.07%,KMT2A;KMT2C;NSD3;NSD1;SETD4;SETD7;SETD1B
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.44605141624991596,1.0510571464319385,0.3937007874015748,0.7543355942780253,1.0,3/12,3.31%,CDH5;ITGA5;VEGFD
prerank,phosphatase activator activity (GO:0019211),-0.4003952318837418,-1.0510045462498703,0.4,0.7954530511874336,1.0,9/14,24.30%,PHACTR4;CALM1;CALM2;CALM3;PPP2R5B;PPP2R5D;PPP1R15A;PPP2R5A;B3GAT3
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3523071733905043,-1.0506974934339777,0.3701149425287356,0.7905765360944257,1.0,8/24,17.26%,RPL26;RPL41;RPL5;RPS7;RPS13;RPS14;GNL3;CCT5
prerank,protein homodimerization activity (GO:0042803),0.24985081874383772,1.0503189672747681,0.3348314606741573,0.7526631270241967,1.0,110/590,15.77%,KMT2A;TNNC1;DPP4;SMAD3;NADK2;ZHX2;NR2F2;PDGFRA;FGFR1;MTUS2;MAPK4;ENPP1;GHR;CPQ;GBP2;APOA2;SHMT1;ZBTB4;BMPR1A;NR6A1;S100A6;SNX6;GLIPR2;HSD17B1;DGKD;S100A10;AOX1;KIT;TERT;WRN;IL17D;UBA5;CRYL1;EFEMP2;FECH;TPST1;ARNT;BCL2;TPM1;RDH5;MCL1;APPL2;TPR;IDH1;ZDHHC3;CREB3L3;FOXP3;TRIM5;GBP5;BST2;NOS2;DPYD;GBP4;GYG1;SPPL3;GLCE;STAT1;GOLGA5;RIPK2;SNX9;EXD1;PHB2;BAX;PDXK;LRRK2;APPL1;TPM4;FBXO4;PLEK;PAFAH1B3;DNM1L;BCL2L1;IRAK3;SMAD4;CSF1;DGAT2;TRIM21;NQO2;EEA1;ABCD3;THAP1;NOG;RAP1GAP;MAP3K13;PGRMC1;SUPV3L1;PON3;MZF1;BHLHE41;CCDC66;NPR3;NRF1;SDCBP2;PIP4K2B;ADRA2C;TIMM9;CIB2;ERCC5;TARBP2;RCHY1;PML;GDF15;CHMP4A;CHMP4B;ADRA2A;CUBN;STK4;HSPB6;FLRT3;PKD2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.4318247371892497,-1.0490535231768234,0.40365111561866124,0.7896798722354827,1.0,6/12,20.73%,NOD1;ATP2A3;RACK1;PYCARD;CASP1;BAD
prerank,myosin II binding (GO:0045159),-0.4419152174771101,-1.0466450545968602,0.39662447257383965,0.791375969103935,1.0,3/10,10.73%,SHROOM4;STXBP5L;SHROOM1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4084855622221319,-1.044697338422442,0.43149284253578735,0.7910084107459235,1.0,2/14,1.62%,SLC26A7;SLC26A2
prerank,beta-tubulin binding (GO:0048487),0.35569617976755574,1.0401500677042357,0.38747884940778343,0.7749635630956235,1.0,6/31,9.78%,GJB6;DLEC1;UXT;EML4;PDCD5;APPL1
prerank,dynactin binding (GO:0034452),0.4512658633488002,1.0392237444969803,0.42435424354243545,0.7737500540181469,1.0,2/12,7.65%,SNX6;GSK3B
prerank,endopeptidase activator activity (GO:0061133),-0.4482230609191461,-1.0391397979547028,0.4270833333333333,0.8013651499486513,1.0,4/10,26.69%,PSMD14;PSENEN;PSME1;NLRC4
prerank,methylated histone binding (GO:0035064),0.3226427243072853,1.0384763910363641,0.3924050632911392,0.7719617422554946,1.0,25/62,24.69%,KDM7A;SUZ12;MORC3;DPF2;TRIM24;ZMYND11;GLYR1;TAF7;RRP8;BPTF;MORC4;KDM8;PYGO1;LRWD1;CHD8;MBTD1;MPHOSPH8;PHF1;PHF13;PHF8;ZCWPW1;TAF1;WDR5;ING5;ATRX
prerank,protein kinase C binding (GO:0005080),0.3382199791495775,1.03837628217581,0.41680960548885077,0.7686137714702584,1.0,12/43,15.76%,PRKCSH;NELL1;PARD6G;DACT1;PARD6A;TOP2B;PLEK;GRK5;DACT2;CAVIN3;ADCY6;PRKD2
prerank,phospholipase A2 activity (GO:0004623),0.3774190396075962,1.0378593993808805,0.420863309352518,0.7662248368231472,1.0,3/26,8.09%,PLA2G4A;PLA2G4C;PLA2G6
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.30449442561285556,1.036902300255117,0.4024767801857585,0.7649352803088599,1.0,13/74,10.05%,NADK2;FAM20C;FAM20A;DGKD;HYKK;PI4KA;PANK2;PIK3C2A;FAM20B;GALK2;PDXK;GK5;TRPT1
prerank,cyclic nucleotide binding (GO:0030551),0.3912146131491614,1.0366885854747507,0.4052044609665427,0.7618666114697081,1.0,5/21,6.52%,RAPGEF4;PDE5A;SLC19A1;POPDC2;CNBD2
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3313165957469134,1.0340967355083581,0.40348101265822783,0.7649324613601677,1.0,6/49,6.53%,MPPED2;ATP1A2;DUSP10;DUSP28;PTPN22;DUSP16
prerank,cGMP binding (GO:0030553),-0.4230281224238064,-1.0336206628905875,0.44672131147540983,0.811567243919065,1.0,4/11,9.24%,PDE11A;PDE10A;RAPGEF2;PDE2A
prerank,protein phosphatase 2A binding (GO:0051721),-0.3503114549316279,-1.0327033267093964,0.3977777777777778,0.8088466718372077,1.0,6/23,16.20%,GRIN3A;FOXO1;DAB2IP;MFHAS1;MAPT;ADCY8
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.25919885280908533,-1.0292985904503393,0.3885542168674699,0.8132575207554882,1.0,23/91,15.71%,PLCB1;HIP1;KCNJ2;SYTL2;HIP1R;SNX3;CLVS1;KCNH1;SDCBP;SYT7;STXBP6;PLEKHA5;LDLRAP1;RAB35;SNAP91;MARK1;KCNQ1;AMER2;KIF16B;SNX18;MAPT;KRIT1;TWF1
prerank,endoribonuclease activity (GO:0004521),0.35281681567299417,1.0266585066613938,0.43157894736842106,0.7799782175200604,1.0,12/32,23.42%,PIWIL4;NYNRIN;SND1;SMG6;ENDOU;SLFN14;ZC3H12B;ERN2;RNASEL;YBEY;ZC3H12A;KHNYN
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.4064075990407306,-1.025853636174406,0.46458333333333335,0.8173335776864142,1.0,4/13,12.24%,RYR2;PRKAR1A;PRKAR2B;KCNQ1
prerank,NF-kappaB binding (GO:0051059),0.37522822187860183,1.025427896099841,0.43031358885017423,0.7794132723862421,1.0,5/24,7.65%,MTDH;CPNE1;FOXP3;ANXA4;GSK3B
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3754368909157113,1.023808694637873,0.44502617801047123,0.780138070539232,1.0,4/25,6.27%,PLEKHA2;GAB2;ADAP2;PLEKHA4
prerank,potassium ion antiporter activity (GO:0022821),-0.3933117505902024,-1.0235818172607196,0.4236559139784946,0.8188013437160035,1.0,3/15,6.32%,SLC9A2;SLC24A2;SLC9A8
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.4367492543493678,1.023548700056101,0.4074074074074074,0.777219677988896,1.0,3/12,11.58%,GAB2;FRS2;SH2B3
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.4572636232487792,1.0221181036503182,0.44594594594594594,0.7738885306914666,1.0,3/10,12.10%,DUSP10;DUSP16;DUSP5
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.4572636232487792,1.0221181036503182,0.44594594594594594,0.7738885306914666,1.0,3/10,12.10%,DUSP10;DUSP16;DUSP5
prerank,phosphate ion binding (GO:0042301),-0.4347039236792559,-1.0219831272235609,0.4282744282744283,0.8180311462822631,1.0,5/10,29.65%,PDE2A;PNP;ADSS2;ADSS1;RELA
prerank,cardiolipin binding (GO:1901612),0.4485847633990232,1.0209983209954525,0.4277456647398844,0.7730640426614305,1.0,4/10,25.30%,GSDME;OPA1;GSDMD;STOML2
prerank,snoRNA binding (GO:0030515),-0.3230608556611979,-1.0204556666999194,0.4168618266978923,0.8171984250300361,1.0,15/30,35.68%,BYSL;NOP56;NUDT16L1;IMP3;SNU13;UTP6;BMS1;HEATR1;IMP4;NUDT16;NOP10;PRKDC;NHP2;NUDT1;DHX37
prerank,peptidoglycan binding (GO:0042834),-0.4334468167008517,-1.0199609126833014,0.45114345114345117,0.8132687854401968,1.0,4/10,15.58%,NOD1;PGLYRP1;RNASE7;NOD2
prerank,pyrophosphatase activity (GO:0016462),0.3194066360186973,1.0197781352556117,0.4344391785150079,0.7727635022861137,1.0,5/50,7.45%,ENPP3;ENPP1;DCTPP1;ENTPD7;DCP2
prerank,alpha-actinin binding (GO:0051393),0.3699185344411108,1.018985852579935,0.42657342657342656,0.77138395312605,1.0,7/24,17.90%,DAG1;SYNPO2;PRICKLE4;CACNA1C;RARA;PKD2;PDLIM2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.29900553056456836,1.0183339625064054,0.40476190476190477,0.7696459358405446,1.0,11/75,8.95%,SDR9C7;RDH10;LDHAL6B;PGD;PHGDH;CRYL1;RDH5;ME2;PTGR1;DHDH;GLYR1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.3454444221174528,-1.0176212318846625,0.4153498871331828,0.8141907419703968,1.0,5/23,8.81%,HIP1;HIP1R;SNX3;CLVS1;PLEKHA5
prerank,guanyl ribonucleotide binding (GO:0032561),0.2634212859929805,1.0150429668300909,0.43108108108108106,0.7744658656699098,1.0,50/196,19.74%,MPPED2;GBP6;PDE5A;GBP2;RRAS2;SLC19A1;RAB10;RAB22A;ARL3;RHOBTB2;ARF4;GBP5;RHOF;GTPBP10;GBP4;RRAD;RHOQ;LRRK2;ARF3;RAP2C;GEM;RABL6;GBP7;TUBA1C;TUBE1;RHOC;TUBB6;PIP4K2B;RHOU;ARL4A;MIEF1;TUBB2B;ATL1;GBP3;RAB5A;RIT1;TUBD1;TRIM23;ARF1;RAN;RAP2B;LSG1;GNAI3;RHOT1;RANBP17;ARL6;DIRAS1;RHOT2;ARFIP2;NRAS
prerank,TBP-class protein binding (GO:0017025),-0.34526415091146556,-1.014570379429426,0.4230769230769231,0.817314419553708,1.0,11/21,38.56%,ESR1;HHEX;TAF11;PSMC5;GTF2A2;TAF1B;RUVBL2;THRA;GTF2B;PSMC1;YEATS2
prerank,metalloaminopeptidase activity (GO:0070006),0.4083908311328316,1.0130235115066066,0.4394213381555154,0.7760367645118382,1.0,6/16,14.01%,ANPEP;MMP14;NPEPPS;ERAP1;RNPEP;LNPEP
prerank,tau protein binding (GO:0048156),-0.2978570331857304,-1.0130011490531332,0.42962962962962964,0.8165782215551969,1.0,11/40,15.98%,ACTB;SNCA;S100B;HSP90AB1;LGMN;HDAC6;MARK1;TTBK1;HSP90AA1;BRSK2;MAP2
prerank,ribosomal small subunit binding (GO:0043024),-0.37192008874068083,-1.0128323253065723,0.4403470715835141,0.8118509435117625,1.0,9/17,37.27%,CPEB2;NPM1;EIF1B;EIF1;PIM1;ERAL1;DHX29;MTIF2;UNG
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.43010667968018834,1.0126907033625592,0.42578125,0.77344755239534,1.0,4/12,15.92%,TENT5A;PAPOLG;TENT2;PAPOLB
prerank,ligand-gated calcium channel activity (GO:0099604),-0.35735731889219735,-1.0084902866737944,0.43636363636363634,0.8184166716304964,1.0,5/19,9.11%,RYR2;GRIN2A;RYR3;GRIN2B;GRIN1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.4264021678323927,-1.0055547521042145,0.45670995670995673,0.8212465292065326,1.0,2/11,4.81%,LEF1;GATA2
prerank,mechanosensitive ion channel activity (GO:0008381),-0.40801439764967073,-1.005264027230814,0.44635193133047213,0.8170800484069954,1.0,1/12,0.51%,PIEZO2
prerank,retinoic acid receptor binding (GO:0042974),0.39915645267208566,1.002711873386994,0.46415770609318996,0.7952730386022088,1.0,3/17,6.88%,NCOA6;TACC1;NSD1
prerank,phosphatase inhibitor activity (GO:0019212),0.3757490013036576,1.0026012522852286,0.45880149812734083,0.7921089208880494,1.0,8/20,24.31%,PTN;ANP32E;BOD1L1;URI1;STYX;STYXL1;PPP1R2;CABIN1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.362028437173695,1.0021627222259528,0.4626334519572954,0.789694400959679,1.0,5/25,6.49%,MICAL3;CYP27A1;POR;FMO5;NOS2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3206358231899364,1.002131211797021,0.46296296296296297,0.7863847123155578,1.0,9/49,7.88%,PLA2G4A;ANXA2;ANXA3;ANXA1;CPNE1;ANXA4;PLA2G4C;ESYT1;ANXA5
prerank,steroid hydroxylase activity (GO:0008395),0.40070610661357964,1.0001022344360193,0.48811700182815354,0.7877745045208625,1.0,2/16,3.21%,CYP7B1;CYP27A1
prerank,protein phosphatase activator activity (GO:0072542),0.4270853903949658,0.9997640659651703,0.45569620253164556,0.7852779080140386,1.0,1/13,0.16%,IGFBP3
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.2649207632818918,0.9992509691763514,0.46808510638297873,0.783271606824316,1.0,34/173,16.64%,ZBTB20;ZEB2;MXI1;KCNIP3;ZBTB4;NFATC4;AEBP1;GZF1;OTP;ZNF3;FOXP3;PPARA;ZBTB37;SKI;ZNF25;ZFP37;ZEB1;CREM;E4F1;HEYL;FOXO3;ZNF219;THAP1;MZF1;BHLHE41;NR3C1;HIC1;PRDM5;ZBTB21;ZBTB12;POU5F1;JDP2;POU6F1;ZBTB5
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3529182280391272,0.9979454804699598,0.47602131438721135,0.7832431194647794,1.0,14/29,23.43%,DUSP10;TPR;DUSP16;ATF7;MAPK14;DUSP5;MAPKAPK5;MAPKAPK3;DIRAS1;TNIP1;MAPK7;CDK5RAP3;PRMT1;DUSP4
prerank,MAP kinase phosphatase activity (GO:0033549),0.4270299554422952,0.9978785452877502,0.48956356736242884,0.7801017059928179,1.0,3/12,12.10%,DUSP10;DUSP16;DUSP5
prerank,phosphotyrosine residue binding (GO:0001784),-0.30967896201832484,-0.996703841839675,0.46329113924050636,0.8352217122141408,1.0,14/37,24.79%,PLCG2;BCAR3;PIK3R1;SHE;PIK3R3;LDLRAP1;VAV1;SYK;PTPN5;SHD;IRS1;SAMSN1;SHC3;PFN1
prerank,U6 snRNA binding (GO:0017070),-0.39440719071366437,-0.9944867493756653,0.4758909853249476,0.8364964562474516,1.0,7/14,30.83%,SART3;EIF5A;LSM4;LSM2;LSM3;LSM8;PRPF8
prerank,SH3 domain binding (GO:0017124),-0.270759712697866,-0.9881500253070516,0.48360655737704916,0.8488929768083568,1.0,11/62,10.75%,AFAP1L1;SGIP1;SHANK3;ENAH;ELMO1;ADAM15;DAB2IP;ARHGAP27;ABI3;VASP;CBL
prerank,ion gated channel activity (GO:0022839),-0.3292033921260626,-0.9860872664021344,0.48842592592592593,0.8490413699615666,1.0,9/24,15.36%,ANO1;ANO3;KCNT1;TMEM63C;ANO4;TTYH2;TTYH3;ANO2;TTYH1
prerank,general transcription initiation factor binding (GO:0140296),-0.3195231276812744,-0.9845382294324575,0.4782608695652174,0.8481722074311026,1.0,12/25,38.56%,ESR1;HHEX;TAF11;PSMC5;RELA;GTF2A2;TAF1B;RUVBL2;THRA;GTF2B;PSMC1;YEATS2
prerank,mannosyltransferase activity (GO:0000030),0.36514211363293947,0.9816432250920607,0.4808362369337979,0.8167453979633172,1.0,4/21,7.25%,TMTC4;TMTC1;ALG9;POMT2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.3042895617785429,-0.9787702877587005,0.45260663507109006,0.8590971473903566,1.0,9/30,16.84%,CST3;GAS6;SNCA;SERPINB9;PTTG1;SPOCK1;RPS6KA1;CD27;UBE2O
prerank,DNA secondary structure binding (GO:0000217),0.34440669873281493,0.9783787675847043,0.4804088586030664,0.8211684109868539,1.0,6/31,14.03%,KMT2A;WRN;FANCM;RBBP8;RAD51B;ERCC5
prerank,estrogen receptor binding (GO:0030331),-0.31419105578870427,-0.9781085146633274,0.49878345498783455,0.8557323931996735,1.0,5/32,7.65%,LEF1;RERG;ESR1;CTNNB1;DDX54
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.40553125159200776,-0.9778191902777792,0.5085106382978724,0.8514814157880803,1.0,6/12,31.60%,B3GNT2;B3GNT9;B3GNT3;B3GNT6;B4GAT1;B3GALT1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.34431787514899703,0.9775175026931736,0.5017361111111112,0.8199894661785312,1.0,5/28,11.18%,TRAF5;EDA;STAT1;CASP8AP2;TRAP1
prerank,sodium channel regulator activity (GO:0017080),-0.2962626412015031,-0.9763023991167092,0.46649484536082475,0.850564896998464,1.0,18/37,29.86%,FGF14;FGF12;FXYD5;YWHAH;CAMK2D;NEDD4L;NOS1;FGF13;FXYD1;SCN2B;SCN1B;SGK1;SGK2;SGK3;PKP2;RANGRF;FGF11;FXYD6
prerank,cysteine-type endopeptidase activity (GO:0004197),0.28523778442639763,0.9742773294897242,0.5015015015015015,0.824761996661897,1.0,21/78,18.29%,USP18;CASP12;CFLAR;CASP4;CTSH;USP24;USP9X;ESPL1;USP8;USP47;CTSW;CAPN15;USP40;USP35;USP34;USP36;CTSF;USP12;CASP3;USP15;USP10
prerank,neuropeptide hormone activity (GO:0005184),0.3587278479716102,0.9739639717316535,0.4925373134328358,0.8221253331667556,1.0,2/22,5.27%,GHRH;UCN
prerank,carbohydrate kinase activity (GO:0019200),0.42074397482176173,0.9724533261012961,0.47105788423153694,0.8224812841907705,1.0,5/11,18.09%,GALK2;XYLB;KHK;HK1;NAGK
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.37477534314529576,-0.9720344335902211,0.4989648033126294,0.8570988846810575,1.0,2/15,1.62%,SLC26A7;SLC26A2
prerank,phosphatase binding (GO:0019902),0.27233662966813743,0.9692768735097568,0.5036179450072359,0.8271198070033935,1.0,23/105,16.48%,SMAD3;CDH5;CRY2;CRY1;IKBKE;DZIP3;MTMR3;MVP;DLG1;MAPK14;PPP6R3;PTK2;SHOC2;JAK1;CDC27;CNST;WNK1;TBK1;EIF2AK3;SH3YL1;IQGAP1;SMAD2;NFATC2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4360012175184602,0.9684766452385482,0.5064695009242144,0.8256893337746795,1.0,3/10,11.35%,NAA16;NAA30;NAA15
prerank,single-stranded DNA binding (GO:0003697),0.27551874894916456,0.9654742294248427,0.5,0.82960297480108,1.0,25/93,20.14%,RBMS1;SSBP2;POLR2D;CRY2;NUCKS1;TOP1;FBH1;NABP1;FUBP1;RPA3;MCM4;RTF1;RBBP8;MCM6;RAD51B;ERCC5;ERCC1;PCBP2;DHX36;XPC;TDP2;LONP1;SMC6;CTC1;NABP2
prerank,endonuclease activity (GO:0004519),0.3067716662114359,0.9623799372339578,0.5145299145299145,0.8338749013336682,1.0,12/49,15.81%,PIWIL4;NTHL1;NYNRIN;SND1;SMG6;ENDOU;OGG1;SLFN14;ERCC5;ZC3H12B;DIS3;ERN2
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.43290878871100114,0.9608875301425773,0.5,0.8341762986347518,1.0,3/10,10.40%,USP27X;STAMBP;STAMBPL1
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.21108639009680644,-0.9579379930791078,0.5913461538461539,0.8906599036938996,1.0,71/248,22.39%,DNM3;GNAO1;RAB27A;RIT2;RERG;VWA8;ABCA3;GNAS;KIF1C;EEF1A1;NKIRAS1;MYL6;RAB6B;GTPBP1;RAB27B;RAB38;EEF2;RAB3C;ARL1;RHOB;ARHGDIB;RAB35;GFM1;RRAGB;ATAD1;ARL8A;MFN2;GCH1;RHOG;KIF26A;MFN1;HSP90AA1;GSPT2;ABCD2;KIF15;HRAS;RAC1;KRAS;RAB5C;GNA12;RHOH;GPN3;KIF5A;GNAQ;TOR1B;GNA14;IRGM;HBS1L;MYO18A;RAP1A;DNAJC27;RRAGC;RABL3;GNAL;GNA13;RHOBTB1;GPR88;TPPP;RAB1B;RAC3;SAR1B;IFT22;ATL2;BMS1;RND2;RAB32;GNG3;ARL2;GSPT1;RAB18;CHD1L
prerank,kinase activity (GO:0016301),-0.23560729839347927,-0.9567473361369855,0.5317725752508361,0.8887332356120883,1.0,30/109,19.24%,DGKB;DGKI;DGKH;ITPKB;PGK1;PIK3C2B;DGKZ;AKT1;PGM2L1;CAMK2A;RFK;PINK1;FN3K;IP6K2;LYN;ETNK1;BCKDK;PIK3CD;CERK;SEPHS1;DGKG;PPIP5K2;PRKD1;PPIP5K1;PANK1;CKB;FN3KRP;IRAK1;NADK;PIK3C3
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.36218872944312364,-0.9560915642597861,0.5377969762419006,0.8854244380823083,1.0,3/15,6.29%,PIK3R1;PIK3R6;PIK3R3
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.36437672425827794,-0.9545441552844807,0.5427251732101617,0.8845478521215989,1.0,3/14,14.45%,CAPN1;CAPN10;CAPNS1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.33345256492526704,-0.9538022756380268,0.5458612975391499,0.8767891004929006,1.0,8/21,19.65%,CDK14;CDK6;CDK15;CDK19;CDKL2;CDK2;CDK4;CCNK
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.33345256492526704,-0.9538022756380268,0.5458612975391499,0.8767891004929006,1.0,8/21,19.65%,CDK14;CDK6;CDK15;CDK19;CDKL2;CDK2;CDK4;CCNK
prerank,phosphatidylglycerol binding (GO:1901611),-0.3730654991623273,-0.9509965044057284,0.5082644628099173,0.8795607518962392,1.0,2/13,3.78%,PITPNC1;PITPNA
prerank,methylation-dependent protein binding (GO:0140034),0.29951103094995063,0.9501812478391373,0.5344,0.8559909009683897,1.0,22/57,24.69%,KDM7A;SUZ12;MORC3;TRIM24;ZMYND11;GLYR1;RRP8;BPTF;MORC4;KDM8;PYGO1;LRWD1;CHD8;MBTD1;MPHOSPH8;PHF1;PHF13;PHF8;ZCWPW1;WDR5;ING5;ATRX
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.34271815089740804,-0.9500614940926876,0.4956521739130435,0.8771119907555875,1.0,5/18,16.09%,GAS6;SNCA;SERPINB9;RPS6KA1;CD27
prerank,chloride channel inhibitor activity (GO:0019869),0.4263493872022748,0.9487225892383606,0.5308151093439364,0.8564079731011123,1.0,3/10,14.08%,WNK4;STX8;WNK1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.3520859862527318,-0.9485727344006015,0.5303370786516854,0.8761881380410489,1.0,4/16,11.28%,MACROD2;RPS3;CD38;SMUG1
prerank,endopeptidase activity (GO:0004175),0.2411406007310789,0.9469981538550086,0.587641866330391,0.8570551430828114,1.0,39/257,14.27%,DPP4;USP18;ADAMTSL5;ADAMTS12;ADAMTS10;ADAMTS1;ADAMTSL4;ADAMTS6;NRDC;THSD4;CASP4;CPNE1;MMP14;CORIN;CTSH;USP24;USP9X;ESPL1;PSMB10;ACR;PLAU;PSMA3;USP8;USP47;CTSW;PSMA5;PMPCB;NLN;ADAM19;PAPLN;CELA1;PLAT;USP40;SENP1;ADAMTS7;KDM8;USP35;USP34;USP36
prerank,magnesium ion binding (GO:0000287),0.2553375358408804,0.9460265696074435,0.5720338983050848,0.8560697127848529,1.0,32/135,19.45%,EYA2;OXSR1;TSSK3;DCTPP1;CLYBL;WRN;IDH1;STK3;SIK3;PDXK;LRRK2;GEM;HACL1;IRAK3;ADPRS;OPA1;SRPK1;IDH2;CIB2;NUAK2;FIGNL1;STK4;ERN2;YDJC;EPHX2;RAN;ABL2;DHX36;PGM1;TDP2;SRR;MVK
prerank,transcription corepressor binding (GO:0001222),0.33563048069200196,0.9460122455322124,0.5231788079470199,0.85271351313832,1.0,2/27,3.78%,RORA;SUZ12
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.29148258451554987,-0.9455051463189291,0.5277777777777778,0.8794582728110195,1.0,11/33,18.10%,RNF144B;RNF144A;RPS3;DCUN1D2;UBE3D;DCUN1D5;DCUN1D1;RNF125;PARK7;FOXL2;TOLLIP
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.40970118470360256,0.945122696048531,0.5314285714285715,0.8513737075980752,1.0,4/12,10.01%,CDK8;CDK7;CDK12;BRD4
prerank,lipoprotein particle receptor binding (GO:0070325),0.3410660969908251,0.9445202999984553,0.5334476843910806,0.8494174391566677,1.0,4/27,6.64%,APOA2;HSPG2;APBB1;CRP
prerank,G protein-coupled receptor binding (GO:0001664),0.25897390605068804,0.9432020452592259,0.5720221606648199,0.8493112300927573,1.0,19/132,15.17%,WNT4;WNT6;GRK3;WNT10B;WNT3A;WNT2B;WNT5B;ARHGEF11;WNT5A;ADM;INSL3;ARHGEF12;HOMER3;DVL3;ARRB1;RNF43;CCL25;CCRL2;RYK
prerank,deoxyribonuclease activity (GO:0004536),-0.36140340156811707,-0.9407851788816481,0.538135593220339,0.8869975041711458,1.0,2/14,5.90%,RPS3;MRE11
prerank,calcium:sodium antiporter activity (GO:0005432),-0.40138223118978067,-0.9395307638108337,0.5463917525773195,0.8853947582409504,1.0,5/10,21.79%,SLC24A2;SLC8A1;SLC3A2;SLC8B1;SLC24A5
prerank,galactosyltransferase activity (GO:0008378),0.40895413860090024,0.9376965470910085,0.513671875,0.858900436969316,1.0,2/11,7.26%,A4GALT;B4GALT1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.37514611033526724,-0.9375057840210451,0.5599173553719008,0.8857025935353376,1.0,3/13,12.62%,PIP5K1B;PIK3C2B;PIK3CD
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.33373840069796523,0.9369507182459414,0.5574614065180102,0.8573226373833212,1.0,9/28,18.80%,PRKAA2;MAP2K6;LRRK2;MAPK14;MAP2K5;MAP2K1;MAPKAPK5;MAPKAPK3;MAP2K4
prerank,signal sequence binding (GO:0005048),0.3134875313913888,0.9368961019792011,0.5498281786941581,0.8541467044631547,1.0,5/35,7.23%,TNPO1;KDELR3;KPNA6;KPNA7;KPNA4
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.35937745555612943,-0.9349350733690043,0.5596707818930041,0.8878954854148406,1.0,9/14,41.57%,NCF2;CYBB;KMO;NOX4;CYB5R4;NCF1;NOX3;NCF4;DUOX1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4019035068349278,-0.9338507359263349,0.55625,0.885852347010971,1.0,4/11,6.77%,TRPC3;TRPC5;TRPC4;TRPC6
prerank,nuclear receptor coactivator activity (GO:0030374),0.2973012791198404,0.9329630274338548,0.5764525993883792,0.860238009133109,1.0,16/52,18.40%,ZMIZ1;NCOA3;NCOA6;TACC1;SFR1;SS18;MED12;BRD8;NCOA2;CARM1;RBM14;CNOT9;CCAR1;TMF1;PPARGC1B;KDM1A
prerank,ephrin receptor binding (GO:0046875),0.35047081079810405,0.9321848079944896,0.5377697841726619,0.8588558463792636,1.0,4/21,12.76%,EFNB2;PTPN1;EFNA1;EFNB1
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.23481641508587928,-0.9310378819475642,0.6402640264026402,0.8887607007021219,1.0,12/100,7.21%,MYO10;CYTH3;ARAP2;HIP1;CERT1;ARAP3;HIP1R;DAB2IP;SNX3;CLVS1;KCNH1;AKT1
prerank,GTP binding (GO:0005525),0.2442715691947013,0.9306853133440667,0.6210235131396957,0.8589548268843199,1.0,45/172,19.74%,GBP6;GBP2;RRAS2;RAB10;RAB22A;ARL3;RHOBTB2;ARF4;GBP5;RHOF;GTPBP10;GBP4;RRAD;RHOQ;LRRK2;ARF3;RAP2C;GEM;RABL6;GBP7;TUBA1C;TUBE1;RHOC;TUBB6;PIP4K2B;RHOU;ARL4A;TUBB2B;ATL1;GBP3;RAB5A;RIT1;TUBD1;TRIM23;ARF1;RAN;RAP2B;LSG1;RHOT1;RANBP17;ARL6;DIRAS1;RHOT2;ARFIP2;NRAS
prerank,GTPase activity (GO:0003924),-0.2125052980492943,-0.9301545030568027,0.6844262295081968,0.886251335585531,1.0,57/192,22.27%,DNM3;GNAO1;RAB27A;RIT2;RERG;GNAS;EEF1A1;NKIRAS1;RAB6B;GTPBP1;RAB27B;RAB38;EEF2;RAB3C;ARL1;RHOB;ARHGDIB;RAB35;GFM1;RRAGB;ARL8A;MFN2;GCH1;RHOG;MFN1;GSPT2;HRAS;RAC1;KRAS;RAB5C;GNA12;RHOH;GPN3;GNAQ;GNA14;IRGM;HBS1L;RAP1A;DNAJC27;RRAGC;RABL3;GNAL;GNA13;RHOBTB1;TPPP;RAB1B;RAC3;SAR1B;IFT22;ATL2;BMS1;RND2;RAB32;GNG3;ARL2;GSPT1;RAB18
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.40165781205210216,-0.9277153959904604,0.5951417004048583,0.8876630253191029,1.0,4/10,6.26%,DPP10;DPP6;FAP;PRCP
prerank,hexosyltransferase activity (GO:0016758),-0.22734703636510287,-0.9269363629970918,0.6206896551724138,0.8850157995377795,1.0,20/101,15.97%,TMTC2;CSGALNACT1;FUT9;HEXB;EXT1;POMGNT1;DPY19L1;LFNG;ALG5;MFNG;B3GNT2;B4GALT4;PIGM;MGAT4A;GCNT1;CHSY3;B3GNT9;TMTC3;B3GALNT2;POMGNT2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.24108989314912888,-0.9265209527076409,0.6291208791208791,0.8813971806474895,1.0,17/72,15.71%,PLCB1;HIP1;KCNJ2;SYTL2;HIP1R;SDCBP;SYT7;STXBP6;LDLRAP1;RAB35;SNAP91;MARK1;KCNQ1;AMER2;SNX18;KRIT1;TWF1
prerank,neuropeptide receptor binding (GO:0071855),0.3758973466717336,0.926251552331238,0.5613382899628253,0.8661439605817393,1.0,1/14,2.00%,GHRH
prerank,hormone activity (GO:0005179),0.28653927670730145,0.9261125817985447,0.583596214511041,0.8632016448214641,1.0,7/54,16.12%,GHRH;PTHLH;UCN;NPPC;AGRP;CCL25;INHA
prerank,GTPase binding (GO:0051020),0.23959392733051854,0.9249506941235526,0.6262886597938144,0.8625861116924819,1.0,41/195,16.55%,RAPGEF4;AKAP13;RNF152;AFDN;SPTBN1;RADIL;FGD4;AMBRA1;PARD6A;MYCBP2;UNC13B;RANBP2;PLCE1;OPTN;RASA1;EXOC2;RALBP1;NGFR;GOLGA5;CHM;STRN3;MICALL1;LRRK2;IQGAP2;DOCK7;TRIOBP;CDC42EP4;DNM1L;RAB34;DVL3;RAP1GAP;IFT20;WASF1;TBC1D7;MYO1C;ABCA1;GOLGA4;IQGAP1;NDRG1;MYO5A;NOX1
prerank,exopeptidase activity (GO:0008238),0.29234344883482255,0.9245021944656481,0.5732484076433121,0.8603438020313539,1.0,12/50,14.11%,DPP4;DPEP2;ANPEP;DPP8;NPEPPS;CTSH;ERAP1;BLMH;DPP7;RNPEP;LNPEP;KDM8
prerank,single-stranded DNA helicase activity (GO:0017116),-0.3244908095819947,-0.9239307408862606,0.5498839907192575,0.8832117619125008,1.0,9/19,31.35%,HELQ;RAD51;RFC4;POLQ;WRNIP1;RFC5;RFC2;CHTF18;PIF1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3543171305785301,0.9197135812823232,0.5549828178694158,0.8686399318528998,1.0,3/20,8.89%,CMPK2;CASK;DLG1
prerank,gated channel activity (GO:0022836),-0.36115399749676746,-0.9188257403232086,0.597254004576659,0.8914423216514393,1.0,1/14,0.51%,PIEZO2
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3409594074265888,-0.9183771852051817,0.5826612903225806,0.8878309206912531,1.0,4/15,15.39%,EPB41;SCARB1;SNAP91;WDFY1
prerank,NADPH binding (GO:0070402),-0.361964543759713,-0.9166836646632068,0.5478260869565217,0.8875445095432024,1.0,4/13,25.66%,KCNAB1;MTRR;NDOR1;CRYZ
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.39836703433796034,-0.9161883834493465,0.5810526315789474,0.8842783279446516,1.0,7/10,41.57%,NCF2;CYBB;NOX4;NCF1;NOX3;NCF4;DUOX1
prerank,3'-5' DNA helicase activity (GO:0043138),0.36647244623743697,0.9156693862641266,0.5854126679462572,0.8740580981890234,1.0,5/16,13.28%,WRN;ASCC3;FBH1;FANCM;MCM6
prerank,carboxy-lyase activity (GO:0016831),0.33623555263129856,0.9143705792819731,0.5670840787119857,0.8739318689718502,1.0,5/23,17.32%,AZIN2;BCKDHA;UMPS;FAHD1;PCK2
prerank,double-stranded RNA binding (GO:0003725),0.27290744898516855,0.9142730474685037,0.5993640699523053,0.8709415025514289,1.0,14/70,14.41%,SIDT1;EIF2AK2;DDX60;VIM;RC3H1;MTDH;ZBP1;OASL;OAS2;ADAR;ILF3;SUPV3L1;TARBP2;IFIH1
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.2361259681693722,-0.913771519226936,0.6634304207119741,0.8855965776854372,1.0,25/85,30.27%,NDST3;MGLL;ABHD2;GDPD1;CA2;LIPE;BCHE;AOAH;GDE1;ABHD6;PLAAT3;LPL;PNPLA6;PNPLA3;PLA2G7;PLA2G4F;PAFAH1B2;FAAH;PTRH2;ABHD15;PLAAT1;LIPC;PLA2G4B;PGLS;PGAP1
prerank,WW domain binding (GO:0050699),0.331170276799024,0.9125116986912221,0.5831873905429071,0.8717254620113529,1.0,6/26,12.55%,TCEAL7;PMEPA1;LITAF;SCNN1A;TCEAL3;TCEAL6
prerank,receptor antagonist activity (GO:0048019),0.35846816874187093,0.9123243244465377,0.5814393939393939,0.868951388286007,1.0,4/17,17.49%,WFIKKN1;DKK3;LRPAP1;IL18BP
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.2871492345742285,0.9121708802171075,0.5974643423137876,0.8661685376974787,1.0,11/55,13.14%,MCU;ITPR1;ANXA2;SLC24A3;ATP2B4;TMEM165;PKD1L3;PANX1;TRPC1;GRIN3B;ATP2B1
prerank,clathrin adaptor activity (GO:0035615),-0.34521800768410194,-0.9118950643244567,0.5553145336225597,0.8855654634512791,1.0,7/15,27.44%,HIP1;HIP1R;LDLRAP1;AP2B1;AP2A2;AP2A1;AP2M1
prerank,RNA polymerase binding (GO:0070063),-0.3255920504927395,-0.9102935277376417,0.5833333333333334,0.8849562491971197,1.0,6/18,17.82%,TCERG1L;STOM;YTHDC2;ANP32B;BRCA1;PPIB
prerank,ankyrin binding (GO:0030506),-0.32087766259075107,-0.909688587906163,0.5974842767295597,0.8820611412902535,1.0,6/19,14.81%,CDH1;SLC8A1;NRCAM;SPTB;CACNA1D;PTPRC
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.4123969175851951,0.909297810968497,0.5899419729206963,0.869400415141773,1.0,4/10,15.61%,KDM7A;KDM2A;KDM8;KDM2B
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.37203621311436375,-0.908391378176596,0.598343685300207,0.8806365304862724,1.0,6/11,31.97%,SLC2A9;SLC5A11;SLC23A1;SLC23A2;SLC2A10;SLC5A3
prerank,calcium channel activity (GO:0005262),-0.23381006176965285,-0.905295291355992,0.6656626506024096,0.8836796369514855,1.0,9/84,4.60%,CACNA1E;CACNB2;TRPC3;SLC24A2;RYR2;CACNB4;TRPC5;TRPC4;OPRM1
prerank,proton transmembrane transporter activity (GO:0015078),-0.2687831478635208,-0.9030545701850746,0.6243523316062176,0.884310302499019,1.0,15/39,26.40%,CLCN3;ATP6V1B2;COX4I1;UQCRH;UQCR11;COX8A;NDUFA4;COX6A1;CLCN5;ATP6V1F;NDUFA4L2;CYB5A;UQCR10;UQCRQ;COX4I2
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.34348579930377277,-0.9022394638216653,0.6324786324786325,0.8817324986004277,1.0,5/15,12.62%,PIK3C2B;PIK3R3;ATM;PI4K2A;PIK3CD
prerank,voltage-gated anion channel activity (GO:0008308),-0.34423560926881713,-0.9006910900963037,0.6050228310502284,0.8809775765004078,1.0,5/15,16.91%,ANO1;CLCN3;CLCN1;VDAC1;CLCN5
prerank,receptor tyrosine kinase binding (GO:0030971),0.27971105960259,0.8998009979392798,0.6163723916532905,0.8874536671364454,1.0,12/56,14.53%,CBLB;GAB2;FRS2;PTPN14;ANGPT1;LRP4;PTPN2;SH2B3;MAP3K7;PTPN1;SHC2;NCK1
prerank,fibroblast growth factor binding (GO:0017134),0.33978429989132847,0.8997488952027514,0.599271402550091,0.8843353994292872,1.0,3/21,5.55%,FGFR1;KL;GLG1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.39206322898461965,0.8993987698278736,0.6082089552238806,0.8819351250057985,1.0,1/12,3.48%,AOX1
prerank,ubiquitin protein ligase binding (GO:0031625),-0.19951504368710668,-0.8992215640538459,0.8009049773755657,0.8800633366408731,1.0,67/254,22.01%,HSPA8;FOXO1;MID1;PRR5L;SMAD7;RPL5;ACTG1;RPL11;PRKAR1A;GABARAP;HSP90AB1;ATP6V0C;HERC2;SLF1;BAG1;MFHAS1;TNFRSF1B;HDAC6;GABARAPL1;UBB;PINK1;RFFL;ELOB;HSPBP1;SPOP;BAG6;CALR;MFN2;USP13;CD40;TNK2;ANKRA2;RPL23;NLK;GPI;PRKAR2B;TPI1;EGFR;HSP90AA1;UBOX5;WASHC1;KDM4A;FZD4;UBA52;CAMLG;TUBA1B;CDKN1A;HSPA5;GPR37;YOD1;BRCA1;LTBR;UBE2D1;CKB;TRIM37;PACRG;TRIM28;SMAD5;PATZ1;WRAP53;UBE2J1;FZD5;USP2;BAG4;NKD2;TRAF1;ATXN3
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.23573501047283785,-0.8989765112389578,0.6898550724637681,0.8763483707197055,1.0,13/70,15.97%,CSGALNACT1;HEXB;EXT1;POMGNT1;LFNG;MFNG;B3GNT2;MGAT4A;GCNT1;CHSY3;B3GNT9;B3GALNT2;POMGNT2
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.2517107255590249,-0.8987606081738071,0.6236842105263158,0.8726254373153222,1.0,13/51,17.03%,SLCO1C1;SLCO2A1;SLC7A5;SLC16A10;CLCN3;SLC5A5;SLC5A6;SLC22A6;SLC25A30;MFSD2A;SLC35E3;SLCO4A1;SLC20A2
prerank,transcription coregulator binding (GO:0001221),0.2842854388668704,0.8978545394952737,0.6037735849056604,0.8820989877966543,1.0,4/50,4.00%,RORA;SMAD3;SUZ12;TERT
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.3049949219951893,0.8955421475215142,0.6287128712871287,0.8839131648462475,1.0,13/38,19.99%,PLA2G4A;SNX12;PLEKHA4;DENND1A;SNX27;WDR45B;ATG2A;SH3PXD2B;WIPI2;SNX21;PLEKHF1;RUBCNL;SESTD1
prerank,small GTPase binding (GO:0031267),0.2366799312004331,0.895250824022291,0.6618421052631579,0.8813556959788553,1.0,37/170,16.55%,RAPGEF4;AKAP13;RNF152;AFDN;FGD4;PARD6A;MYCBP2;UNC13B;RANBP2;PLCE1;OPTN;EXOC2;RALBP1;NGFR;GOLGA5;CHM;STRN3;MICALL1;LRRK2;IQGAP2;DOCK7;TRIOBP;CDC42EP4;DNM1L;RAB34;DVL3;RAP1GAP;IFT20;WASF1;TBC1D7;MYO1C;ABCA1;GOLGA4;IQGAP1;NDRG1;MYO5A;NOX1
prerank,protein kinase activator activity (GO:0030295),-0.2421795465312936,-0.8928037785475244,0.6608478802992519,0.8820157296036499,1.0,13/60,15.48%,GRM5;RPLP1;CALM1;GAS6;CALM2;CALM3;STK11;FGF13;ALS2;GPRC5A;RGCC;CDKN1A;IRGM
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.3162750724848634,0.8922812664470188,0.6277372262773723,0.8845095597641016,1.0,3/29,3.49%,SLC13A3;SLC19A1;SLC26A9
prerank,aspartic-type peptidase activity (GO:0070001),-0.37822812867397104,-0.8908499648197389,0.6004228329809725,0.8824265512345347,1.0,1/10,6.54%,CTSD
prerank,anion:anion antiporter activity (GO:0015301),-0.33214152251762763,-0.8886323126038677,0.6112266112266113,0.8833694255594579,1.0,2/17,1.62%,SLC26A7;SLC26A2
prerank,triglyceride lipase activity (GO:0004806),-0.3105662431394783,-0.8885883073545193,0.6186252771618626,0.879283553982904,1.0,5/20,28.38%,LIPE;LPL;PNPLA3;LIPH;LIPC
prerank,MAP kinase activity (GO:0004707),0.37034760805564293,0.8885742441346747,0.5898876404494382,0.8891482059474027,1.0,4/14,13.32%,MAPK4;MAPK6;MAPK14;MAPK9
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3925800026225675,0.88645497023628,0.5942549371633752,0.8905890099086813,1.0,3/11,11.35%,NAA16;NAA30;NAA15
prerank,protein tyrosine kinase binding (GO:1990782),-0.23557043518024662,-0.8863576052456936,0.6913946587537092,0.8800759007553111,1.0,14/71,14.92%,DOCK4;NRG3;GRB14;GRM5;BMPR2;GAS6;CEACAM1;DUSP22;RACK1;CBL;ACVR1;HSP90AA1;TJP2;SHC4
prerank,anion transmembrane transporter activity (GO:0008509),-0.3641154219893218,-0.8861163544908965,0.6275720164609053,0.8764871118561344,1.0,4/12,16.43%,ABCG2;SLC22A6;SLC39A8;ABCC5
prerank,acetylcholine receptor activity (GO:0015464),-0.2999656990644096,-0.880164137062083,0.6674008810572687,0.8856302616762562,1.0,5/22,20.27%,CHRM3;CHRM2;CHRNA4;CHRFAM7A;CHRNA7
prerank,phosphatase activity (GO:0016791),0.26008070373803155,0.8797469279174656,0.6531531531531531,0.9019289767539962,1.0,12/73,12.10%,ATP1A2;PLPP3;DUSP10;DUSP28;PTPN22;DUSP16;MDP1;PLPPR3;NT5C;NOCT;PPP1CB;DUSP5
prerank,NADP binding (GO:0050661),0.3060810834915756,0.8762910452782231,0.6197654941373534,0.9059698706573651,1.0,6/32,7.81%,HSD17B1;GMDS;PGD;NOS2;DPYD;NNT
prerank,alpha-tubulin binding (GO:0043014),-0.282643602732389,-0.8755203758272114,0.6752941176470588,0.8913418326711595,1.0,8/31,13.20%,TTLL7;DIP2B;SNCA;EFHC2;HDAC6;ARL8A;TRIM36;WASHC1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.344967261940072,0.8738229540538638,0.6293577981651376,0.9080624192371053,1.0,1/16,0.90%,SLC13A3
prerank,androgen receptor binding (GO:0050681),-0.2903298045613547,-0.8721108008469379,0.6438053097345132,0.8942741466605768,1.0,6/25,14.75%,PRKCB;PKN1;TRIM68;CALR;KDM4C;PARK7
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.209449246669884,0.868372884859474,0.831981460023175,0.9164272618632169,1.0,84/431,17.70%,ATP1A2;GBP6;PRKAG2;ENPP1;OXSR1;GBP2;KSR1;TSSK3;RRAS2;BMPR1A;MYO1B;RAB10;DAPK1;RAB22A;ARL3;RRM1;TOP1;LATS2;TGFBR1;RHOBTB2;ARF4;GBP5;RHOF;GTPBP10;GBP4;MAP4K1;WNK4;RRAD;STK3;RHOQ;SIK3;PDXK;LRRK2;ARF3;TLK2;RAP2C;PFKM;AKT3;GEM;HACL1;RABL6;GBP7;OAS2;TUBA1C;IRAK3;TUBE1;RHOC;CLPX;ABCD3;TUBB6;DAPK2;SRPK1;MCM6;PIP4K2B;RHOU;ERCC6;WNK1;ABCF1;TRIB1;TRNT1;P2RY1;NUAK2;ARL4A;ABCA1;STK4;ERN2;TUBB2B;HSPA9;ATL1;GBP3;RAB5A;RIT1;TUBD1;TRIM23;P2RX4;MKNK2;ARF1;RAN;RAP2B;LSG1;CHD8;RHOT1;TAP2;DMPK
prerank,low-density lipoprotein particle binding (GO:0030169),-0.3193953725634685,-0.8676012316742066,0.6157303370786517,0.8995277719151579,1.0,4/16,7.10%,THBS1;SORL1;STAB1;SCARB1
prerank,histone deacetylase binding (GO:0042826),0.24873372652401465,0.8672035030739607,0.6869300911854104,0.915751931096903,1.0,24/88,18.61%,GLI3;ZMYND15;DACT1;MIER3;BCOR;MIER1;FOXP3;HDAC4;TOP2B;MEF2A;GMNN;CIR1;SMG5;HOXA10;BHLHE41;HIC1;RAD9A;HDAC2;KAT2B;PKN2;NIPBL;YWHAE;DHX36;CHD4
prerank,phosphatidic acid binding (GO:0070300),0.33051886109466866,0.8643911898807611,0.644404332129964,0.9182871422458443,1.0,7/19,19.99%,SMPD3;PACSIN2;MICALL1;OPA1;MAPKAP1;PITPNM1;SESTD1
prerank,myosin binding (GO:0017022),0.2672376314459053,0.8627749464950448,0.7036423841059603,0.9184284483252089,1.0,5/55,3.84%,CALD1;KIRREL1;SPATA6;TRAK1;RAB10
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.3491990723556091,0.8566856482175929,0.6186770428015564,0.9279769641313697,1.0,1/15,0.80%,SLC1A3
prerank,damaged DNA binding (GO:0003684),0.27947252312569476,0.8550909436168299,0.6834415584415584,0.9281317290134049,1.0,10/44,15.40%,CRY2;CREBBP;NTHL1;RPA3;XRCC1;DCLRE1A;RBBP8;OGG1;ERCC5;ERCC1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.38230165181383935,0.8543086656666538,0.6412213740458015,0.9266111839972945,1.0,1/11,0.88%,ITPR1
prerank,mRNA binding (GO:0003729),0.21488911663676039,0.8534694827164573,0.7994891443167306,0.9251617805118171,1.0,59/249,20.84%,CELF2;RBMS1;RBMS3;SAMD4A;SHMT1;PTBP3;RBFOX2;PCF11;RC3H1;RBMS2;IGF2BP1;PABPC5;TPR;SECISBP2L;NANOS2;CPEB1;SRRM2;NOVA1;RNF20;SNIP1;HNRNPC;NYNRIN;NOCT;FUBP1;ACO1;TDRD7;IGF2BP2;SRSF4;EIF4ENIF1;DDX6;SF3B6;PTBP2;RBM5;THOC5;ZC3H12B;GEMIN5;RBM15;RBM14;SRSF5;CSTF3;HNRNPR;CPEB3;SSB;HNRNPA2B1;PUM2;FXR2;SHFL;SLBP;PCBP2;DHX36;GRSF1;NANOS1;DDX5;KHDRBS1;IREB2;KHSRP;RBM25;ELAVL1;PARN
prerank,metallocarboxypeptidase activity (GO:0004181),-0.28097401637775865,-0.8532028039105317,0.7022332506203474,0.9254942098693287,1.0,5/26,10.48%,AGBL4;CPE;CPD;CPA6;ACE2
prerank,DNA polymerase activity (GO:0034061),0.31577046087028626,0.8501689797473169,0.6518650088809946,0.9288455593098852,1.0,4/22,8.90%,POLH;TERT;POLG;REV1
prerank,phospholipase activity (GO:0004620),0.2539476135235339,0.8499259156814395,0.7442572741194488,0.9261671788986305,1.0,7/67,10.73%,SMPD3;PLA2G4A;PLCE1;PLCB3;PLA2G4C;PLA2G6;ENPP2
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.25562919161180997,-0.8488355131260374,0.7456359102244389,0.9300579123088882,1.0,8/42,12.61%,PLCG2;BCAR3;PIK3R1;SHE;PIK3R3;LDLRAP1;VAV1;SYK
prerank,mannose binding (GO:0005537),0.3637292589107829,0.8457116225379937,0.6512915129151291,0.9315948376776997,1.0,3/12,13.88%,CLN5;ACR;LMAN1L
prerank,phosphatidylinositol binding (GO:0035091),-0.21322044022840053,-0.8449119364541767,0.8193146417445483,0.9341736988976839,1.0,18/91,15.43%,EPB41;MCF2L;HIP1;PITPNC1;PITPNA;HIP1R;MPPE1;CCDC88A;SCARB1;SNAP91;PIGU;PIGK;FES;GAP43;SNX8;PASK;WDFY1;MAPT
prerank,lipoprotein particle binding (GO:0071813),0.3191393133296576,0.8441903225060283,0.6469594594594594,0.9315177457123464,1.0,4/20,11.03%,COLEC12;APOA2;CRP;CDH13
prerank,adenyl ribonucleotide binding (GO:0032559),0.21158197637519538,0.8433850523052951,0.84125,0.9301127026732705,1.0,43/291,14.75%,MPPED2;ATP1A2;RAPGEF4;PRKAG2;ENPP1;OXSR1;KSR1;TSSK3;BMPR1A;SLC19A1;MYO1B;DAPK1;RRM1;TOP1;LATS2;TGFBR1;POPDC2;CNBD2;MAP4K1;WNK4;STK3;SIK3;PDXK;TLK2;PFKM;AKT3;HACL1;OAS2;IRAK3;CLPX;ABCD3;DAPK2;SRPK1;MCM6;PIP4K2B;ERCC6;WNK1;ABCF1;TRIB1;TRNT1;P2RY1;NUAK2;ABCA1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.3553831087355024,0.8411464780511394,0.6566604127579737,0.9313849641986954,1.0,3/14,9.52%,MTHFD1;ALDH4A1;PYCR3
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.2944712350605482,-0.8401496483348931,0.6752336448598131,0.9399215708850251,1.0,9/21,24.48%,REV3L;POLA1;POLE;POLD1;POLB;POLE3;POLQ;POLK;CHRAC1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.30046999724352524,0.8380370555394778,0.6925858951175407,0.9343577055933566,1.0,1/26,0.48%,PTN
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.33675155804529805,-0.8367603770849628,0.6909871244635193,0.9423262275823324,1.0,6/12,17.19%,JMJD1C;KDM4D;KDM4C;KDM4A;PHF2;HR
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.32082045180275987,0.8365944827604087,0.6768402154398564,0.9341672645404134,1.0,2/18,5.06%,HSD17B1;RDH5
prerank,peptidase activator activity (GO:0016504),-0.2884237006765162,-0.8346245426970833,0.7353629976580797,0.9421897082236503,1.0,6/22,17.43%,MAL;PSMD14;PINK1;CAV1;PSENEN;PSME1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.26923566719975656,-0.8331862617636182,0.711943793911007,0.9408158549802885,1.0,10/29,22.24%,CIT;PRKAR1A;INKA2;SPRED2;PRKAR2B;PKIG;CDKN1A;PKIB;SPRED1;HEXIM2
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.27728122225540053,-0.8330763270820379,0.7085308056872038,0.9368808023210401,1.0,4/27,6.71%,SLC12A2;SLC9B2;CNNM4;ATP2A3
prerank,Toll-like receptor binding (GO:0035325),-0.33321529164983615,-0.8318904627500466,0.6843177189409368,0.9350220302398972,1.0,7/11,33.67%,DAB2IP;TOLLIP;MYD88;TLR6;TLR1;S100A9;TIRAP
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.3341814292388421,-0.8308913579830022,0.6818181818181818,0.9329847116139235,1.0,2/12,11.18%,ENTPD1;SLC25A42
prerank,single-stranded RNA binding (GO:0003727),-0.24356820523637654,-0.8302286809336498,0.7941888619854721,0.9302024107514187,1.0,6/43,8.16%,STRBP;PTBP1;ADARB2;ZFR2;CNBP;DDX11
prerank,myosin V binding (GO:0031489),-0.3116044513269761,-0.8289165831082218,0.7099391480730223,0.9286954356838986,1.0,3/15,7.38%,RAB6B;RAB27B;RAB3C
prerank,metalloexopeptidase activity (GO:0008235),0.26662841761135636,0.8284552560067824,0.732484076433121,0.946979221106473,1.0,12/51,14.01%,CPQ;ANPEP;AEBP1;MMP14;PEPD;NPEPPS;CPB2;ERAP1;RNPEP;CPXM2;AGBL2;LNPEP
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.3595766896978825,-0.826707536919695,0.6694386694386695,0.9291290891849676,1.0,2/10,7.38%,ADARB2;APOBEC1
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.28664897981976384,-0.8254280911800831,0.7291666666666666,0.927443887522385,1.0,5/21,18.69%,AKAP6;RYR2;KCNQ1;AKAP1;AKAP5
prerank,calcium-release channel activity (GO:0015278),0.3304792296903018,0.8252939955864181,0.6983546617915904,0.950119586561507,1.0,6/17,20.85%,ITPR1;TPCN1;PKD2;TRPA1;ITPR2;ITPR3
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3080666447642981,0.8242479894038903,0.705574912891986,0.9489611956591675,1.0,4/22,12.10%,DUSP10;MTMR3;DUSP16;DUSP5
prerank,cysteine-type peptidase activity (GO:0008234),0.2461442442465004,0.8233582598876903,0.7625570776255708,0.9475150634269204,1.0,19/73,18.29%,USP18;CASP4;CTSH;USP24;USP9X;ESPL1;USP8;USP47;CTSW;BLMH;USP40;USP35;USP34;USP36;CTSF;USP12;CASP3;USP15;USP10
prerank,neuropeptide receptor activity (GO:0008188),-0.2683699335803019,-0.8217344517646837,0.747016706443914,0.9302582342019211,1.0,8/29,25.91%,SORCS1;SORCS3;OPRM1;TACR3;GPR37;NMUR2;GRPR;KISS1R
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.30761295206959927,0.821515407368403,0.7220216606498195,0.9476988977649307,1.0,9/22,22.79%,RBMS3;CPEB1;ILF3;CPEB3;DHX36;KHSRP;ELAVL1;ZC3H12A;ZFP36L2
prerank,pseudouridine synthase activity (GO:0009982),-0.31765124335674744,-0.8212072276191386,0.7127659574468085,0.9273183464034747,1.0,7/13,28.33%,PUS7;PUS3;TRUB1;PUSL1;RPUSD2;RPUSD3;RPUSD1
prerank,CCR chemokine receptor binding (GO:0048020),0.2899434398618947,0.8203044748877744,0.7051926298157454,0.9468756130069815,1.0,5/28,15.01%,MSMP;CCL2;NES;CCL25;CCRL2
prerank,organic cation transmembrane transporter activity (GO:0015101),0.33080214550094705,0.8167559787690941,0.6946564885496184,0.9505086116749626,1.0,6/16,21.35%,SLC5A7;SLC22A2;SLC22A4;SLC44A2;SLC7A8;SLC22A3
prerank,death domain binding (GO:0070513),0.35339344919943194,0.8150676597000985,0.6653543307086615,0.9503959149734771,1.0,4/11,10.73%,BCL2;MCL1;BAX;BCL2L1
prerank,syntaxin binding (GO:0019905),-0.22047669965914035,-0.8126984580935652,0.7936507936507936,0.9386121152091915,1.0,22/61,26.68%,SYT1;SYNPR;NSF;SNAP25;STXBP5L;STXBP1;STX16;CPLX1;SNPH;NAPA;SYT9;SYT2;CACNA1A;SYPL1;SYT6;VPS18;SYT10;SYT5;VAMP1;STX7;SNAP29;SYT17
prerank,palmitoyltransferase activity (GO:0016409),-0.2631567855446968,-0.810282160059019,0.7577197149643705,0.9389774479961924,1.0,13/28,33.48%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;YKT6;ZDHHC5;ZDHHC4;GOLGA7B;ZDHHC13;GOLGA7
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.2966804855089495,0.8088107031028018,0.7068062827225131,0.9585155458128554,1.0,2/24,3.85%,CAMK1D;DAPK1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.2692758555280081,-0.8082030939281999,0.7414187643020596,0.9385941495353607,1.0,10/24,28.90%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;YKT6;ZDHHC4;GOLGA7B
prerank,SH2 domain binding (GO:0042169),0.2803612509733312,0.8080667128306458,0.7477797513321492,0.9567992469674521,1.0,3/31,3.63%,DLC1;DAG1;AFAP1
prerank,hexosaminidase activity (GO:0015929),0.3402659451860275,0.8045651711558122,0.699443413729128,0.959938499907362,1.0,1/12,2.27%,CEMIP2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.31147324540504867,-0.8043260015363376,0.7231075697211156,0.9415613063506241,1.0,7/13,51.26%,MIF;ECI1;IDI1;DCT;HSD3B2;EHHADH;IDI2
prerank,solute:proton symporter activity (GO:0015295),-0.2974745049625571,-0.8033150893628109,0.7548387096774194,0.9394129602900732,1.0,12/16,44.77%,SLC15A2;SLC2A9;SLC36A1;SLC39A8;SLC36A2;SLC2A10;SLC15A1;MFSD3;SLC15A4;SLC11A2;SLC25A3;SLC2A13
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2803633094952363,0.8000415167672577,0.7385398981324278,0.9649204773976509,1.0,7/31,15.01%,UBE2U;UBE2Z;UBE2C;UBE2E3;UBE2Q2;BIRC6;UBE2R2
prerank,thiol-dependent deubiquitinase (GO:0004843),0.23285350886689307,0.7995693676276261,0.8403614457831325,0.9626831856233974,1.0,30/83,24.11%,USP18;USP27X;STAMBP;USP24;USP9X;USP8;USP47;STAMBPL1;MYSM1;USP40;USP35;USP34;USP36;USP45;USP12;USP15;USP32;USP10;JOSD1;USP39;BRCC3;USP4;USP7;PAN2;USP26;ZC3H12A;OTUD5;USP19;USP25;OTUD7B
prerank,kinase activator activity (GO:0019209),-0.25387384393431073,-0.7989147340267068,0.762589928057554,0.9429157200866302,1.0,6/30,13.86%,RPLP1;STK11;MALT1;FGF13;GPRC5A;RGCC
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.2390666386999767,-0.7981479202071062,0.8267326732673267,0.9403354886688815,1.0,12/38,23.14%,SHANK3;PIK3R1;SHANK2;GRIP1;LDLRAP1;MAPK8IP3;MMS19;SHANK1;DEDD2;CARD10;NUP62;IRS1
prerank,P-type ion transporter activity (GO:0015662),-0.323767451796693,-0.7951292277817026,0.7376344086021506,0.9415441264828396,1.0,6/12,27.63%,ATP2C1;ATP2A3;ATP2A2;ATP2B3;ATP2B2;ATP2C2
prerank,nucleosomal DNA binding (GO:0031492),0.3014338601686056,0.7920420464743793,0.7259528130671506,0.972583805340505,1.0,8/21,18.61%,MBD2;HNRNPC;GATAD2B;ACTL6A;HDAC2;SMARCA4;SMARCC1;CHD4
prerank,N-methyltransferase activity (GO:0008170),0.2999344396092281,0.790576820009182,0.7363796133567663,0.9719403370551222,1.0,7/20,23.12%,HNMT;ZCCHC4;FDXACB1;PEMT;METTL15;METTL5;PRMT1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.28519870380375134,0.7904087115558966,0.768313458262351,0.9691868259388519,1.0,4/27,6.37%,RNF217;RNF19A;SIAH2;PPARA
prerank,disordered domain specific binding (GO:0097718),0.29187041789652346,0.7893367281650358,0.7626527050610821,0.967969694506909,1.0,3/23,8.30%,FN1;NCOA3;TEAD2
prerank,SUMO binding (GO:0032183),0.3296094040195499,0.7869969755627519,0.7504621072088724,0.9688144986572956,1.0,4/13,14.99%,RNF111;CASP8AP2;CBX4;PML
prerank,Notch binding (GO:0005112),0.2952756572031293,0.7864397197689325,0.7442273534635879,0.9667956009376195,1.0,3/22,5.79%,SNED1;AAK1;DTX1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.24583508673214916,0.7840021028482604,0.8042071197411004,0.967876267540183,1.0,18/54,20.85%,MIER3;MIER1;HDAC4;ACY3;ASPA;NTAN1;HINT3;NAAA;ACR;SIRT4;AMDHD2;HDAC2;PDF;AGA;NIT1;PIGL;SIRT2;NADSYN1
prerank,kinase inhibitor activity (GO:0019210),-0.24582827331915946,-0.783551677356182,0.7995226730310262,0.9559559832616716,1.0,9/33,15.23%,SNCA;SMCR8;NPM1;LRP6;SH3BP5L;MAPK8IP1;PRKRIP1;RHOH;CDKN1A
prerank,heme binding (GO:0020037),-0.2066468420383766,-0.7818438244197055,0.8635097493036211,0.9546947620558967,1.0,20/65,28.13%,NOS3;SDHC;GUCY1B1;NOS1;HMOX2;CYP2A6;PTGIS;CYBB;HEBP1;EIF2AK1;CYP2S1;SDHD;CYP46A1;CYB5A;NOX4;CYP2R1;HMOX1;ABCB6;STEAP4;CYP26B1
prerank,MHC protein binding (GO:0042287),-0.2757483688729349,-0.7814833670800799,0.7819383259911894,0.9513461636578047,1.0,4/20,14.24%,ATP5F1A;CD74;ATP5F1B;TUBB4B
prerank,cation transmembrane transporter activity (GO:0008324),0.2423302443718909,0.7794081479301638,0.8341232227488151,0.9720953465843569,1.0,7/48,12.14%,SLC7A2;SLC6A9;SLC38A6;PKD1L3;SLC41A1;SLC38A1;SLC38A9
prerank,neuropeptide binding (GO:0042923),-0.27978445751235864,-0.7776055055688159,0.7837259100642399,0.953565745948643,1.0,2/18,4.64%,OPRM1;SORL1
prerank,ADP binding (GO:0043531),-0.2581735642017855,-0.7774852372352793,0.795774647887324,0.9498727554802947,1.0,6/25,15.94%,ME1;PGK1;ATP5F1A;GCLC;ATP5F1D;MYO18A
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.2727238037775067,0.7771691516318473,0.7735849056603774,0.9727668072651037,1.0,11/29,19.09%,LCT;ABHD10;MGAM;ADPRS;CTBS;GANAB;GANC;NEU3;GBA2;PGGHG;IDUA
prerank,ferrous iron binding (GO:0008198),-0.27394436724968707,-0.7766631305675372,0.8052516411378556,0.9472110899415283,1.0,3/21,4.96%,FTH1;SNCA;FTL
prerank,histone demethylase activity (GO:0032452),0.2836952547453698,0.7763620981328004,0.7793345008756567,0.97105697749728,1.0,9/27,20.38%,KDM7A;KDM3B;JARID2;KDM5B;KDM2A;KDM8;KDM2B;KDM1A;JMJD6
prerank,GDP binding (GO:0019003),0.23655920667439617,0.7754719965849401,0.8248407643312102,0.9694642510134928,1.0,19/63,23.15%,RRAS2;RAB10;RAB22A;ARL3;RAP2C;GEM;MIEF1;RAB5A;RIT1;TRIM23;RAN;RAP2B;GNAI3;DIRAS1;NRAS;RAB14;RRAGD;RAP2A;RAB11B
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.2355599323160504,-0.7750015978664179,0.8341121495327103,0.9458927206375632,1.0,10/34,22.28%,DIS3L2;EXOSC2;EXD2;ANGEL2;XRN2;CNOT2;ERI1;EXOSC4;CNOT8;TOE1
prerank,Wnt-activated receptor activity (GO:0042813),0.31648091702329006,0.7741808036743758,0.737037037037037,0.9684643288090784,1.0,2/15,4.46%,FZD2;ROR1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.2873164876226413,0.7729591761776633,0.7521514629948365,0.9675673845583432,1.0,8/24,19.99%,PLA2G4A;OSBPL8;OSBPL5;PLEKHA8;PLEKHF1;ARFIP2;RUBCNL;SESTD1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.26276075873487686,0.771124205702398,0.8063943161634103,0.9675451704233603,1.0,9/34,17.01%,FAM20A;STK3;IGF2;PARP16;MAP2K1;MTCP1;IQGAP1;STK4;RICTOR
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.31834741382453463,0.7702262082849527,0.7486725663716814,0.9660365567667939,1.0,5/15,19.99%,PLA2G4A;SH3PXD2B;PLEKHF1;RUBCNL;SESTD1
prerank,muscle alpha-actinin binding (GO:0051371),0.3067255538618145,0.7674707170491234,0.7690941385435168,0.9675911474447327,1.0,7/15,26.76%,SYNPO2;PRICKLE4;PKD2;PDLIM2;PDLIM7;PDLIM1;PDLIM5
prerank,adenylyltransferase activity (GO:0070566),0.2840252095601552,0.7665907400379275,0.7767695099818511,0.9659838055060704,1.0,9/21,24.45%,PAPOLG;OASL;OAS2;TENT2;PAPOLB;FLAD1;TENT4B;SELENOO;PAPOLA
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.19286376449814,0.762019721493662,0.950632911392405,0.9698224285694202,1.0,47/269,16.37%,SMAD3;STAT2;AMBRA1;TRAF5;PARP9;APBB1;IKBKE;BCL2;VCL;PTPN22;DTX1;CUL4A;FHIT;DTX3L;CCDC50;RNF20;NGFR;STAT1;GSK3B;TNFRSF14;SKI;SNX9;UBE2C;PSMA3;SLC22A18;SUMO1;SLF2;SMAD6;TRIOBP;DIO2;DNM1L;SPOPL;SMG5;CUL3;EGR2;ARRB1;JAK1;RTN4;TRIB1;PML;FAF2;MUL1;CXCR4;POU5F1;HSPA9;SMAD2;AXIN2
prerank,chemoattractant activity (GO:0042056),0.2747556999400095,0.7618686428055683,0.7707231040564374,0.9671477004130221,1.0,2/26,3.31%,CXCL10;VEGFD
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.32979903085622586,-0.7587069304178997,0.8161925601750547,0.9657317487266555,1.0,5/10,30.98%,ANKRD13A;ANKRD13B;FAN1;LAPTM5;FAAP20
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.2838194759866265,0.7567528172787249,0.7930434782608695,0.9716594986298073,1.0,3/22,6.64%,HSPG2;APBB1;CRP
prerank,hyaluronic acid binding (GO:0005540),-0.32999317503407055,-0.7550442119366809,0.7719298245614035,0.9667878233090273,1.0,2/10,4.97%,LAYN;CEMIP
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.33000627746390476,0.7468675522826523,0.7775551102204409,0.982572529685093,1.0,11/11,67.02%,DDAH2;PADI2;ALLC;PADI6;PADI3;AGMAT;PADI4;PADI1;ARG1;ARG2;DDAH1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.31264689116728855,0.7421186495105424,0.7873134328358209,0.9861572454002117,1.0,3/13,18.20%,AGPAT4;AGPAT3;ABHD5
prerank,CARD domain binding (GO:0050700),-0.28578778916021635,-0.7411995578167123,0.820675105485232,0.9815664360735402,1.0,5/14,20.03%,NOD1;IRGM;NOD2;CARD10;CASP1
prerank,ATP binding (GO:0005524),0.18683159351160716,0.740720503157757,0.9675405742821473,0.9850875942901407,1.0,38/266,14.75%,ATP1A2;PRKAG2;ENPP1;OXSR1;KSR1;TSSK3;BMPR1A;MYO1B;DAPK1;RRM1;TOP1;LATS2;TGFBR1;MAP4K1;WNK4;STK3;SIK3;PDXK;TLK2;PFKM;AKT3;HACL1;OAS2;IRAK3;CLPX;ABCD3;DAPK2;SRPK1;MCM6;PIP4K2B;ERCC6;WNK1;ABCF1;TRIB1;TRNT1;P2RY1;NUAK2;ABCA1
prerank,ribonuclease P activity (GO:0004526),-0.3001039461774982,-0.7387905815768846,0.7995991983967936,0.9808794078593556,1.0,2/11,12.68%,PRORP;RPP30
prerank,G protein-coupled receptor activity (GO:0004930),0.18718639456740227,0.7347502126408582,0.9872286079182631,0.9901699016109172,1.0,17/239,7.58%,LPAR1;ADGRD1;LGR4;FPR2;ADORA2A;GCGR;ADGRV1;F2RL3;GLP2R;MC2R;C5AR2;PDGFRB;QRFPR;RXFP2;BDKRB2;OPRD1;ADGRL1
prerank,5'-3' exonuclease activity (GO:0008409),-0.2860319276838984,-0.7347136512620079,0.8119469026548672,0.9820859804652399,1.0,9/14,32.50%,MRE11;XRN2;DCLRE1C;CPSF3;FAN1;EXO1;DCLRE1B;FEN1;TRIR
prerank,carboxypeptidase activity (GO:0004180),-0.2220273992908347,-0.7337788240248689,0.8942065491183879,0.9795492336540907,1.0,10/35,22.12%,AGBL4;CPE;CPD;CPA6;ACE2;MINDY2;CPXM1;VASH1;MINDY1;CPZ
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.284119515873679,-0.7331219287344672,0.8364389233954451,0.9765669033260834,1.0,7/14,25.38%,MTMR6;MTMR12;MTMR7;MTMR2;MTMR1;SYNJ1;MTMR9
prerank,MHC class I protein binding (GO:0042288),-0.28663663568991493,-0.7329401268767126,0.8258196721311475,0.972975255160359,1.0,3/13,14.24%,ATP5F1A;ATP5F1B;TUBB4B
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.3238854316191019,0.7322204689015345,0.8015414258188824,0.990441170980601,1.0,2/11,14.61%,FBXO11;CARM1
prerank,serine-type peptidase activity (GO:0008236),0.2060034053519107,0.7321159695968417,0.9217391304347826,0.9876618720691027,1.0,9/96,12.97%,DPP4;PRSS57;CORIN;CTSH;ACR;PLAU;ENDOU;CELA1;PLAT
prerank,aspartic-type endopeptidase activity (GO:0004190),0.31251177098374033,0.7283099699991976,0.7904761904761904,0.989582322260688,1.0,12/12,68.77%,SPPL3;PSEN1;BACE2;SPPL2A;DDI2;BACE1;PGC;ASPRV1;SPPL2B;CTSE;NAPSA;HM13
prerank,single-stranded telomeric DNA binding (GO:0043047),0.3221911998785591,0.7281185925349527,0.7969639468690702,0.9869491187357494,1.0,4/11,20.14%,RAD50;HNRNPA2B1;CTC1;NABP2
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3120266511152558,-0.7275031524025577,0.8024193548387096,0.9757474206154713,1.0,6/10,40.61%,NAA50;BRCA2;USP22;MSL3;KAT8;HAT1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.2735900858242612,-0.7260203045822389,0.8463157894736842,0.9737031484686215,1.0,7/16,25.38%,MTMR6;MTMR12;MTMR7;MTMR2;MTMR1;SYNJ1;MTMR9
prerank,ATPase activator activity (GO:0001671),0.28028818896157975,0.7249902860553573,0.8520499108734403,0.988086836692212,1.0,6/20,18.88%,DNAJA2;TOR1AIP1;DNAJC1;ATP1B2;DNAJB2;DNAJB6
prerank,DNA replication origin binding (GO:0003688),0.2696396434676297,0.7244827370510344,0.8211091234347049,0.9858128775189708,1.0,5/23,15.43%,ORC5;MCM4;MCM6;ORC3;ORC4
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.21872475458475737,-0.7243598606072993,0.8602941176470589,0.9719153726193861,1.0,7/35,15.78%,H3-3A;NPM1;SMARCB1;HDAC1;RRN3;PARK7;KLF10
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.2790882582499124,-0.7230244281350644,0.8384458077709611,0.9695262005153381,1.0,6/14,22.01%,MINDY3;USP13;MINDY2;YOD1;MINDY1;ATXN3
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.24677922171462738,0.7226020533303702,0.8440677966101695,0.9854003591603373,1.0,7/34,15.01%,UBE2U;UBE2Z;UBE2C;UBE2E3;UBE2Q2;BIRC6;UBE2R2
prerank,lipid phosphatase activity (GO:0042577),-0.2783421173492573,-0.7222025679655285,0.8376068376068376,0.9668662342940433,1.0,6/14,18.89%,PLPPR1;INPP5K;PLPP1;PLPPR2;SGPP1;PLPPR5
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.29756035613552245,-0.721831104404211,0.821656050955414,0.9636352733392877,1.0,3/11,12.13%,MAP3K5;MAP3K20;EGFR
prerank,BMP binding (GO:0036122),0.3131755763586864,0.7216513314710284,0.7980198019801981,0.9838054519755349,1.0,1/11,2.58%,NBL1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.26406960341910035,0.7176278527244965,0.8591304347826086,0.9857637967808563,1.0,1/24,0.82%,CMPK2
prerank,ATPase regulator activity (GO:0060590),0.2390502857402744,0.7165028793571919,0.8907563025210085,0.9843562454604019,1.0,11/38,18.88%,SIL1;DNAJA2;TOR1AIP1;DNAJC1;FNIP1;ATP1B2;GRPEL1;DNAJB2;ATP5IF1;HSPH1;DNAJB6
prerank,deubiquitinase activity (GO:0101005),0.20621867161591687,0.7160824444489379,0.9398496240601504,0.9819665456283087,1.0,30/88,24.11%,USP18;USP27X;STAMBP;USP24;USP9X;USP8;USP47;STAMBPL1;MYSM1;USP40;USP35;USP34;USP36;USP45;USP12;USP15;USP32;USP10;JOSD1;USP39;BRCC3;USP4;USP7;PAN2;USP26;ZC3H12A;OTUD5;USP19;USP25;OTUD7B
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.28916087308280475,0.7129043420522849,0.8076923076923077,0.9830250408646182,1.0,2/15,11.22%,AGPAT4;AGPAT3
prerank,phosphatidate phosphatase activity (GO:0008195),-0.2852498754673324,-0.7084729219495299,0.8526315789473684,0.9746217530615126,1.0,6/13,18.89%,PLPPR1;PLPP5;PLPP1;PLPPR2;LPIN3;PLPPR5
prerank,histone deacetylase activity (GO:0004407),0.2699797855215228,0.7060889705803353,0.8474264705882353,0.9878126646705029,1.0,3/19,6.29%,MIER3;MIER1;HDAC4
prerank,omega peptidase activity (GO:0008242),0.20298907229644325,0.7030305483405145,0.9610778443113772,0.9885475984323924,1.0,31/89,24.11%,USP18;USP27X;STAMBP;USP24;USP9X;USP8;USP47;STAMBPL1;MYSM1;USP40;USP35;USP34;USP36;USP45;USP12;USP15;USP32;USP10;JOSD1;USP39;BRCC3;USP4;USP7;APEH;PAN2;USP26;ZC3H12A;OTUD5;USP19;USP25;OTUD7B
prerank,thioesterase binding (GO:0031996),0.31256644324659805,0.7022023432640658,0.8432539682539683,0.9865910306640959,1.0,1/11,3.10%,TRAF5
prerank,FMN binding (GO:0010181),0.30587511895999436,0.7015551945612062,0.8093385214007782,0.9845280007049948,1.0,3/11,13.81%,POR;NOS2;HAO1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.3039738841107412,0.6993237689537286,0.8290441176470589,0.9843147800063922,1.0,12/12,69.63%,GEMIN5;CYFIP2;CYFIP1;LARP1;NCBP3;AGO2;EIF4E2;EIF4E3;NCBP2;NCBP1;EIF4E;DCPS
prerank,chloride channel regulator activity (GO:0017081),0.28825185537254794,0.6992052497310863,0.8503787878787878,0.9816660778960378,1.0,3/14,14.08%,WNK4;STX8;WNK1
prerank,gamma-tubulin binding (GO:0043015),-0.24195516437721137,-0.6962600827002527,0.8811659192825112,0.9840241233642931,1.0,8/22,24.37%,PAK1;DIXDC1;ARHGEF7;BRCA2;RAB11FIP5;CDK5RAP2;RACGAP1;TUBGCP3
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.22038217294900098,0.6948178749821214,0.9006410256410257,0.9835618271192058,1.0,5/49,6.86%,ZFAND6;IKBKE;OPTN;DZIP3;PARP10
prerank,adenyl nucleotide binding (GO:0030554),-0.2879095791437643,-0.6938941500877404,0.8622047244094488,0.9788578249573829,1.0,5/11,24.79%,BAG1;HSPBP1;GRPEL2;BAG4;PFN1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.2879095791437643,-0.6938941500877404,0.8622047244094488,0.9788578249573829,1.0,5/11,24.79%,BAG1;HSPBP1;GRPEL2;BAG4;PFN1
prerank,ribonuclease activity (GO:0004540),0.21186045332497752,0.6909539480606507,0.9264705882352942,0.9845978232312633,1.0,16/56,23.79%,PIWIL4;NYNRIN;SND1;SMG6;ENDOU;SLFN14;ZC3H12B;ERN2;EXOSC10;RNASEH1;RNASE3;RNASEL;YBEY;ZC3H12A;KHNYN;RNASEH2A
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.3087999109422975,0.6890458899995475,0.8423153692614771,0.9837826851268828,1.0,2/10,7.52%,DSE;GLCE
prerank,death receptor binding (GO:0005123),-0.26413268259344724,-0.6871325971519068,0.8875,0.9813652046545649,1.0,7/15,30.17%,DAB2IP;NGF;TMBIM1;NTF3;MYD88;FADD;PIDD1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.2765433439093268,0.6866350216810895,0.8657844990548205,0.9834314420374893,1.0,4/17,13.63%,DPYD;PTGR1;LBR;PECR
prerank,DNA polymerase binding (GO:0070182),-0.24928459889853635,-0.6854571770695559,0.8851351351351351,0.9794098250942601,1.0,4/18,16.12%,HMGB1;HSP90AB1;HSP90AA1;RAD51
prerank,protein kinase regulator activity (GO:0019887),0.19307071626916664,0.6834234313321801,0.962043795620438,0.9839736709773637,1.0,5/95,5.19%,CXCL10;PRKAG2;PARVA;TAOK3;CCND3
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.27168260635492225,-0.6820162427017414,0.8739495798319328,0.9787590833583385,1.0,6/13,24.52%,ZGRF1;DICER1;GEN1;ENDOV;FAN1;EXO1
prerank,serine-type endopeptidase activity (GO:0004252),0.1993322862365364,0.6818223101973261,0.9417910447761194,0.9827347615296014,1.0,7/80,12.97%,DPP4;CORIN;CTSH;ACR;PLAU;CELA1;PLAT
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.22276153302415033,-0.6814103344342166,0.9047619047619048,0.9758068886260459,1.0,5/26,15.86%,CSGALNACT1;B3GNT2;CHSY3;B3GNT9;B3GALNT2
prerank,tRNA binding (GO:0000049),0.2209643286300233,0.6800761352953631,0.9173290937996821,0.9818327595386388,1.0,10/43,16.09%,TERT;SEPSECS;PUS1;CTU1;TRNAU1AP;TRMT10B;TRNT1;ALKBH1;MRPS27;SSB
prerank,ribosome binding (GO:0043022),0.21650057552675622,0.6789900350904221,0.9246231155778895,0.9802011307103465,1.0,11/46,16.03%,SRP68;SBDS;CPEB1;NAA16;NAA15;SLFN14;EFL1;GEMIN5;MRPS27;CPEB3;SRP19
prerank,Hsp70 protein binding (GO:0030544),-0.2152118829908514,-0.6786852216297742,0.9216589861751152,0.9745208520166148,1.0,16/31,42.21%,SNCA;RPS3;NOD2;GPR37;SACS;PACRG;DNAJA1;MVD;METTL21A;IQCG;CYP2E1;TSC1;DNAJC8;CYP1A1;FICD;HDAC8
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.2957245671193347,0.6783912481163228,0.8333333333333334,0.9780981826049524,1.0,4/12,21.06%,NOCT;PAN3;PARN;PAN2
prerank,ATP hydrolysis activity (GO:0140603),0.22284092687964313,0.6765339557769885,0.919672131147541,0.9771485426377272,1.0,2/41,1.89%,RNF213;ABCA4
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.28905990694665873,-0.6752176498875451,0.8861283643892339,0.973932154427246,1.0,5/10,30.98%,ANKRD13A;ANKRD13B;FAN1;LAPTM5;FAAP20
prerank,ubiquitin-specific protease binding (GO:1990381),-0.23928520642068343,-0.6739915726280513,0.9057815845824411,0.971457357564739,1.0,4/19,14.75%,RAD23A;SART3;BAG6;PARK7
prerank,four-way junction DNA binding (GO:0000400),0.26709218998861955,0.6738952105440341,0.8759259259259259,0.9770783609299132,1.0,3/17,13.33%,WRN;FANCM;RAD51B
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.2546476153070301,0.6683747205686565,0.8754646840148699,0.979438654693017,1.0,9/20,25.86%,USP9X;USP47;SENP3;SENP1;USP7;OTUD5;USP25;SENP2;DESI2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.24957076539351783,0.6676210609963444,0.8920863309352518,0.9774571209346136,1.0,3/22,6.86%,IKBKE;OPTN;PARP10
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.2602303008641126,-0.6646713767257989,0.8925438596491229,0.9755396488545636,1.0,2/12,9.20%,H3-3A;HDAC1
prerank,hydro-lyase activity (GO:0016836),-0.19458585363674852,-0.664189523742894,0.9515738498789347,0.9723928626249083,1.0,8/41,16.00%,CA4;CA2;PARK7;FAHD2A;ENO1;HACD3;APIP;CYP2S1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.27691854086559486,-0.6622612262820045,0.8755186721991701,0.9703295132754515,1.0,5/11,39.60%,RDH11;DHRS13;RDH12;ALDH3A1;RDH13
prerank,microtubule plus-end binding (GO:0051010),0.2594215096473539,0.6621834178776639,0.9079189686924494,0.979501210892297,1.0,7/20,23.17%,CLASP1;CLIP4;FBXW11;TTBK2;MAPRE3;CLIP3;MAPRE2
prerank,O-methyltransferase activity (GO:0008171),-0.285265435666178,-0.6597025649303945,0.8736842105263158,0.9688693859728313,1.0,3/10,22.46%,ASMT;FTSJ3;COQ3
prerank,RNA cap binding (GO:0000339),0.26681620262692757,0.6532297244115722,0.8858695652173914,0.9842144213421008,1.0,5/16,25.93%,LSM1;GEMIN5;CYFIP2;CYFIP1;LARP1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.29275290788455305,0.6497602186902194,0.8645038167938931,0.9844856442713866,1.0,5/10,31.06%,ECHDC3;HADHA;ECHS1;ECHDC2;HSD17B4
prerank,3'-5' exonuclease activity (GO:0008408),0.2086083191507429,0.6382278930988544,0.9488054607508533,0.9905649013179124,1.0,11/45,16.69%,WRN;RAD50;POLG;EXD1;NOCT;DIS3L;USB1;RAD9A;DIS3;EXOSC10;ERI3
prerank,ATPase binding (GO:0051117),0.18855205371767444,0.6343525052667379,0.9827586206896551,0.9908203911886729,1.0,17/71,18.96%,TMTC4;SLC26A9;PTPN3;SNTA1;TOR1AIP1;TRPC1;ATP1B2;TCIRG1;ABCA1;CHMP4A;ATP6V1E1;PKD2;TAF9;NUFIP1;ATP5IF1;ANK2;PGR
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.24356372120234443,-0.6282699342469479,0.9262295081967213,0.9871574460373622,1.0,9/14,51.21%,PRORP;RPP30;POP7;TSEN34;ELAC2;RPP21;POP1;RPP40;POP5
prerank,death receptor activity (GO:0005035),0.27308940370401585,0.62410934451654,0.9054325955734407,0.9950492786547718,1.0,2/11,7.89%,NGFR;TNFRSF14
prerank,sequence-specific mRNA binding (GO:1990825),0.27789348913104395,0.6204373656591666,0.9031620553359684,0.9949174861406676,1.0,5/10,30.61%,SSB;SHFL;DHX9;ETF1;FMR1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.21458756849147742,0.618830953780984,0.9381625441696113,0.9934282006377398,1.0,13/33,25.20%,DCP2;NOCT;XRN1;DIS3L;USB1;DIS3;EXOSC10;ERI3;PARN;PAN2;PNPT1;ANGEL1;EXOSC5
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.24232569662545417,-0.6097686420589967,0.9163179916317992,0.9945473038090924,1.0,10/12,53.73%,GPR88;RRH;OPN1MW3;OPN1MW;ELOVL4;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,transaminase activity (GO:0008483),0.27433247524229487,0.6082200863943789,0.8907407407407407,0.9973678210427471,1.0,3/11,22.27%,ABAT;AGXT;PSAT1
prerank,RNA methyltransferase activity (GO:0008173),-0.2177711461137139,-0.6007872443770639,0.9375,0.9955066589065326,1.0,9/19,42.03%,TRMT13;FTSJ3;TRMT9B;METTL8;BCDIN3D;FBL;TRDMT1;FBLL1;METTL4
prerank,snRNA binding (GO:0017069),0.19592164314132843,0.5975696993761433,0.9764150943396226,1.0,1.0,6/42,16.30%,RBM41;SNRPA1;SF3B3;RNPC3;GEMIN5;DDX21
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.17656237798739427,-0.5926675493916371,0.9902439024390244,0.9959543673809335,1.0,19/42,37.68%,CCND1;CNPPD1;CDKN1A;CCNF;CCNG1;CCNC;CCNK;HEXIM2;CCNE2;CDK5R2;CCNE1;CCNQ;CDKN2D;INCA1;CKS1B;CCNB2;CCNT1;CCNA2;CCNB1
prerank,mRNA methyltransferase activity (GO:0008174),0.24784983363676302,0.5777363307588249,0.9580952380952381,1.0,1.0,12/12,75.23%,METTL16;PCIF1;CMTR1;METTL3;CMTR2;TRMT61B;NSUN2;RNMT;TRMT61A;METTL14;TRMT10C;METTL8
prerank,GABA receptor binding (GO:0050811),0.25045780978736115,0.5737462145810309,0.9152215799614644,1.0,1.0,2/11,11.93%,TRAK1;JAKMIP1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.24317047223516033,0.5708012042637729,0.9505494505494505,1.0,1.0,5/13,24.33%,TRMT10B;THUMPD3;FTSJ1;METTL1;TARBP1
prerank,microtubule minus-end binding (GO:0051011),0.23982766955066157,0.5703029183353547,0.9401544401544402,1.0,1.0,3/13,15.11%,TUBGCP4;TUBGCP2;TUBGCP5
prerank,5'-nucleotidase activity (GO:0008253),0.24019766280360066,0.5692589324369951,0.9531531531531532,1.0,1.0,2/13,10.23%,NT5C;NT5DC1
prerank,vitamin D receptor binding (GO:0042809),-0.2184792199822672,-0.5607069218699922,0.9748858447488584,1.0,1.0,3/14,17.25%,MED30;TAF11;RXRA
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.19893204768020212,-0.5600751737957333,0.9736842105263158,1.0,1.0,1/21,1.20%,GRIK2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.1852045213390058,0.5595580814841916,0.988013698630137,1.0,1.0,13/40,24.33%,HNMT;RRP8;COMT;THUMPD3;AS3MT;DNMT3A;PEMT;CARNMT1;LRTOMT;ICMT;METTL2A;METTL2B;TARBP1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.22556641412540815,-0.5572321666200379,0.9711934156378601,0.9994964069844943,1.0,7/11,42.81%,RPS3;HMCES;NEIL2;APEX1;APLF;NEIL1;NEIL3
prerank,nucleotidase activity (GO:0008252),-0.20554442773489717,-0.5544420799345224,0.963718820861678,0.9969195600957813,1.0,4/15,19.75%,BPNT2;NT5C2;NT5C3A;ACP3
prerank,exoribonuclease activity (GO:0004532),-0.22075968547106753,-0.5463939715562871,0.9478957915831663,0.9959297284330203,1.0,7/12,45.39%,EXOSC2;EXOSC4;EXOSC1;EXOSC3;EXOSC8;EXOSC9;CNOT7
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.2412946255199359,0.5461063152638234,0.9462151394422311,1.0,1.0,2/10,15.46%,CDKN2B;KAT2B
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.22078408321679624,-0.5459926869757646,0.9599198396793587,0.992566297101842,1.0,6/11,35.10%,NUDT16L1;NUDT3;NUDT16;DCPS;NUDT11;NUDT1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.23812061230788611,0.5446693234133894,0.9509803921568627,1.0,1.0,1/10,7.26%,B4GALT1
prerank,nuclear export signal receptor activity (GO:0005049),-0.22425358910058557,-0.5383754361336993,0.9635974304068522,0.9913817679762207,1.0,4/11,27.78%,XPO7;XPO1;NUP42;XPO6
prerank,N-acyltransferase activity (GO:0016410),0.18282737365202598,0.5260091842259647,0.9867768595041322,1.0,1.0,2/32,4.30%,CERS6;CERS5
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.20675599331066802,-0.5234911191872239,0.973630831643002,0.9916990460333304,1.0,6/12,41.45%,NDUFS7;AIFM2;CRYZ;NQO1;CBR4;CBR1
prerank,endodeoxyribonuclease activity (GO:0004520),-0.18258166337623333,-0.5196841419883336,0.9912280701754386,0.9890648906793856,1.0,8/20,31.40%,RPS3;MRE11;DCLRE1C;ENDOV;EXO1;APEX1;ENDOG;FEN1
prerank,antiporter activity (GO:0015297),0.19752491007667766,0.5177588065336503,0.9802513464991023,1.0,1.0,4/20,15.14%,SLC35D1;SLC35D2;SLC35C1;SLC25A10
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.22945043856124575,0.511627637910892,0.9701195219123506,1.0,1.0,4/11,25.44%,SLC22A4;SLC22A3;SLC25A20;SLC25A29
prerank,ubiquitin binding (GO:0043130),0.14971654426383807,0.5058559793081203,0.9984871406959153,1.0,1.0,2/73,3.40%,SMAD3;NEDD4
prerank,purinergic nucleotide receptor activity (GO:0001614),0.2025790605848315,0.4944914713926215,0.974609375,1.0,1.0,3/15,16.77%,P2RX1;P2RY1;P2RX4
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.15646565178327526,0.4609418804533387,0.9983079526226735,1.0,1.0,11/35,27.21%,FTO;TRPT1;DTWD1;ALKBH1;TYW3;PUS10;FTSJ1;DUS3L;QRSL1;QTRT1;GATB
prerank,methyltransferase activity (GO:0008168),0.1491661156585257,0.459892682332753,1.0,1.0,1.0,8/46,19.01%,METTL27;AMT;RRP8;COMT;AS3MT;MGMT;CARNMT1;LRTOMT
prerank,glutathione transferase activity (GO:0004364),0.1686438347744056,0.45368621376715723,0.9928571428571429,1.0,1.0,2/23,11.83%,GSTK1;GSTA3
prerank,tRNA methyltransferase activity (GO:0008175),0.17459208101431678,0.43509447617067665,0.9963636363636363,1.0,1.0,6/16,24.33%,THUMPD3;TYW3;FTSJ1;METTL2A;METTL2B;TARBP1
prerank,N-acetyltransferase activity (GO:0008080),0.15646021036754915,0.41081876287076063,0.9982142857142857,1.0,1.0,3/19,15.46%,ESCO1;NAT2;KAT2B
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.17658505963590732,0.40876801603715207,0.996116504854369,0.9980338525787641,1.0,11/11,82.35%,CHRNA5;CHRNB1;CHRNB2;CHRNA10;CHRNA2;CHRNA1;CHRNB4;CHRNA3;CHRNA9;CHRNA7;CHRNA4
prerank,ribonuclease P RNA binding (GO:0033204),-0.15808891577708573,-0.3770466697816399,1.0,0.9995816029792635,1.0,6/10,51.21%,RPP30;POP7;RPP21;POP1;RPP40;POP5
